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Summary 
In the adult central nervous system (CNS), injured axons have limited ability to 
regenerate. This regenerative failure is accounted in part by the fact that upon 
lesion, an inhibitory glial scar is formed. Besides, injured CNS neurons are not 
able to mount a regenerative program and express the genes needed to promote 
axonal elongation. In contrast, in the peripheral nervous system (PNS), axons are 
able to regenerate given the efficient Wallerian degeneration, the removal of 
inhibitory molecules by Schwann cells and macrophages, and the ability to 
express regeneration-associated genes as a response to the retrograde transport 
of injury signals. 
In this Thesis we aimed at further dissecting mechanisms related to the 
failure of axonal regeneration in the CNS namely: i) the inhibitory action of 
different myelin components; ii) the retrograde transport of injury signals and iii) 
the anterograde transport of regeneration enhancers.  
Most of the inhibitory molecules identified following CNS injury are myelin-
associated proteins and chondroitin sulphate proteoglycans. By using shiverer 
mice, we aimed at further unraveling the importance of myelin during axonal 
regeneration, as this model lacks compact myelin in the CNS. Although shiverer 
mice displayed a standard glial scar, an increased axonal regeneration and 
sprouting was observed after spinal cord injury. In vitro, we demonstrated that 
besides myelin proteins, myelin lipids, that are severely decreased in the shiverer 
spinal cord, specifically cholesterol and sphingomyelin, were inhibitory for axon 
outgrowth through a mechanism involving Rho activation. In vivo, and supporting 
the importance of myelin lipids in repressing axonal regeneration, 2-
hydroxypropyl-β-cyclodextrin, a drug that reduced lipid levels in the injury site, 
promoted axonal regeneration following spinal cord injury. In summary, our work 
supports that myelin lipids should be considered together with myelin proteins as 
targets to improve axonal growth following injury.  
ERK, JNK and STAT-3 are positive injury signals that trigger a regenerative 
response following PNS lesion. To further understand the importance of injury 
signaling, we used dorsal root ganglia (DRG) neurons that comprise a central 
branch that does not regenerate and a peripheral branch that regrows after 
lesion. Whereas injury to the central branch of DRG neurons also led to activation 
and retrograde transport of ERK, JNK and STAT-3, only injury to the peripheral 
branch was able to elicit a gain in intrinsic growth capacity. By analysis of dynein-
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bound axoplasm proteins through antibody microarrays following either 
peripheral or central branch injury, a broad differential activation and transport of 
signals after each injury type was observed. From these, increased levels of Hsp-
40, ROCK-II and GSK3β after central branch injury were identified not only in the 
axoplasm but also in DRG cell bodies. In summary, activation and transport of 
canonical positive injury signals is not sufficient to increase intrinsic growth 
capacity, and limited regenerative response may be accounted by activation of 
inhibitory injury signals including ROCKII and GSK3β. 
To study the anterograde transport of regeneration enhancers, in vivo 
radiolabeling of DRG neurons coupled to mass spectrometry and kinesin 
immunoprecipitation of spinal cord extracts was performed. Following peripheral 
conditioning lesion, increased intrinsic growth capacity was accompanied by 
increased anterograde transport of cytoskeleton components, metabolic enzymes 
and potential axonal regeneration enhancers, in the central branch of DRG 
neurons. Changes in axonal transport induced by peripheral conditioning were 
broad including mitochondria, lysosomes and synaptic vesicles. In summary, a 
peripheral injury induces a global increase in axonal transport that by extending 
to the central branch, allows a rapid and sustained support of regenerating 
central axons. 
Overall, in this Thesis we contributed to: i) characterize cholesterol and 
sphingomyelin as novel axonal regeneration inhibitors; ii) identify ROCK-II and 
GSK3β as repressors of axonal regeneration that are linked to the retrograde 
transport machinery and iii) identify augmented axonal transport as a key feature 
of the increased regeneration ability produced after a peripheral conditioning 
injury. 
 
 
 
  Sumário 
15 
 
Sumário 
No sistema nervoso central (SNC), após lesão os axónios têm pouca capacidade 
de regeneração. Este facto deve-se à formação de uma cicatriz glial inibitória após 
lesão. Além disso, os neurónios do SNC não são capazes de produzir uma 
resposta regenerativa e expressar os genes necessário à regeneração quando 
lesionados. Pelo contrário, no sistema nervoso periférico (SNP), os axónios são 
capazes de regenerar devido a uma eficiente degeneração Walleriana onde há a 
remoção de moléculas inibitórias pelas células de Schwann e macrófagos, e 
devido ainda à sua capacidade para expressar genes associados à regeneração 
como resposta ao transporte retrogrado de sinais positivos de regeneração. 
Nesta Tese, os nossos objectivos foram desvendar mecanismos 
relacionados com a ausência de regeneração após lesão no SNC nomeadamente: 
i) a acção inibitória de diferentes componentes da mielina; ii) o transporte 
retrogrado de sinais de regeneração e iii) o transporte anterogrado de 
potenciadores de regeneração. 
A maior parte das moléculas inibitórias identificadas após lesão no SNC 
são proteínas associadas à mielina e proteoglicanos de sulfato de condroítina. 
Usando ratinhos shiverer procuramos perceber a importância da mielina na 
regeneração axonal, uma vez que este modelo não apresenta mielina compacta 
no SNC. Apesar de os ratinhos shiverer formarem uma cicatriz glial semelhante a 
ratinhos selvagens, observamos que os seus axónios têm maior capacidade de 
regeneração e maior plasticidade após uma lesão na espinal medula. In vitro, 
mostrámos que além das proteínas da mielina, os seus lípidos que estão bastante 
diminuídos na espinal medula de ratinhos shiverer, especificamente colesterol e 
esfingomielina, são inibitórios para o crescimento axonal por um mecanismo 
dependente na activação de Rho. Suportando o facto de os lípidos da mielina 
serem inibidores da regeneração axonal, o uso in vivo de 2-hidroxipropil-β-
ciclodextrina, um fármaco capaz de reduzir a quantidade de lípidos acumulada na 
zona lesionada, aumentou a regeneração axonal após lesão na espinal medula. 
Em suma, o nosso trabalho mostra que além das proteínas da mielina, os seus 
lípidos também deveriam ser considerados alvos para promover regeneração 
axonal após lesão.  
ERK, JNK e STAT-3 são sinais positivos de regeneração que são activados 
após lesão no SNP e desencadeiam uma resposta regenerativa. Para melhor 
compreender a importância dos sinais de regeneração, usámos neurónios dos 
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gânglios da raiz dorsal que possuem um ramo central que não é capaz de 
regenerar e um ramo periférico que regenera quando lesionado. Apesar de uma 
lesão no ramo central dos neurónios dos gânglios da raiz dorsal também levar à 
activação e transporte retrogrado de ERK, JNK e STAT-3, apenas a lesão no ramo 
periférico é capaz de promover um aumento na capacidade regenerativa desses 
neurónios. A análise através de um microarray de anticorpos das proteínas 
axoplasmáticas ligadas à dineína após lesão no ramo periférico ou central 
permitiu a identificação de alterações extensas na activação e transporte de sinais 
de lesão. Destes, podemos destacar um aumento de Hsp-40, ROCK-II e GSK3β 
após lesão no ramo central, não apenas no axoplasma, mas também no corpo 
celular dos neurónios dos gânglios da raiz dorsal. Em suma, a activação e 
transporte de sinais positivos de lesão não é suficiente para aumentar a 
capacidade intrínseca de regeneração dos neurónios. A baixa capacidade 
regenerativa poderá também ser devida à activação de sinais de lesão inibitórios 
como ROCK-II e GSK3β. 
Para estudar o transporte anterogrado de potenciadores de regeneração, 
os neurónios dos gânglios da raiz dorsal foram marcados com radioactividade in 
vivo e posteriormente amostras de espinal medula foram analisadas por 
espectrometria de massa e imunoprecipitação de quinesina. Após lesão periférica 
condicionante, o aumento na capacidade intrínseca de regeneração foi 
acompanhada por um aumento do transporte anterogrado de componentes do 
citoesqueleto, enzimas metabólicas e possíveis potenciadores de regeneração no 
ramo central dos neurónios dos gânglios da raiz dorsal. As alterações no 
transporte axonal despoletadas por uma lesão periférica condicionante foram 
bastante extensas e incluem aumento no transporte de mitocôndrias, lisossomas 
e vesiculas sinápticas. Em suma, uma lesão periférica condicionante induz um 
aumento global no transporte axonal no ramo central dos neurónios dos gânglios 
da raiz dorsal, que permitem uma resposta regenerativa rápida e continuada. 
Globalmente, nesta tese nós contribuímos para: i) a caracterização o 
colesterol e esfingomielina como novos inibidores de regeneração; ii) a 
identificação de ROCK-II e GSK3β como estando ligados à maquinaria de 
transporte retrogrado levando à repressão da regeneração axonal e iii) a 
identificação do aumento do transporte axonal como uma característica 
fundamental para o aumento da capacidade regenerativa produzida por uma 
lesão condicionante periférica. 
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Abbreviation list 
5HT  5-hydroxytyptamine 
9CPA  9-cyclopentyladenine 
aCSF  Artificial CSF 
ALS  Amyotrophic lateral sclerosis 
AKT  Protein kinase B 
APC  Anaphase promoting complex 
Arg-1  Arginase 1 
ATF-3  Activating transcription factor 3 
ATP  Adenosine-5'-triphosphate 
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CNS  Central nervous system 
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CRMP-2 Collapsin response mediator protein 2 
Csk  C-terminal Src kinase 
CSPG  Chondroitin sulfate proteoglycans 
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CST  Corticospinal tract 
CTB  Cholera toxin B 
db-cAMP  Dibutyryl cyclic adenosine monophosphate 
DLK  Dual leucine zipper kinase 
DREZ  Dorsal root entry zone 
DRG  Dorsal root ganglia 
DRI  Dorsal root injury 
ECM  Extracellular matrix 
EGL  External plexiform layer 
Elk-1  E twenty-six like transcription factor 1 
ERK  Extracellular signal regulated kinase 
ESCs  Embryonic stem cells 
GalCer Galactocerebroside 
GAP-43 Growth associated protein 43 
Gb4  Globotetrahexosylceramide 
GDNF  Glial-derived neurotrophic factor 
GFAP  Glial fibrillary acidic protein 
GM1   Ganglioside GM1 
GS  Sulfatide 
GSK3β Glycogen synthase kinase 3 beta 
HPβCD 2-hydroxypropyl-β-cyclodextrin 
HDAC5 Histone deacetylase-5 
HPRT  Hypoxanthine-guanine phosphoribosyltransferase 
HPTLC High-performance thin-layer chromatography 
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IGL  Inner granule layer 
IL-1α  Interleukin-1α 
IL-6  Interleukin-6 
IL-10  Interleukin-10 
JNK  c-Jun N-terminal kinases 
Lac  Lactocerebroside 
LIF  Leukemia inhibitory factor 
MAG  Myelin associated glycoprotein 
MAIs  Myelin associated inhibitors 
MAP1b Microtubule-associated protein 1B 
MAPKKK Mitogen-activated protein kinase kinase kinase 
MBP  Myelin basic protein 
MCP-1 Monocyte chemoattractant protein-1 
MHC-II Major histocompatibility complex II 
mRNA  Messenger RNA 
MSC  Bone marrow stromal cells 
mTOR  Mammalian target of rapamycin 
NCAM  Neural cell adhesion molecule 
NFIL3  Nuclear factor, interleukin 3 regulated 
NGF  Nerve growth factor 
NgR  Nogo-66 receptor 
NLS  Nuclear localization signal 
Npc1  Niemann-Pick type C1 
NPY  Neuropeptide Y 
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NSCs  Neural stem cells 
NT-3  Neurotrophin 3 
NT-4  Neurotrophin 4 
OEC  Olfactory ensheating cells 
OMgp  Oligodendrocyte myelin glycoprotein 
PC  Phosphatidylcholine 
PE  Phosphatidylethanolamine 
PI  Phosphatidylinositol 
PI3K  Phosphoinositide 3-kinase 
Plk3  Polo-like kinase 3 
PNS  Peripheral nervous system 
PS  Phosphatidylserine 
PTEN  Phosphatase and tensin homologue 
RAGs  Regeneration associated genes 
RGM  Repulsive Guidance Molecules 
RhoGDI Rho GDP dissociation inhibitor 
ROCK   Rho-associated kinase 
SEMA-3 Class 3 semaphorins 
Shi  Shiverer 
Smad1 Mothers against decapentaplegic homolog 1 
SOCS-3 Suppressor of cytokine signaling 3 
Sox11  sex determining region Y-box 11 
SCa  Slow component a 
SCb  Slow component b 
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SCI  Spinal cord injury 
SNI  Sciatic nerve injury 
SpH  Sphingomyelin 
Src  Proto-oncogenic cytoplasmic tyrosine kinase 
STAT-3 Signal transducer and activator of transcription 3 
Syd  Sunday Driver 
TG  Triglycerides 
TNF-α  Tumor necrosis factor-α 
TNFR  Tumor necrosis factor receptor 
TTR  Transthyretin 
UTR  Untranslated regions 
Vip  Vasointestine peptide 
Wld
s
  Slow wallerian degeneration 
WT  Wild type 
ZBP-1  Zipcode-binding protein-1 
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1. Historic perspective on axonal regeneration 
For many years, the nervous system was seen as unalterable following 
maturation. Axonal elongation of central nervous system (CNS) axons was 
thought to be exclusive of the development stage. Ramon y Cajal made the first 
descriptions on axonal regeneration of peripheral nerves by the end of the XIX 
century, and went on to characterize the abortive regeneration of CNS axons both 
in spinal cord and in the cerebral cortex (Ramon y Cajal and May, 1928).  
Ramon y Cajal described the peripheral nerve as an environment that could 
guide and fuel the regrowth of the injured axons. In his own words: “the great 
influence that the proximity of the peripheral stump has on the growth and 
orientation of the outgrowing newly formed fibers. We believe it likely that this 
action is exercised through ferments or stimulating substances formed by the 
rejuvenate Schwann cells of the distal stump poured out by the regions near the 
scar. These substances have not only an orienting function, but they are also 
trophic in character, since the sprouts that have arrived at the peripheral stump 
are robust, show a great capacity for ramification and grow straight to their goal 
without vacillations, as though they were following an irresistible attraction” 
(Ramon y Cajal and May, 1928) (Fig. 1, left image). This description points out the 
importance of Schwann cells in the regenerative process, and indeed, the ability 
of Schwann cells to dedifferentiate and support regeneration following injury is 
one of the most important features of peripheral nervous system (PNS) 
regeneration (Vargas and Barres, 2007; Gaudet et al., 2011). He then described 
the difficulty of CNS axons to regenerate, where only in young animals a small 
and limited ability to regenerate is found: “For our part, by dint only of persistent 
explorations were we able, finally, to discover unquestionably active production 
of new fibers, although ephemeral and, therefore, frustrated. Such vicarious 
sprouting is exclusively observed in young animals (cat and dog of ten to twenty 
days) and at the levels of the varicosities along the trajectories at the terminal 
clubs of the axons interrupted inside the white matter (central stumps). Two main 
varieties are presented: 
a. From a thick, terminal (retraction ball) or en passant varicosity arise several 
fine and pale radiations that get lost in the neighboring territories where 
they ramify and end in a pale tip. Because it evokes the shape of the 
tortoise, I named such a singular disposition the testudinoid apparatus. 
Introduction 
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b. At the frontiers of a necrosed axon segment, the surviving neurofibrils of 
the neighboring varicosity enter into active proliferation, generating certain 
tufts of small branches that invade the dead protoplasm, where they end 
my means of boutons or rings. Because of its shape which somewhat 
recalls that of the cuttlefish, I baptized such an unusual disposition with 
the name of cephalopodic apparatus” (Ramon y Cajal and May, 1928) (Fig. 
1 right image). 
 
Figure 1. Ramon y Cajal drawings of peripheral and central nervous system injuries. Left: injured 
sciatic nerve. In the left nerve, both ends are kept together, allowing axonal regrowth to the distal 
portion, while in the right nerve, the gap created does not allow axonal regrowth. Right: injured 
spinal cord displaying scar tissue and absence of axonal growth through the formation of retraction 
bulbs. Adapted from (Ramon y Cajal and May, 1928). 
 
Although many advances have been made in the axonal regeneration field, 
and despite that several molecular mechanisms underlying axonal growth have 
been dissected, the general view has not changed greatly since the first 
descriptions by Ramon y Cajal. To date, despite of the several ongoing clinical 
trials, still only very limited axonal regeneration is achieved in the CNS. As such, 
new studies to understand and improve regeneration of CNS axons are of the 
utmost importance. 
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2. Axonal elongation during development  
During development, axonal elongation occurs both in PNS and CNS. During this 
process, neurons express a genetic program that allows a robust elongation and 
the correct interpretation of the guidance cues to reach their post-synaptic 
targets (Polleux and Snider, 2010). In many ways, regeneration can be viewed, at 
least in part, as a recapitulation of the developmental process, since axons need 
to regrow towards their targets. Axonal elongation declines during development 
due to loss of the neuronal intrinsic ability to elongate (Cai et al., 2001; Goldberg 
et al., 2002). As such, the developing nervous system has been used as a model 
to identify genes that may be crucial for the control of axon elongation (Moore et 
al., 2009). 
Throughout development, neural progenitor cells divide asymmetrically, 
giving rise to a new progenitor daughter cell and a neuron. The newborn 
unpolarized neurons start migrating to their final destination. During this 
process, neurons become polarized forming an axon and a leading process that 
later will form the dendrites (Barnes and Polleux, 2009) (Fig. 2). 
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Figure 2. Pattern of the in vivo neuronal polarization and migration of cerebellum granule neurons 
(CGN) and pyramidal cortical neurons. A. Representation of the polarization of the CGN in the 
mammalian cerebellum. The progenitor cells divide rapidly in the external plexiform layer (EGL, 1) 
and upon cell cycle exit, start to adopt a bipolar morphology (2). Then, progenitors migrate 
tangentially with a leading and a trailing process (3). Another process emerges orthogonally from 
the cell body (4), and becomes the leading process, directing migration towards the inner granule 
layer (IGL, 5). The trailing processes form a characteristic T-shaped axon (purple), whereas the 
leading process gives rise to the dendritic domain (green, 6). B. Representation of the radially 
migrating pyramidal neurons in the mammalian neocortex. Neurons are generated between E11 and 
E17 in the ventricular zone by asymmetric division of radial glial progenitors. The progenitor cells 
have a long basal process attached to the basal membrane and a short apical process on the 
ventricle side (1). Upon division (2), the post mitotic neuron (blue) goes through a multipolar 
transition where multiple neurites emerge from the cell body (3), before one major process forms in 
the radial direction and becomes the leading process (4). The neuron initiates a radial migration 
along the radial glial process and leaves behind a trailing process that elongates tangentially in the 
intermediate zone (purple, 5). The cell body continues to migrate towards its final destination (the 
top of the cortical plate), while the axon rapidly elongates (6). The leading process gives rise to the 
apical dendrite (green, 7), which initiates local branching in the marginal zone (until radial 
A 
B 
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migration ends). During the first postnatal week, the cell body will then translocate ventrally (8-9) 
and neurons born at later stages (orange) will bypass them (inside-out accumulation pattern, 10). 
Adapted from (Barnes and Polleux, 2009). 
 
In this stage, neurons possess a high intrinsic ability to elongate. This 
ability is transcription dependent and relies on the activity of several signaling 
pathways, like phosphoinositide 3-kinase (PI3K), phosphatase and tensin 
homologue (PTEN) and glycogen synthase kinase 3 beta (GSK3β) (Barnes and 
Polleux, 2009; Polleux and Snider, 2010). Local protein synthesis and degradation 
also play an important role for correct axonal elongation (Campbell and Holt, 
2001). In this context, the ubiquitin-proteasome system emerged as a key player 
in the control of axon growth during development. 
The ubiquitin ligase anaphase promoting complex (APC) and its activator 
protein, Cdh1 were shown to be important regulators of axon growth during 
development in post-mitotic neurons (Konishi et al., 2004), acting on the nucleus, 
limiting axon growth (Stegmuller et al., 2006). A reduction in Cdh1 in CGN leads 
to an increase in axon length, both in vitro and in vivo (Konishi et al., 2004) which 
is achieved by targeting both SnoN and Id2 for degradation (Lasorella et al., 
2006; Stegmuller et al., 2006). However, it is not clear if upon completion of 
development of the nervous system, Cdh1-APC plays a similar role namely, if it 
limits axon overgrowth in the adult nervous system, or even if it inhibits axonal 
regeneration. 
 
 2.1. Cytoskeletal dynamics in neuron polarization and axonal growth 
Upon formation, the immature neurons polarize, giving rise to one axon and 
several dendrites. Upon polarization, maturation proceeds with axon and dendrite 
elongation (Polleux and Snider, 2010). Most players responsible for axon 
initiation and elongation were identified using in vitro cultures of hippocampal 
neurons, a system where the timeline for polarization and elongation are very 
well defined (Dotti et al., 1988) (Fig. 3). 
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Figure 3. Neuronal polarization of hippocampal neurons in vitro. In dissociated cultures of 
postmitotic hippocampal neurons, stage 1 neurons present an intense lamellipodia and filopodia 
that leads to the emergence of multiple immature neurites, stage 2. Then a critical step occurs, and 
neurons become asymmetric and a single neurite grows rapidly originating the axon (red), stage 3. 
Subsequently there is a rapid elongation of both axon and dendrites (stage 4), and finally neurons 
present dendritic spines and the axonal initial segment. Adapted from (Polleux and Snider, 2010) 
 
The in vitro studies led to the notion that this polarization was mainly due 
to intrinsic neuronal factors. Cytoskeleton dynamics was found to be crucial for 
polarization and growth. In immature hippocampal neurons (stage 2), before 
axon formation, there is local actin destabilization in one of the neurites that will 
then become the axon. The importance of actin stability was shown by the use of 
actin-destabilizing agents like lactrunculin B and cytochalasin D that promoted 
axon formation (Bradke and Dotti, 1999). The local stability of actin is regulated 
by profilin that promotes actin polymerization and cofilin that promotes actin 
depolimerization (Witte and Bradke, 2008). Contrary to actin, during axon 
formation there is microtubule stabilization that is needed for microtubule 
protrusion. In fact, local microtubule stabilization by the application of taxol is 
able to induce axon formation (Witte et al., 2008). GSK3β activity is essential for 
the regulation of microtubule stability. It does so by regulating the activity of 
several microtubule binding proteins like microtubule-associated protein 1B 
(MAP1b), collapsin response mediator protein 2 (CRMP-2) and adenomatous 
polyposis coli protein. 
Besides axonal polarization, cytoskeleton dynamics is also important for 
axonal growth. In fact, microtubule destabilization underlies the formation of a 
retraction bulb, a structure that impedes axonal growth. Furthermore, stabilizing 
microtubules with the use of taxol promotes axonal growth (Erturk et al., 2007). 
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The role of actin dynamics during axonal growth still needs to be further 
addressed. 
 
 2.2. Growth cone, leading the way 
The distal tip of the growing axon, the growth cone, is the structure responsible 
for axonal elongation (Fig. 4). At the growth cone there is the integration of the 
extracellular cues and this structure is responsible for the elongation through the 
correct pathway (Jung et al., 2011). 
 
Figure 4. Growth cone structure. The scheme represents a mature growth cone composed of 
dynamic actin filaments at the periphery, forming the lamellipodia and stable microtubules in the 
axon shaft. Adapted from (Bradke et al., 2012). 
 
Extracellular cues guide growing axons to reach their correct targets (Fig. 
5). Neurotrophins stimulate axonal growth and are required for the transcription 
of genes important for elongation to take place. Although the initial phase of 
axonal growth is independent of neurotrophins, the later stages of axonal growth 
require neurotrophins, and their absence leads to cell death and innervation 
failure (Polleux and Snider, 2010). Besides neurotrophins, during development 
the growth cone is exposed to several guidance cues, like semaphorins, ephrins 
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and netrin (Song and Poo, 1999). The optic nerve formation and development has 
been the typical model to study the importance and the mechanism of action of 
these molecules. It was shown that guidance cues influence developing axons by 
promoting either local protein synthesis (attraction) or degradation (repulsion) 
(Jung et al., 2011).  
 
Figure 5. Action of guidance cues in the growth cone. Attractive guidance cues induce growth cone 
attraction by the stimulation of local protein synthesis (left) and repulsive guidance cues induce 
repulsion by stimulation of protein degradation (right). Adapted from (Jung et al., 2011). 
 
Furthermore, it has been described that the attractive/repulsive behavior of 
the extracellular cues is dependent on the cyclic adenosine monophosphate 
(cAMP): cyclic guanosine monophosphate (cGMP) ratio (Nishiyama et al., 2003). 
Guidance cues can be divided in cAMP- or cGMP- responsive. In the cAMP-
responsive group are included netrin-1, myelin associated glycoprotein (MAG), 
nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), which 
attract axons with high levels of cAMP, and repulse axons with low levels of cAMP 
(Song and Poo, 1999). In the cGMP-responsive group are included semaphorins 
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and neurotrophin-3 (NT-3), which attract axons with high levels of cGMP, but 
repulse axons with low levels of cGMP (Song and Poo, 1999; van Horck et al., 
2004). Since the levels of cAMP vary from development to adulthood, this 
mechanism allows understanding how some molecules that attract axons during 
development become inhibitory in the adult nervous system. 
 
3. Regeneration of PNS axons – axonal regeneration is possible. 
Injured PNS neurons are able to regrow to a significant extent and are often used 
as a model to understand how axonal regeneration can be achieved in the 
nervous system. This regenerative ability is supported by numerous factors that 
can be divided in two categories: extrinsic and intrinsic. The extrinsic factors 
include the role played by the supporting glia and the immune response triggered 
by the injury. The intrinsic factors comprise the ability of the neurons to express 
genes that allow their survival and increase their ability to regrow their axons 
following injury. These are known as regeneration-associated genes (RAGs). Below 
we will discuss in detail the importance of these mechanisms in the successful 
PNS regeneration. 
 
3.1. Extrinsic factors – the importance of Wallerian degeneration 
Wallerian degeneration was first described in 1850 by Augustus Volney Waller 
(Waller, 1850) and comprises all the mechanisms that happen in the distal part of 
the nerves allowing the clearance of the debris and the formation of a favorable 
environment for axonal regeneration to take place (Fig. 6). Although one may 
think that once an axon is cut from the cell body it dies immediately actually, 
following PNS injury, the distal stumps of severed axons are still able to transmit 
action potentials when stimulated (Luttges et al., 1976) and do survive for a few 
days before they start degenerating (Gaudet et al., 2011). In young rats the delay 
between injury and the onset of degeneration is 1 day (Lubinska, 1977) while in 
humans it takes several days for degeneration to occur (Chaudhry and Cornblath, 
1992). The clearance of the distal end of injured nerves is essential to achieve 
axonal regeneration. Below the mechanisms by which myelin and axonal debris 
are cleared will be discussed. 
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Figure 6. Wallerian degeneration. Following PNS injury there is dying back of the distal axons and 
Schwann cell dedifferentiation (2). Then macrophages invade the nerves and together with Schwann 
cells they clear the myelin debris (3). The Schwann cells align forming the bands of Bungner which 
serve as a rail for the regenerating axons (4) culminating in successful regeneration (5).  Adapted 
from (Gaudet et al., 2011). 
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3.1.1. Axonal degeneration and break down. 
Calcium influx is one of the first signals that an injury has occurred. It leads to 
calpain activation which triggers the resealing of the membrane of the injured 
axons (Krause et al., 1994; Howard et al., 1999).  Upon injury, membrane 
disruption promotes a transient calcium influx that activates the intracellular 
signaling responsible for the membrane reseal (Krause et al., 1994) and for local 
protein synthesis (Chierzi et al., 2005). Calcium influx activates calcium-
dependent enzymes including adenylate cyclase, promoting increased cAMP 
levels that signal to the downstream effector dual leucine zipper kinase (DLK) 
promoting cytoskeleton rearrangements needed for growth cone assembly 
(Ghosh-Roy et al., 2010). Besides cytoskeleton rearrangements, local protein 
synthesis and degradation are important for growth cone formation. These 
processes are tightly regulated by the mammalian target of rapamycin (mTOR), 
p38MAPK and caspase-3 (Verma et al., 2005). Following axonal injury, the correct 
formation of a growth cone is a key step leading to axonal regeneration. 
An elegant study using in vivo imaging showed that approximately 20 min 
following injury, both proximal and distal ends suffer 200-300μm fast 
degeneration in a process called acute axonal degeneration. Following this 
process, the proximal end is stabilized and can start regenerating as early as 30h 
after injury, while the distal ends can persist up to 48h before starting to 
degenerate (Kerschensteiner et al., 2005). 
At the distal part of injured axons, the first visible sign of injury is the 
axonal membrane beading and swelling. The mechanisms by which the beading 
and swelling occur are independent of calcium and of the ubiquitin-proteasome 
system, since they are not inhibited by calcium chelators or by ubiquitin-
proteasome inhibitors (George et al., 1995; Zhai et al., 2003). These 
morphological changes occur before the onset of cytoskeleton disintegration, a 
process called granular disintegration of the axonal cytoskeleton where the 
microtubules and neurofilaments are dismantled leading to axonal fragmentation 
(Gaudet et al., 2011). This process is calcium and ubiquitin-proteasome system-
dependent, and it can be inhibited by blocking the ubiquitin-proteasome system 
(Zhai et al., 2003) or by blocking the ion-sensitive protease calpain (George et al., 
1995). These two mechanisms have different roles. The ubiquitin-proteasome 
system disassembles microtubules, while the calcium-activated calpain response 
secures neurofilament degradation. Once this process starts, the complete 
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destruction of the cytoskeleton components into fine debris is completed in one 
hour (George et al., 1995; Beirowski et al., 2005; Kerschensteiner et al., 2005). 
The degenerative process was initially envisaged as a passive process, 
where axons died given the lack of connectivity to the cell body. It is now known 
that it is an active process, intrinsic to the axons that can be controlled and 
delayed. This paradigm shift has emerged with the studies in the slow wallerian 
degeneration (Wld
s
) mouse (Perry et al., 1990), in which the injured distal nerve 
ends degenerate much slower and are able to conduct action potentials for 2-3 
weeks while wild type animals only conduct action potentials for 3 days (Lunn et 
al., 1989; Tsao et al., 1999). The study of the Wld
s
 mouse also revealed the 
importance of axonal degeneration in the regenerative process. The delayed 
cytoskeleton disintegration is accompanied by a delay in myelin sheath 
breakdown and macrophage influx, ultimately leading to impaired axonal 
regeneration (Bisby and Chen, 1990). 
 
3.1.2. The importance of Schwann cells 
Schwann cells are the glial cells of the PNS. They play an essential role in nerve 
physiology since they are responsible for the trophic support of developing and 
mature neurons, and also for myelin insulation (Bhatheja and Field, 2006). There 
are two types of Schwann cells: myelinating and non-myelinating Schwann cells. 
Myelination occurs only in large caliber axons (>1μm), with each Schwann cell 
myelinating a single axon (Fig. 7, left image). Myelin insulation allows the axon to 
conduct action potentials much faster. The small caliber axons are ensheathed in 
a structure called Remak bundle, where a single Schwann cell wraps multiple 
axons, separating them by a thin layer of cytoplasm (Fig. 7, right image). 
 
Figure 7. Schwann cell organization in PNS axons. In PNS axons, Schwann cells can either myelinate 
a single axon (diameter >1µm) or wrap several axons (diameter <1µm) with a thin layer of 
cytoplasm forming a remak bundle.  Adapted from (Salzer, 2008). 
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The fast and vast response of Schwann cells to PNS injury is one of the 
main reasons for the successful regeneration of these nerves. Immediately 
following injury, in the distal part of the severed axons, Schwann cells start to 
dedifferentiate even before axonal degeneration starts. The mechanism by which 
Schwann cells sense the axonal injury is not yet known. This dedifferentiation 
which is also sometimes described as Schwann cell activation following injury, 
comprises the downregulation of genes related to myelination such as of the 
genes involved in cholesterol synthesis and structural proteins: P
0
, myelin basic 
protein (MBP) and MAG (Jessen and Mirsky, 2008). At the same time there is the 
activation of a set of molecules typical from immature Schwann cells, like L1, 
Neural Cell Adhesion Molecule (NCAM) and glial fibrillary acidic protein (GFAP) 
(Jessen and Mirsky, 2008), the expression of numerous trophic factors essential 
for neuronal survival, such as BDNF (Meyer et al., 1992), glial-derived 
neurotrophic factor (GDNF) (Naveilhan et al., 1997), NGF (Heumann et al., 1987) 
and the production of several cytokines like leukemia inhibitory factor (LIF) (Curtis 
et al., 1994), tumor necrosis factor-α (TNF-α), interleukin-1α (IL-1α) (Shamash et 
al., 2002) and interleukin-6 (IL-6) (Bolin et al., 1995). c-Jun was identified as being 
essential for the dedifferentiation of Schwann cells. It is activated following injury 
and it inhibits myelin gene expression (Parkinson et al., 2008). Besides 
downregulation of myelin genes, c-Jun activation is also needed for GDNF and 
artemin expression (Fontana et al., 2012). The important role of c-Jun in the 
Schwann cell response to injury is shown by impairment in axonal regeneration 
when Schwann cells are depleted of c-Jun (Fontana et al., 2012). 
The transcriptional changes suffered by Schwann cells following injury, 
lead to myelin breakdown and ultimately stimulate proliferation of both 
myelinating and non-myelinating Schwann cells. Three days following injury 
Schwann cells start to proliferate and align along the basal lamina forming the 
bands of Bunger, which provide support and growth factors for the regenerating 
axons. The aligned Schwann cells produce trophic factors and laminin, an 
adhesion molecule that is part of the extracellular matrix of basal lamina tubes 
and is essential for axon growth (Sanes, 1982; Cornbrooks et al., 1983; Chen and 
Strickland, 2003). 
Myelin contains numerous proteins that are inhibitory to axonal growth. 
The myelin inhibitors that are better characterized are: Nogo (Chen et al., 2000; 
GrandPre et al., 2000), MAG (McKerracher et al., 1994; Mukhopadhyay et al., 
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1994) and oligodendrocyte myelin glycoprotein (OMgp) (Kottis et al., 2002; Wang 
et al., 2002b). From these three proteins, only MAG is present in PNS myelin 
(McKerracher et al., 1994). Following injury, there is an accumulation of myelin 
and of its axonal growth inhibitors that, if not removed, impairs axonal 
regeneration. This has been shown in animals with slow Wallerian degeneration 
where the delay in myelin clearance delays PNS regeneration (Brown et al., 1991). 
Schwann cells and macrophages are responsible for myelin clearance after PNS 
injury (Vargas and Barres, 2007). Schwann cells degrade myelin using hydrolytic 
enzymes in intracellular vacuoles (Holtzman and Novikoff, 1965). During the first 
days following injury, the contribution of macrophages for myelin clearance is 
small and Schwann cells are responsible for almost all myelin removal (Perry et 
al., 1995). Schwann cells are able to clear their own myelin, phagocyte 
extracellular debris and also may function as antigen presenting cells by 
presenting myelin through major histocompatibility complex II (MHC-II) although 
this last function is not clear (Holtzman and Novikoff, 1965; Hirata et al., 1999).  
 
3.1.3. The immune response  
The immune response in injured PNS nerves is an important feature for their 
successful regeneration. The immune response is triggered by the expression of 
several cytokines by Schwann cells (Shamash et al., 2002). Cytokine expression 
stimulates Schwann cells to express the monocyte chemoattractant protein-1 
(MCP-1), an essential component for macrophage recruitment (Subang and 
Richardson, 2001; Tofaris et al., 2002). In this respect, mice lacking MCP-1 recruit 
to injured nerves only half of the number of macrophages during Wallerian 
degeneration (Toews et al., 1998). 
Macrophages are also able to clear myelin debris and their invasion into 
injured nerves completes the myelin removal started by Schwann cells. Actually, 
myelin removal by macrophages is the last phase of myelin debris clearance. 
Within 48h after injury, the blood nerve barrier is broken allowing for the invasion 
of many serum components such as complement and antibodies (Bouldin et al., 
1991). These proteins along with MCP-1 expression by Schwann cells lead to the 
recruitment of macrophages which starts 3 days post-injury and macrophage 
infiltration is maximum at 14-21 days following injury (Avellino et al., 1995). 
Myelin degradation by macrophages is mediated by opsonins and is dependent 
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on the complement system (Bruck and Friede, 1990), such that the invasion of 
complement components and antibodies into injured nerves is essential, since 
they “label” myelin debris making them more visible for macrophage removal 
(Bruck and Friede, 1990).  
By far, macrophages are the immune cell type that plays the most 
important role in PNS regeneration. Other leukocytes play small roles in PNS 
regeneration. Neutrophils invade injured nerves early after injury and are able to 
degrade myelin. However their importance in nerve regeneration is not known. In 
the last phase of the immune response, T cells fine tune immune response 
producing several pro- and anti-inflammatory cytokines (Gaudet et al., 2011). 
 
3.2 Intrinsic factors 
This section served as the basis for the review manuscript: Mar FM, Bonni A and 
Sousa MM (2014). Cell intrinsic control of axon regeneration. EMBO Rep. In press 
doi: 10.1002/embr.201337723 that is reprinted at the end of the introduction 
section. The successful regeneration of PNS axons is not only due to the removal 
of myelin negative cues during Wallerian degeneration. PNS neurons also respond 
to injury by increasing their ability to regrow. Neurons are able to sense an 
axonal injury many centimeters away from the cell body and to change their 
transcriptional profile and express several RAGs that increase their ability to 
regenerate. Bellow I will discuss in detail how PNS axons sense an injury and what 
are the important features of their regenerative response. 
 
3.2.1. Important neuronal features that allow a regenerative response to be 
mounted 
Neurons are highly polarized cells, where in many cases the cell body and the 
axon terminal can be separated by many centimeters. Most of the protein 
synthesis occurs in the cell body following which proteins need to be “shipped” to 
their correct location. As such, axonal transport is of the utmost importance to 
deliver proteins along the axons, but also to transmit signals from the axon 
terminal to the cell body. Although limited, protein synthesis can occur along the 
axon and in the growth cone during elongation. The local protein synthesis is of 
extreme importance for local early responses to axonal injury and to growth cone 
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guidance cues. The importance of axonal transport and local protein synthesis 
will be discussed in detail. 
 
3.2.1.1. Axonal transport 
The axoplasm represents 99% of the neuronal cytoplasm, but protein synthesis in 
the axon is limited. As such, most of the axoplasm constituents are synthesized 
in the cell body and then transported to their final destination. Also, axon 
terminals often receive target derived signals that need to be communicated to 
the cell body. Given the great length of the axons, those activities pose a great 
challenge for the neuron. Most of the axonal transport is made along the 
microtubules in an adenosine-5'-triphosphate (ATP)-dependent way by cargo 
binding to molecular motors (Fig. 8). In axons, microtubules are uniformly 
arranged with their plus ends facing the axon terminal (plus-end-out orientation). 
Two main motors are capable of binding microtubules: kinesin, that is 
responsible for the transport towards the distal axon tip (plus-end), known as 
anterograde transport and dynein that is responsible for the transport from the 
axon tip to the cell body (minus-end), known as retrograde transport (Guzik and 
Goldstein, 2004). 
Besides kinesin and dynein, myosin is another motor performing axonal 
transport. Contrary to kinesin and dynein that move along microtubules, myosin 
moves along actin filaments (Seabra and Coudrier, 2004). Myosin is incapable of 
long distance transport, a function performed by kinesin and dynein. Instead, it is 
responsible for short distance transport, like local insertion of proteins in the 
plasma membrane. It also interacts with neurofilaments being responsible for 
their organization (Bridgman, 2004). 
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Figure 8. Axonal transport. Kinesin is responsible for the anterograde transport and dynein for the 
retrograde transport. Both move along microtubules. Myosin moves along actin filaments and is 
responsible for small range transport. Adapted from (Chevalier-Larsen and Holzbaur, 2006). 
 
3.2.1.1.1. Anterograde transport 
The anterograde transport is responsible for axon maintenance by supplying it 
with structural, synaptic and cytosolic proteins like glycolytic enzymes, vesicles 
and membranous organelles like mitochondria. Most studies characterizing the 
different components of anterograde transport were made during the 1980s by 
radiolabeling newly synthesized proteins in laboratory animals and then by 
chasing them along the axons (Grafstein and Forman, 1980; Wujek and Lasek, 
1983; Lasek et al., 1984). The different transport rates observed suggested the 
existence of at least two different mechanisms of anterograde transport. The first 
direct evidences came 20 years later with the development of techniques that 
allowed the direct observation of cargoes moving in living cells (Kaether et al., 
2000; Ligon and Steward, 2000; Wang and Brown, 2001, 2002). In the axon, the 
anterograde transport of proteins is essentially done by the slow component of 
axonal transport which is divided in slow component a (SCa), that is responsible 
for the transport of neurofilament proteins, tubulin and microtubule-associated 
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proteins at a rate of 0,2-1 mm/day; and the slow component b (SCb) that 
transports glycolytic enzymes and actin, among others, at a rate of 2-8 mm/day 
(Lasek et al., 1984; Brown, 2003). Vesicles and membranous organelles are 
transported in the fast component at 50-400 mm/day (Lasek et al., 1984; Brown, 
2003). Surprisingly, the motors and the kinetics of both slow and fast 
components of axonal transport are similar and the different average rates are 
explained by an intermittent behavior of cargoes during transport (Brown, 2003). 
Slow transport components, although traveling at the same rate as the fast 
component, spend more time in a stationary stage along the way resulting in a 
lower average rate (Brown, 2003; Roy et al., 2007). These findings raised new 
questions such as: How is the intermittent behavior controlled? What triggers 
movement and stoppage? These questions remain unanswered. 
Kinesin is a superfamily composed of more than 45 kinesins divided in 15 
families (Fig. 9). In axonal transport, kinesin1 is the most relevant and studied 
kinesin family. This family is coded by 3 different genes: KIF5A, KIF5B and KIF5C 
(Hirokawa et al., 2009).  
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Figure 9. Kinesin protein family. Adapted from (Hirokawa et al., 2009). 
 
KIF5B is ubiquitously expressed, while KIF5A and KIF5C are neuron 
specific. Kinesin1 generically known as Kinesin heavy chain, usually binds cargos 
through adaptor proteins – kinesin light chains – forming a tetramer composed of 
two heavy chains and two light chains (Hirokawa et al., 2009) (Fig. 10). ATP 
hydrolysis provides the required energy to generate the motile force (Hirokawa et 
al., 2009). 
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Figure 10. Kinesin structure. Kinesin is composed by two heavy chains and two light chains. 
Adapted from (Hirokawa et al., 2010). 
 
Besides axonal maintenance, anterograde transport is of particular 
importance during axonal regeneration since it supplies the necessary proteins 
for this process, particularly the structural components tubulin, actin and 
neurofilament (Tashiro and Komiya, 1992; Jacob and McQuarrie, 1996). In fact the 
speed of axonal regeneration is similar to the rate of the slow component of 
anterograde transport, confirming the idea that the anterograde transport 
supplies regrowing axons (Wujek and Lasek, 1983). 
 
3.2.1.1.2. Retrograde transport 
Retrograde transport is vital for neuronal survival. It encompasses the transport 
of Trk receptors activated through signals released by the axonal targets, such as 
neurotrophins (Heerssen et al., 2004). The retrograde transport of these signals 
is achieved by the formation of signaling endosomes that are linked to the motor 
dynein and transported to the cell body where they activate gene expression of 
survival genes (Delcroix et al., 2003; Ye et al., 2003). Cargos bind dynein through 
adaptor proteins. Dynactin is the main cargo adaptor and is essential for an 
efficient dynein-mediated transport (Kardon and Vale, 2009).  The 
dynein/dynactin complex is well described (Fig. 11) for its role in retrograde 
transport, however it has been reported that under specific circumstances, this 
complex may have bidirectional movement (Ross et al., 2006). 
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Figure 11. Dynein/dynactin complex structure. Dynein is composed by two heavy chains, two light-
intermediate chains, two intermediate chains and two light chains that bind to dynactin for cargo 
transport. Adapted from (Hirokawa et al., 2010). 
 
The importance of retrograde transport is shown by the fact that its 
disruption leads to the onset of neurodegeneration (LaMonte et al., 2002; 
Hafezparast et al., 2003). In fact, in many neurodegenerative diseases such as 
Amyotrophic lateral sclerosis (ALS), defects in retrograde transport are found 
even before the first symptoms appear (Kieran et al., 2005; Ligon et al., 2005). 
Retrograde transport is extremely important to signal injury following nerve 
lesion. Upon injury, there is the local activation of injury signals that are linked to 
dynein (Hanz et al., 2003). This linkage ensures the retrograde transport of the 
injury signals to the cell body (Fig. 12) where they can signal the injury and 
trigger a regenerative response (Ambron et al., 1992; Schmied and Ambron, 
1997; Hanz et al., 2003; Perlson et al., 2005). 
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Figure 12. Retrograde transport of injury signals. Following PNS injury there is local activation of 
injury signals and local translation of proteins that link the activated injury signals to the retrograde 
transport machinery. Adapted from (Rishal and Fainzilber, 2010). 
 
3.2.1.1.3. Defects in axonal transport as the cause of pathological conditions 
Several neurodegenerative diseases present defects in axonal transport, either 
retrograde or anterograde. These defects can happen either due to mutations in 
the motors, microtubule destabilization or other undisclosed mechanisms. 
Charcot-Marie-Tooth type 2A is caused by a single point mutation in KIF1Bβ gene, 
which impairs the axonal transport of synaptic vesicles, resulting in 
neurodegeneration (Roy et al., 2005). Mutations in dynactin have been implicated 
in the disruption of the dynein/dynactin complex, resulting in retrograde 
transport defects and motor neuron cell death (Chevalier-Larsen and Holzbaur, 
2006). Although axonal transport defects have been found in other 
neurodegenerative diseases such as Alzheimer’s, Huntington and ALS (Roy et al., 
2005), whether these defects are a cause or a consequence of neurodegeneration 
is still a matter of debate. 
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Table 1. Axonal transport defects in human disease. Adapted from (Chevalier-Larsen and Holzbaur, 
2006). 
 
 
3.2.1.2. Local protein synthesis in the axon 
Protein synthesis was thought to be exclusive of the neuronal cell body. This 
notion was supported by the lack of evidence of messenger RNA (mRNA) and 
translation machinery on mature axons (Lasek et al., 1973). However, with the 
development of more sensitive techniques it was found that indeed axons 
possess both mRNA and translation machinery (Tennyson, 1970; Giuditta et al., 
1980; Giuditta et al., 1986; Giuditta et al., 1991; Bassell et al., 1998). Moreover, 
metabolic labeling studies showed that axons without cell body are able to 
synthesize proteins de novo (Tobias and Koenig, 1975; Koenig and Adams, 1982; 
Koenig, 1991; Eng et al., 1999). Initially, a small number of mRNAs were 
identified in the axon, but the number of axonally localized mRNAs has been 
growing considerably with the development of more sensitive techniques (Jung et 
al., 2012). 
The targeting of mRNAs to different axonal compartments is a mechanism 
that allows the regulation of local protein synthesis. Current techniques have 
contributed greatly to the identification of novel axonal mRNAs. It also allowed 
the identification of crucial changes of axonal mRNA content from development 
to adulthood (Vogelaar et al., 2009; Gumy et al., 2011).  
Local protein synthesis is particularly important for accurate fast responses 
when there is not enough time to communicate with the cell body. In fact, during 
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development, growing axons are exposed to several guidance cues, like netrin-1, 
ephrin B, semaphorin 3A, NGF and BDNF, which need to be interpreted rapidly for 
the correct pathfinding (Lin and Holt, 2008; Jung et al., 2012). The growth cone is 
the structure responsible for the integration of the environment signals in a 
process dependent on local protein synthesis (Campbell and Holt, 2001; Ming et 
al., 2002). Although CNS axons are able to synthesize proteins in the growth cone 
during development, studies with adult CNS axons fail to show the presence of 
ribosomes, suggesting that adult CNS axons are not able to synthesize locally 
proteins or that this ability is very limited  (Steward and Ribak, 1986; Verma et al., 
2005). This can underlie in part their limited ability to regenerate. In contrast, 
adult PNS axons do possess ribosomes distributed unevenly along the axoplasm, 
close to the plasma membrane (Koenig et al., 2000; Li et al., 2005; Kun et al., 
2007). Schwann cells have also been suggested as a source of ribosomes for PNS 
axons following injury, indicating that Schwann cells may promote local protein 
synthesis (Court et al., 2008; Twiss and Fainzilber, 2009). Protein synthesis is 
generally decreased with axonal ageing, that coincides with reduced axonal 
regeneration potential (Gumy et al., 2010). This evidence further reinforces the 
importance of local axonal synthesis in regeneration. 
As such, besides its importance for axonal steering during development, 
local protein synthesis has been shown to be important following peripheral 
nerve injury by two different mechanisms. It enables the synthesis of vimentin 
and importin-β that can be linked to the retrograde transport machinery along 
with locally activated proteins and transported back to the cell body where they 
can trigger a robust regenerative response (Hanz et al., 2003; Perlson et al., 
2005). Also, the initial steps of axonal regeneration are achieved by local protein 
synthesis, since the arrival to the injury site of proteins synthesized in the cell 
body can take a few days. As such, the formation of a growth cone, an essential 
structure for successful regeneration, as well as the provision of the first building 
blocks of the regrowing axons is obtained by local protein synthesis (Verma et al., 
2005; Willis and Twiss, 2006; Gumy et al., 2010). 
Axonal mRNAs face great challenges: they need to be actively transported, 
stored and protected from degradation at their final destination. The RNA-binding 
proteins play an essential role in this process, by binding to cis-elements in the 
5’- or 3’- untranslated regions (UTR). Upon RNA binding they control its transport, 
stability and translation (Bassell and Kelic, 2004; Patel et al., 2012). The best 
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studied mRNA with axonal localization is β-actin. Its mRNA is controlled by the 
zipcode-binding protein-1 (ZBP-1) that binds to a cis element in the 3’-UTR. This 
cis element in the 3’-UTR is essential for local translation of β-actin in response to 
guidance cues (Leung et al., 2006; Yao et al., 2006). The importance of ZBP-1 has 
been shown by the observation that reduced ZBP-1 activity leads to decreased 
axon regeneration (Donnelly et al., 2011). Additionally, the overexpression of β-
actin 3′UTR competed in vivo with other ZBP-1 cargo mRNAs such as growth 
associated protein 43 (GAP-43) (Yoo et al., 2013). Recently, it has also been 
shown that axonal translation of β-actin supports axon branching, while that of 
GAP-43 promotes elongation of sensory neurons (Donnelly et al., 2013). 
In summary, the recent findings support that although local axonal protein 
synthesis is limited, it is of great importance to axonal regeneration. 
 
3.2.2. Injury mechanisms 
The mechanism by which an axon can “warn” the cell body that it has been 
injured is a question that puzzled neuroscientists for many years. Elegant studies 
made in Aplysia neurons in the 90’s described the first injury signals capable of 
increasing the regeneration ability (Ambron et al., 1995; Ambron et al., 1996). 
Since then, many advances were made in how PNS axons are able to sense an 
injury, although many of the proposed signals still lack robust experimental 
evidence (Fig. 13). 
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Figure 13. Injury mechanisms following PNS injury. Following PNS injury there is neuronal 
depolarization (1), interruption of transported target derived signals (2) and local activation and 
transport of injury signals (3). Adapted from (Abe and Cavalli, 2008). 
 
3.2.2.1. Axonal depolarization 
Upon injury, axons are depolarized and this depolarization travels along the axon 
to the cell body. The depolarization is triggered by an inversion in the 
Calcium/Sodium flux. Besides depolarization, Calcium influx is essential for the 
resealing of the axonal membrane (as described above), local transformation of 
the cytoskeleton to form a growth cone and local activation of protein synthesis 
(Chierzi et al., 2005; Erez et al., 2007; Kamber et al., 2009; Bradke et al., 2012). 
In C. elegans sensory neurons, the amplitude of the axonal calcium waves 
correlates with the extent of regeneration, and conversely inhibition of voltage-
gated calcium channels, or of calcium release from internal stores, reduces the 
regenerative growth of axons (Ghosh-Roy et al., 2010). Although the effects on 
neurons are not consensual, the use of weak electrical stimulation has been 
shown to improve both the regeneration of motor (Brushart et al., 2002; Al-Majed 
et al., 2004) and sensory neurons (Udina et al., 2008).  
More recently it has been shown that strong electrical stimulation of dorsal 
root ganglia (DRG) neurons inhibits their axon outgrowth. Loss of electrical 
activity following PNS lesion due to a decrease in the L-type voltage-gated Ca
2+
 
channel was described as an important signal to increase axonal regeneration 
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(Enes et al., 2010). These results suggested that the electrical activity may be a 
negative signal that once lost can trigger the injury response in DRG neurons. 
In summary, axonal depolarization is thought to be the first signal of 
injury. However it is seen as a transient signal that, if not followed by other injury 
signaling mechanisms, cannot trigger a robust, sustained regenerative response. 
 
3.2.2.2. Negative injury signals 
During development axons elongate until they find their targets. Once an axon 
finds its target, the neuron receives several target-derived factors through 
retrograde transport that repress the elongation machinery of neurons converting 
the growth cone into a presynaptic terminal. 
Upon injury, the neurons are disconnected from their targets and there is 
an interruption of the normal supply of target-derived signals. This decrease in 
the supply of target derived signals is thought to alleviate the repression of axon 
elongation allowing regeneration. These signals are known as negative injury 
signals since their absence can trigger a regenerative response. It has been 
shown that neurotrophins are dramatically decreased in DRG neurons following 
injury (Raivich et al., 1991). Although neurotrophins fulfill many of the 
requirements for a negative injury signal, their role in nerve regeneration is still 
unclear. In accordance with a negative injury signal function, it has been 
described that administration of NGF to injured nerves could delay regeneration 
(Gold, 1997). However, in other studies, the administration of neurotrophins 
following injury was linked to an improvement in PNS regeneration (Molteni et al., 
2004). Other studies have also described that PNS regeneration may be 
independent of NGF (Diamond et al., 1992; Tannemaat et al., 2008). 
The notion that naïve neurons continuously receive signals that repress 
axonal growth that are relieved following PNS injury is an appealing idea. The 
identification of these signals may lead to the development of new methods to 
improve axon regeneration. However, this hypothesis still lacks robust 
experimental evidence and so far no clear negative injury signals have been 
identified. 
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3.2.2.3. Positive injury signals 
The first evidence that axons can produce molecules capable of triggering a 
regenerative response following injury emerged in the 90s using Aplysia neurons 
as a model. It was shown that injecting axoplasm extracted from injured nerves in 
naïve neurons, an injury-like behavior was triggered in the injected neurons. By 
labeling the injured nerves with γ32P ATP there was evidence that these signals 
were dependent on phosphorylation (Ambron et al., 1995). Combining these 
results with previous data on a SV40-type nuclear localization signal (NLS) that 
targeted axonal proteins to the nucleus through the retrograde transport 
machinery  (Ambron et al., 1992; Schmied and Ambron, 1997), the authors 
proposed that under normal circumstances, the signal proteins have an hidden 
NLS, that after injury is exposed by phosphorylation leading to targeting of the 
signal to the nucleus triggering a response to injury. The importance of 
retrograde transport of NLS proteins was shown later when an NLS synthetic 
peptide was injected into the injured nerve precluding the increase in the 
regeneration capacity by competition with the intrinsic signals (Hanz et al., 2003). 
A decade later, the molecular mechanisms underlying the activation of 
positive injury signals and for their transport were described, but the initial idea 
was maintained. One of the most important features added to the injury signaling 
mechanism was the importance of local translation in injured axons. The concept 
that axons are able to synthesize proteins allowed to understand how a protein 
containing a NLS is able to undergo retrograde transport only following injury. 
The NLS-mediated import of proteins to the nucleus is mediated by their binding 
to importins (Gorlich and Kutay, 1999). It is also important to note that NLS 
proteins bind with low affinity to importin-α, but with high affinity to importin-α/β 
heterodimers (Kohler et al., 1999). In normal nerves only importin-α is present 
making it unlikely that NLS proteins are retrogradely transported to the nucleus. 
However, following injury, there is the local translation of importin-β. The 
synthesis of importin-β allows for the formation of importin-α/β heterodimers 
which bind to NLS and link those proteins to the retrograde transport machinery 
through dynein binding (Hanz et al., 2003). Recently, it has been shown that the 
axonal localization of importin-β mRNA is essential for the correct assembly of 
the retrograde transport machinery of injury signals (Ben-Tov Perry et al., 2012). 
Besides importin-β, RanBP1 is also locally synthesized following injury and able to 
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dissociate RanGTP from importins, allowing the binding of new importin-α/β 
heterodimers to dynein (Yudin et al., 2008). 
So far, the study of rodent injured sciatic nerves led to the identification of 
three injury signals that are locally activated and retrogradely transported to the 
cell body: the extracellular signal regulated kinase (ERK) (Hanz et al., 2003; 
Perlson et al., 2005), c-Jun N-terminal kinases (JNK) (Cavalli et al., 2005) and 
signal transducer and activator of transcription 3 (STAT-3) (Ben-Yaakov et al., 
2012). The local activation of ERK and STAT-3 following sciatic nerve injury has 
been shown (Sheu et al., 2000), but only recently the molecular mechanisms by 
which these proteins are translocated to the cell body and induce a regenerative 
response were dissected (Perlson et al., 2005; Ben-Yaakov et al., 2012). Below I 
will describe the details behind ERK, JNK and STAT-3 function. 
ERK is activated by phosphorylation immediately following injury and it is 
then coupled to the retrograde transport machinery (Hanz et al., 2003). This 
process is dependent on the local synthesis of vimentin following injury. Vimentin 
is able to bind both pERK and importin-β linking pERK to the retrograde transport 
machinery (Fig. 14). pERK is rapidly transported and approximately 20h following 
injury it reaches the cell body where it leads to activation of E twenty-six like 
transcription factor 1 (Elk-1). Moreover, impeding the retrograde transport of 
pERK following injury decreases the subsequent regenerative response (Perlson et 
al., 2005). 
Figure 14. Retrograde transport of pERK following PNS injury. Adapted from (Perlson et al., 2005). 
 
In uninjured nerves, JNK interacts with sunday driver (syd) and both are 
transported in axonal vesicles, both retrogradely and anterogradely (Cavalli et al., 
2005). Following injury JNK is phosphorylated within an hour and there is an 
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increase in the amount of syd that interacts with dynein. This results in an 
increase of the retrograde transport of vesicles containing pJNK and Syd leading 
to an increase in pJNK in the neuron cell body (Cavalli et al., 2005) and to the 
activation of the transcription factor c-jun, increasing the expression of genes 
required for regeneration (Davis, 2000; Lindwall et al., 2004). 
Another described positive injury signal is STAT-3. STAT-3 is a 
transcription factor of the JAK-STAT pathway. Following PNS injury there is a local 
activation of STAT-3 and nuclear translocation in both motor and sensory neurons 
occurs (Lee et al., 2004). This activation is important to increase the regeneration 
ability of DRG neurons (Qiu et al., 2005; Miao et al., 2006). More recently it was 
shown that in DRG neurons, STAT-3 activation is important to initiate the 
regenerative process. In the absence of STAT-3, injured neurons have a prolonged 
lag in the initiation of regeneration but can then regenerate at normal rate 
(Bareyre et al., 2011). STAT-3 locally synthesized and activated is linked to dynein 
through interaction with importin-α5, allowing STAT-3 to reach the cell body 
peaking at 18h following injury (Ben-Yaakov et al., 2012) (Fig. 15). Moreover, DLK, 
a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family 
that can activate JNK and p38 (Fan et al., 1996), was identified as being important 
for the retrograde transport of pSTAT-3 following injury. DLK KO neurons present 
decreased regeneration following PNS injury due to their failure in the retrograde 
transport of pSTAT-3 (Shin et al., 2012). Surprisingly, Ben-Yaakov et al did not 
find any impairment in the regeneration of DRG neurons that lack STAT-3 
activation. Instead, STAT-3 activation was found to be important in neuronal 
survival to injury (Ben-Yaakov et al., 2012). 
Figure 15. Retrograde transport of pSTAT-3 following PNS injury. Adapted from (Ben-Yaakov et al., 
2012). 
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The transport of activated injury signals for such a long distance as an 
entire axon represents a great challenge to the cell. Protein phosphorylation is a 
reversible process. Cells need to protect the phospho active signals to avoid the 
inactivation of the signals during their course. The function of vimentin in ERK 
transport is not only to link ERK to the retrograde transport machinery. Through 
its binding to ERK, vimentin hides the phosphorylated ERK sites protecting them 
from phosphatase activity (Perlson et al., 2005; Perlson et al., 2006). Another 
possible method to avoid dephosphorylation is by hitchhiking in transport 
vesicles. Indeed, vesicles are used by toxins to avoid degradation (Pellizzari et al., 
1999; Baldwin and Barbieri, 2009). This protection method is also used by JNK 
which is transported in axonal vesicles (Cavalli et al., 2005). 
 
3.2.3. Neuronal response to injury and expression of regeneration associated 
genes (RAGs) 
Although not all injury mechanisms are yet identified, an injury to the PNS 
triggers a robust response in the neuron cell body. Injury induces a transient 
increase in cAMP (Qiu et al., 2002) followed by expression and activation of 
several transcription factors, namely cAMP response element-binding protein 
(CREB) (Gao et al., 2004), c-Jun (Jenkins and Hunt, 1991; Leah et al., 1991), Elk-1 
(Perlson et al., 2005), STAT-3 (Lee et al., 2004; Ben-Yaakov et al., 2012), 
activating transcription factor 3 (ATF-3) (Tsujino et al., 2000; Seijffers et al., 
2006), sex determining region Y-box 11(Sox11) (Tanabe et al., 2003; Jankowski 
et al., 2006) and Mothers against decapentaplegic homolog 1 (Smad1) (Zou et al., 
2009), which lead to a robust alteration of the transcription profile needed to 
increase the neuronal growth competence (Smith and Skene, 1997; Costigan et 
al., 2002; Xiao et al., 2002). Several RAGs have been identified as being 
expressed following injury. Among these genes are: cytoskeleton genes like 
tubulin and actin (Hoffman, 2010), Arginase-1 (Deng et al., 2009), neuropeptide-
Y, vasointestine peptide (Vip) (Xiao et al., 2002), IL-6 (Cao et al., 2006), growth 
associated protein 43 (GAP-43) and CAP-23 (Bomze et al., 2001). 
The changes induced by an injury can be seen in vitro. Naïve adult DRG 
neurons when cultured extend small, highly ramified neurites, while pre-injured 
DRG neurons extend long unbranched neurites. The transcription changes 
induced by an injury promote a transition from branching to elongation (Hu-Tsai 
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et al., 1994; Smith and Skene, 1997). One of the most striking features of injured 
DRG neurons is their ability to overcome myelin inhibition. Pre-injured DRG 
neurons are able to extend neurites even in the presence of an inhibitory 
environment, such as when plated on myelin (Qiu et al., 2002). 
Several groups have tried to find a master regulator of the injury induced 
response. In this respect, cAMP was a major candidate for this role. Besides the 
increase of cAMP levels following injury, the fact that during development 
neurons maintain high levels of cAMP (Cai et al., 2001) led to the idea of cAMP as 
having a central role in the induction of axonal elongation. It was described that 
treatment with dibutyryl cyclic adenosine monophosphate (db-cAMP), a cell 
permeable analog of cAMP increased the regeneration ability of DRG neurons, 
even allowing to overcome myelin inhibition (Neumann et al., 2002; Qiu et al., 
2002). However, cAMP induction does not reproduce the changes produced by a 
PNS injury, falling short to PNS injured neurons (Han et al., 2004; Blesch et al., 
2012). Nevertheless, cAMP is still seen as one of the main targets to improve 
axonal regeneration. So far, manipulation of several of the RAGs led to 
improvements in axonal regeneration but none of the genes identified was able 
to mimic the changes produced by an injury (Blesch et al., 2012). 
 
3.2.4. PNS regeneration: a robust but incomplete process 
Following injury to the PNS, both motor and sensory neurons survive and are able 
to regrow past the injury site. Although the PNS is described as being able to fully 
regenerate, usually this regrowth does not lead to a complete functional recovery 
(de Ruiter et al., 2008; Hamilton et al., 2011). One of the main causes for the 
incomplete functional recovery is the misdirection of the regenerative axons. 
During regeneration of mixed nerves (composed of both sensory and motor 
tracts), injured axons are not able to find their previous targets, leading to an 
incorrect reinnervation. In practical terms, muscles can be reinnervated by 
motoneurons that previously were innervating a different muscle (English, 2005) 
or even by sensory neurons (Brushart et al., 2005). These abnormalities promote 
both motor deficits like contraction of muscles or synkinesis and disturbed 
sensory function (Dyck et al., 1988). Different surgical approaches have been 
tested unsuccessfully to improve correct axonal targeting (Evans et al., 1991; 
Bodine-Fowler et al., 1997; de Ruiter et al., 2008). The use of electrical 
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stimulation to improve targeting is controversial with beneficial (Brushart et al., 
2005) or detrimental (Hamilton et al., 2011) outcomes. Furthermore, methods 
used to improve regeneration tend to increase axonal misdirection (English, 
2005; Hamilton et al., 2011). 
PNS regeneration is seen has a powerful process, particularly when 
compared to regeneration after a CNS injury. However this comparison can give 
the wrong impression that axonal regeneration in the PNS is a perfect process. We 
should not forget that although robust, PNS regeneration still has some 
drawbacks, namely the incorrect re-innervation. 
 
4. CNS regeneration – why does it fail? 
In contrast to the PNS, following injury CNS axons present limited ability to 
regenerate. This abortive regeneration translates in permanent sensory-motor 
impairments. Several differences have been pointed out to explain the lack of 
regenerative ability of CNS neurons, namely the inefficient Wallerian degeneration 
followed by the formation of the glial scar, that is a barrier to regenerating axons, 
and the limited neuronal cell-autonomous response to injury as CNS neurons are 
unable to activate many of the genes necessary for regeneration to take place. 
In the following paragraphs the current view on the ineffective 
regeneration of the CNS will be explored. 
 
4.1. Slow Wallerian degeneration and the formation of the glial scar  
Support of CNS neurons is provided by oligodendrocytes and astrocytes. 
Oligodendrocytes provide myelin insulation to the CNS axons with a single cell 
being able to myelinate several axons, while astrocytes provide trophic support 
and are responsible for the homeostasis of the CNS. Following injury, 
oligodendrocyte apoptosis leads to an accumulation of myelin debris which 
together with astrocyte activation leads to the formation of a glial scar (Fig. 16). 
Furthermore, injury triggers a robust immune response with the production of 
cytokines and chemokines with coordinated infiltration of leukocytes. 
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Following injury, unlike Schwann cells, oligodendrocytes are not able to 
dedifferentiate and clear myelin debris. Indeed, loss of contact with axons and 
the robust inflammatory response leads to oligodendrocyte apoptosis (Vargas 
and Barres, 2007). Moreover, the blood-brain-barrier (BBB) is maintained following 
CNS injury, limiting the infiltration of circulating macrophages (George and 
Griffin, 1994; Popovich and Hickey, 2001) and the resident CNS microglia display 
limited ability to remove myelin when compared to infiltrating macrophages 
(Simard et al., 2006). The small infiltration of macrophages together with the 
lower ability of oligodendrocytes and microglia to phagocyte myelin leads to a 
slow, incomplete Wallerian degeneration, culminating in the accumulation of 
myelin debris. 
Immediately following injury, astrocytes are activated and form a dense 
scar tissue surrounding the injured area (Silver and Miller, 2004). In this acute 
phase the main function of the activated astrocytes is to seal the injured area to 
prevent the injury area to extend (Rolls et al., 2009). 
The glial scar is seen as detrimental for recovery following injury, since it 
impedes axonal regrowth (Fitch and Silver, 2008). Originally seen only as a 
physical barrier (Windle and Chambers, 1950), it was found that reactive 
astrocytes produce several extracellular matrix (ECM) proteins, namely members 
of the chondroitin sulfate proteoglycans (CSPG) that prevent axonal elongation 
(Verma et al., 2008), making the glial scar not only a physical, but also a 
biological barrier for regeneration. However it was found that the glial scar is 
important to restore the BBB and to separate the healthy tissue from the injured 
one, preventing damage progression to the uninjured tissue (Rolls et al., 2009). 
As such, damage control is made by sacrificing the possibility of regeneration of 
injured axons. 
However, past the acute phase, further destruction of healthy tissue occurs 
during a process called secondary injury. The immune response plays an 
important role in this process, with neutrophil invasion of the lesion, followed by 
lymphocytes and later, macrophages. Later, there is an increase in TNF-α leading 
to the production of pro-inflammatory cytokines, promoting apoptosis of 
neuronal and glial cells and thereby increasing the damaged area (Lee et al., 
2000; Genovese et al., 2008). From all infiltrating leukocytes, lymphocytes in 
particular are thought to promote damage during this secondary phase. In this 
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respect, mice lacking T lymphocytes were shown to present attenuated 
neuropathology after spinal cord injury (SCI) (Fee et al., 2003; Potas et al., 2006). 
 
Figure 16. Composition and organization of the glial scar. Adapted from (Silver and Miller, 2004). 
 
4.2. Inhibitory components are present in the CNS following injury 
One of the major causes for the inability of CNS axons to regenerate is the harsh 
environment that is formed following injury. Along the formation of the glial scar 
there is an accumulation of myelin debris composed of several regeneration 
inhibitors. The inhibitory components that CNS axons face following injury can be 
divided in three categories: myelin associated inhibitors (MAI) (Lee and Zheng, 
2012), canonical guidance molecules (Giger et al., 2010), and chondroitin sulfate 
proteoglycans (Galtrey and Fawcett, 2007) (Fig. 17). The relevance of the 
inhibitory environment in the CNS following lesion was shown in seminal studies, 
where axonal regeneration occurred through a peripheral nerve graft implanted 
following SCI (Richardson et al., 1980; David and Aguayo, 1981). 
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Figure 17. Axonal inhibition through exposure to inhibitory molecules of the glial scar. Injured CNS 
axons are exposed to multiple inhibitory molecules that signal through RhoA/Rho-associated kinase 
(ROCK). Adapted from (Yiu and He, 2006). 
 
4.2.1. Myelin associated inhibitors (MAIs) 
MAIs were the first inhibitory components of the CNS identified. CNS myelin was 
found to be inhibitory for neurite outgrowth (Schwab and Caroni, 1988). The 
production of an antibody against a myelin fraction (the IN-1 antibody) was able 
to alleviate the growth inhibition of myelin in vitro (Caroni and Schwab, 1988) and 
to promote corticospinal tract (CST) regeneration following SCI (Schnell and 
Schwab, 1990; Brosamle et al., 2000). Nogo was identified as being one of the 
myelin components responsible for this inhibition, as it was one of the targets of 
the IN-1 antibody (Chen et al., 2000; GrandPre et al., 2000). Three different 
isoforms of Nogo exist (Nogo-A, B and C) and Nogo possesses two main 
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inhibitory regions, a putative extracellular amino acid loop called Nogo-66, which 
is common to all isoforms, and a segment specific for Nogo-A (Oertle et al., 
2003). Besides Nogo, MAG was also identified as a myelin inhibitor (McKerracher 
et al., 1994; Mukhopadhyay et al., 1994). MAG is the only inhibitor that is present 
both in PNS and in CNS myelin which could also account for the better 
regeneration of PNS axons. Although MAG is able to inhibit neurite outgrowth of 
several classes of neurons, it plays a dual role in axonal growth. Adult DRG 
neurons are inhibited by MAG, but DRG from newborn animals are stimulated by 
this protein. This behavior shift occurs within the first days of life (P4) and is 
thought to be related to the decrease in cAMP levels in neurons following 
maturation (Mukhopadhyay et al., 1994; DeBellard et al., 1996). More recently 
OMgp was also found to be another member of this family (Kottis et al., 2002; 
Wang et al., 2002b). 
Extensive in vitro work led to the characterization of the molecular 
mechanisms by which MAIs promote growth cone collapse and outgrowth 
inhibition. The Nogo-66 receptor (NgR) was the first identified receptor for MAIs. 
It is a GPI-linked protein expressed in many types of neurons initially described as 
interacting with Nogo-66 (Fournier et al., 2001). Although the three known MAIs 
do not share any structural feature, MAG and OMgp are also able to interact with 
NgR (Domeniconi et al., 2002; Liu et al., 2002; Wang et al., 2002b). NgR lacks a 
cytosolic domain capable of transducing the inhibitory signals from MAIs and as 
such it needs a co-receptor capable of transducing the inhibitory signals. p75 was 
found to be a NgR co-receptor as neurons lacking p75 presented lower inhibition 
when facing MAIs (Wang et al., 2002a; Wong et al., 2002; Yamashita et al., 2002; 
Park et al., 2005; Shao et al., 2005). Nevertheless, p75 is not expressed in many 
neuron populations limiting its relevance in the in vivo inhibitory effect of MAIs. 
Later, Troy, another member of the tumor necrosis factor receptor (TNFR) family 
which is expressed in most of the adult neurons was identified as the co-receptor 
of NgR (Park et al., 2005; Shao et al., 2005). Furthermore, Lingo-1 was also found 
to be necessary for the complex NgR/p75 or NgR/Troy to be active and 
responsive to MAIs as neurons expressing a dominant negative Lingo-1 present 
lower responsiveness to MAIs (Mi et al., 2004). Although NgR was identified as 
being a MAI receptor mediating MAI inhibition, NgR KO mice are also inhibited by 
MAIs and do not present any improvement in CNS regeneration, suggesting the 
existence of other MAI receptors (Zheng et al., 2005). Indeed, PirB was later 
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identified as an alternative MAI receptor mediating neurite inhibition (Atwal et al., 
2008), which might explain the lack of phenotype in NgR KO mice. 
Myelin inhibition is mediated by the RhoA/Rho-associated kinase (ROCK) 
pathway (Lehmann et al., 1999) (Fig. 17). RhoA is a small GTPase that is 
maintained in the inactive form in the cytoplasm by Rho GDP dissociation 
inhibitor (RhoGDI) binding (Boulter et al., 2010). Upon MAI binding to p75, 
RhoGDI is displaced leading to RhoA activation (Yamashita and Tohyama, 2003). 
Active RhoA is able to activate its downstream effector ROCK leading to cofilin 
phosphorylation by Lim kinase culminating in growth cone collapse and axonal 
regeneration inhibition (Hsieh et al., 2006). 
Based on the in vitro studies as well as on the promising results obtained 
with the IN-1 antibody to promote recovery following CNS injury, MAIs were an 
attractive therapeutic target to promote regeneration following CNS injury. 
However the use of genetic models lowered these expectations. OMgp and MAG 
KO mice do not present any increase in regeneration ability following SCI (Bartsch 
et al., 1995; Ji et al., 2008), while Nogo KO mice were reported to display 
different regeneration abilities, varying from extensive (Kim et al., 2003; Simonen 
et al., 2003) to none (Zheng et al., 2003; Lee et al., 2009). The lack of robust, 
consensual regeneration in MAI single KO mice, together with the fact that the 
three MAIs share the same mechanism of inhibition led to the idea that in vivo, 
Nogo, MAG and OMgp could play redundant roles in restricting axonal 
regeneration. However, the use of triple (MAG, OMgp and Nogo) KO mice did not 
clarify this question. In one of the studies using the triple KO, it was reported that 
indeed, knocking out MAIs generated a synergistic effect, increasing axonal 
regeneration following SCI (Cafferty et al., 2010). However, in another study, 
triple KO mice presented an increase in sprouting ability without showing any 
increase in axon regeneration (Lee et al., 2010).  
Many of the myelin inhibitors signal through RhoA/ROCK. RhoA activity is 
blocked by the toxin C3-ADP-ribosyltransferase (C3) from Clostridium botulinum, 
while ROCK can be inhibited by Y27632. Although inhibition of RhoA/ROCK does 
not induce RAG expression in neurons, both C3 and Y27632 are able to block 
myelin inhibition (Dergham et al., 2002; Winton et al., 2002) and its use in vivo 
promotes axonal regeneration following spinal cord injury (Dergham et al., 2002; 
Boato et al., 2010). 
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MAIs are by far the most studied inhibitors in the CNS. However, the 
existence of numerous inhibitors besides MAIs may underlie the successive flops 
obtained with MAI KO mice. 
 
4.2.2. Guidance cues 
Guidance molecules are of extreme importance during development for the 
correct pathfind of axons. Their expression in the adult CNS indicates that they 
may play other roles like the maintenance of the established network. However 
their role following CNS injury is not well studied. Among the most studied 
guidance molecules are Semaphorins, Ephrins and Repulsive Guidance Molecules 
(RGM). 
 
4.2.2.1.Semaphorins  
Semaphorins are a vast family of proteins that are important for axonal guidance 
by interacting with plexin receptors. Class 3 semaphorins (SEMA-3) are the only 
ones secreted and require neuropilin as a co-receptor (Yoshida, 2012). SEMA-3 is 
the most studied in the context of axonal regeneration. In vitro it leads to growth 
cone collapse of both embryonic and adult DRG neurons (Reza et al., 1999). In 
vivo, following injury, SEMA-3 expression is increased by fibroblasts present in 
the glial scar. This expression forms an exclusion zone for regenerating axons 
(Pasterkamp et al., 1999; De Winter et al., 2002). The use of SM-216289, an agent 
that diminishes the effects of SEMA-3 by blocking its interaction to neuropilin-
1/plexin A (Kikuchi et al., 2003) leads to an increase in regeneration of 
serotonergic fibers following injury, but is unable to increase CST regeneration 
(Kaneko et al., 2006). Besides SEMA-3, other semaphorins have been linked to 
inhibition following CNS injury, namely semaphorin 4D (Moreau-Fauvarque et al., 
2003), semaphorin 7A (Pasterkamp et al., 2007) and semaphorin 6B (Kury et al., 
2004). 
 
4.2.2.2. Ephrins 
The exposure of neurons to ephrins leads to axonal repulsion. Ephrin B3 is 
present in CNS myelin while Ephrin B2 is expressed in reactive astrocytes 
following injury (Bundesen et al., 2003; Benson et al., 2005). Both signal 
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inhibition through the EphA4 receptor and lead to neurite growth inhibition 
(Benson et al., 2005; Fabes et al., 2006). In vivo, blockage of Ephrin A4 receptor 
does not promote regeneration, but CST sprouting is observed (Fabes et al., 
2007). 
Besides axonal growth inhibition, ephrins may be important in the glial 
scar formation. This hypothesis is supported by the fact that the EphA3 receptor 
and EphA7 are expressed in astrocytes following injury (Irizarry-Ramirez et al., 
2005; Figueroa et al., 2006) and also by the reduced glial scar formation in 
Ephrin A4 receptor KO mice (Goldshmit et al., 2004). 
 
4.2.2.3. Repulsive guidance molecules (RGM) 
RGM are a family of cell membrane associated glycosylphosphatidylinositol 
anchored glycoproteins. This family was identified as being repulsive and, 
important for the guidance of chicken temporal retinal axons (Monnier et al., 
2002). In mice, 3 RGM have been identified (RGMa, RGMb and RGMc). Following 
SCI, there is an increased expression of RGM around the injured area leading to 
axon growth inhibition (Schwab et al., 2005; Hata et al., 2006). Local 
neutralization of RGMa with a specific antibody promotes axonal regeneration 
and functional recovery (Hata et al., 2006). Neogenin receptor was identified as 
being the only receptor for RGMa, and it mediates its inhibitory effect 
(Rajagopalan et al., 2004) by a mechanism dependent on the RhoA/ROCK 
pathway (Conrad et al., 2007).  Besides axonal guidance and inhibition several 
other functions were described for RGMa such as importance in neural tube 
morphogenesis, cell adhesion, cell migration, cell polarity and cell differentiation 
(Key and Lah, 2012). 
 
4.2.3. Chondroitin sulphate proteoglycans (CSPGs) 
Upon injury, astrocytes are activated and start the production of extracellular 
matrix proteins, the CSPGs. These proteins represent a vast family of ECM 
proteins composed of a protein core linked to sulphated glycosaminoglycan 
chains. Some members of this family are: aggrecan, brevican, phosphacan, 
neurocan, versican and NG-2 (Silver and Miller, 2004; Rolls et al., 2009). Their 
importance as inhibitors of axonal regeneration is supported by three evidences: 
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following lesion there is an increase in the production and secretion of CSPGs 
(McKeon et al., 1999; Jones et al., 2003; Tang et al., 2003); in vitro assays show 
that CPSGs inhibit neurite outgrowth by growth cone collapse (Dou and Levine, 
1994; Friedlander et al., 1994; Milev et al., 1994; Yamada et al., 1997; 
Schmalfeldt et al., 2000) and treatment with chondroitinase, an enzyme that 
removes glycosaminoglycans from CSPGs (Prabhakar et al., 2005), is able to 
decrease the inhibitory environment formed in the glial scar and promote axonal 
regeneration following SCI (Bradbury et al., 2002; Yick et al., 2003; Caggiano et 
al., 2005). CSPGs mediate its inhibitory effect through receptor protein tyrosine 
phosphatases (Aricescu et al., 2002). Recently, NgR was also found to be a 
receptor for CSPGs, providing evidence that CSPG may share the molecular 
mechanism of inhibition with that of MAIs (Dickendesher et al., 2012). 
 
4.3. CNS neurons are not able to increase their intrinsic ability to 
regenerate 
In contrast to PNS axons, CNS neurons are not able to respond to injury (Zurn and 
Bandtlow, 2006; Huebner and Strittmatter, 2009). Most CNS neurons fail, or have 
a mild increase in the expression of RAGs following injury (Fernandes et al., 1999; 
Ylera et al., 2009). This constitutes a major drawback in axonal regeneration. In 
fact, when RAGs are overexpressed in CNS neurons, increased regeneration ability 
through an inhibitory environment is achieved (Bomze et al., 2001; Kwon et al., 
2007; Yang et al., 2012). 
Although some of the molecular mechanisms underlying RAG activation 
following PNS lesion are known, the reasons underlying the inability of CNS 
neurons to increase RAG expression were not addressed yet. In fact, the injury 
signals in the CNS that could prompt neurons to a pro-regenerative status have 
not yet been identified. Adult CNS neurons are maintained in a non-regenerative 
mode due to suppression of mTOR by PTEN (Park et al., 2008) and by the activity 
of cytokine signaling 3 (SOCS-3), an inhibitor of the JAK-STAT-3 pathway (Smith et 
al., 2009). Following injury, PTEN and SOCS-3 activity is maintained preventing 
any increase in the intrinsic ability of CNS axons to regenerate. Accordingly, it 
was shown that PTEN or SOCS-3 deletion improves regeneration of CNS neurons 
by increasing their growth capacity (Park et al., 2008; Smith et al., 2009). 
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Moreover, these 2 proteins function in independent mechanisms since deleting 
both further improves axonal regeneration following injury (Sun et al., 2011). 
Recently, in C. elegans, the conserved Arf guanine nucleotide exchange 
factor EFA-6, was also reported to be an intrinsic inhibitor of regrowth that 
operates by affecting axonal microtubule dynamics, acting downstream of and/or 
in parallel with DLK (Chen et al., 2011) [58].  
This evidence suggests that besides extrinsic factors, CNS axonal 
regeneration is also impaired by intrinsic repressors. As such, the manipulation of 
the intrinsic control of regeneration has emerged recently as a good target to 
promote axonal regeneration. 
 
5. Conditioning injury model 
Despite the general inability of CNS axons to regenerate, CNS axonal regeneration 
is possible: DRG neurons possess a peripheral branch that regenerates when 
injured (Fig. 18A), and a central branch that enters the spinal cord originating the 
dorsal column fibers that does not regenerate upon injury (Fig. 18B). However, 
when the peripheral branch is lesioned approximately 1 week prior to the lesion 
to its central branch (known as conditioning lesion), the central axons are 
prompted to regenerate and are able to overcome the glial scar inhibitory effect, 
regenerating to a significant extent (Richardson and Issa, 1984; Neumann and 
Woolf, 1999) (Fig. 18C). Besides the increase in regeneration of dorsal column 
fibers of conditioned DRG neurons in vivo, the consequences of a conditioning 
injury can also be observed in vitro, as conditioned DRG neurons have an 
increased neurite outgrowth ability (Fig. 18D,E) and are able to grow on a myelin 
substrate (Qiu et al., 2002). 
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Figure 18. The conditioning effect. The peripheral branch of DRG neurons is able to regenerate 
when injured (A), while the central one is not (B). However when an injury to the peripheral branch is 
performed before the injury to the central branch, the central branch can now regenerate (C). This 
result can also be seen in vitro, as naïve DRG neurons extend small branched neurites (D), while 
conditioned DRG neurons extend long unbranched neurites (E). 
 
The conditioning effect is the consequence of the activation of the 
regenerative machinery prior to the CNS lesion. The increase in the regeneration 
ability of DRG neurons encompasses RAG expression (Smith and Skene, 1997; 
Costigan et al., 2002) and changes in axonal transport induced by the PNS lesion 
(Hoffman, 1989; Hoffman and Luduena, 1996). In fact, the response starts as 
soon as one day following injury (Qiu et al., 2002), and has a long-lasting effect, 
since RAGs are expressed as long as two months following the conditioning injury 
(Ylera et al., 2009). 
The greatest regenerative effect is obtained when the conditioning injury is 
performed one week before the central injury. If the conditioning injury is 
performed following SCI, it does not provide any improvement in regeneration 
(Neumann and Woolf, 1999). A recent study showed that, although it does not 
improve axonal regeneration, the conditioning injury performed after SCI also 
increases the intrinsic ability of DRG neurons to regenerate (Ylera et al., 2009). 
The inability of a “post conditioning” injury to promote regeneration is due to the 
A B C 
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establishment of a thick glial scar that does not allow the regrowth of axons, even 
when expressing RAGs. In fact, the authors elegantly show that when performing 
laser single axon lesion, that cause minimal scarring, a conditioning lesion 
performed two weeks after is able to promote the regeneration of the central 
axons (Ylera et al., 2009). These experiments suggest that following a SCI, there 
is a small window of opportunity for treatment, before the glial scar becomes too 
thick. A prolonged delay in treatment, allows the formation of a thick glial scar 
that prevents the regeneration of central axons, even when these have an 
increased intrinsic ability to regrow. 
The conditioning effect represents a good model on how increasing the 
intrinsic ability of axons to regrow can improve axonal regeneration. As such, 
understanding the mechanism by which a conditioning injury prompts CNS axons 
to regenerate has been the focus of attention on the axonal regeneration field for 
many years. The most relevant finding was the fact that at least in part, the 
conditioning effect was mediated by cAMP (Qiu et al., 2002). This finding 
together with others made cAMP the main target to promote regeneration. In fact, 
the use of phosphodiesterase (enzyme responsible for cAMP degradation) 
inhibitors, such as rolipram was shown to increase cAMP levels and improve 
recovery following SCI (Nikulina et al., 2004; Pearse et al., 2004). However, the 
use of phosphodiesterase inhibitors leads to disabling nausea, limiting its clinical 
application. 
Several studies using array techniques identified broad changes in gene 
expression of conditioned neurons (Costigan et al., 2002; Cao et al., 2006). In 
fact these changes are regulated by the activation of multiple transcription factors 
including c-Jun, sox11, CREB, Smad1, ATF-3, AKRD1, nuclear factor interleukin 3 
regulated (NFIL3) and STAT-3 (Kiryu-Seo and Kiyama, 2011). The conditioning 
injury triggers the expression of traditional RAGs such as GAP-43 and CAP-23 
(Hoffman, 1989), but it also allowed the identification of novel RAGs such as Arg-
1 (Cai et al., 2002; Deng et al., 2009), leukemia inhibitory factor (Cafferty et al., 
2001), IL-6 (Cafferty et al., 2004; Cao et al., 2006) and tissue plasminogen 
activator (Minor et al., 2009). However, none of the identified transcription factor 
or RAGs is able to reproduce the extension of the conditioning effect. As such, 
the quest for clinically relevant molecules that mimic the conditioning lesion 
should be pursued. 
  Introduction 
69 
 
Besides the transcription changes observed following conditioning injury, 
another important alteration occurs that may contribute to axonal regeneration. It 
has been shown that a conditioning injury is able to increase axonal transport in 
both DRG branches (Hoffman and Luduena, 1996; Hoffman, 2010). Furthermore, 
these alterations were identified as being independent of cAMP, since cAMP is 
able to trigger transcription changes but it does not alter axonal transport (Han et 
al., 2004). It has also been shown that conditioned neurons present increased 
protein synthesis in their axons following injury, and this local synthesis may also 
underlie their high ability to regenerate (Zheng et al., 2001; Verma et al., 2005). 
Recently, histone deacetylase 5 (HDAC5) has been described as a key 
element in the conditioning response. Upon injury, the initial depolarization wave 
is able to activate protein kinase Cµ at the cell body promoting nuclear export of 
HDAC5. Absence of HDAC5 at the nucleus leads to increase histone acetylation 
activating the pro-regenerative program (Cho et al., 2013). This epigenetic 
mechanism controls the switch from non-regenerative to growth-competent 
axons. This initial phase where histones are acetylated prime the neuronal DNA to 
the positive injury signals that will be conveyed later through the retrograde 
transport machinery (Cho et al., 2013). In the proposed mechanism, the initial 
depolarization alters neurons so that they can respond rapidly to further signals, 
explaining why the initial depolarization by itself cannot trigger a long-lasting 
response. 
In summary a conditioning injury triggers a robust response to induce 
regeneration. Transcriptional changes together with changes in local protein 
synthesis and axonal transport make the conditioning injury a powerful paradigm 
that can hardly be reproduced by the stimulation of a single gene/protein. 
 
6. Important tools to study CNS axonal regeneration 
The complexity of the CNS makes the study of CNS axonal regeneration a great 
challenge. It is important to distinguish the different types of axonal 
regeneration, as well as the different models available to study it. In this chapter 
such features will be discussed. 
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6.1. Axonal plasticity: regeneration vs sprouting 
The classification of axonal growth following injury is a matter of debate in the 
regeneration field. Indeed in many studies, the terms regeneration and sprouting 
are incorrectly used as synonyms. Although both types of axonal growth are 
induced by injury and can lead to functional improvements, they represent 
distinct types of growth. Axonal regeneration consists on the regrowth of an 
injured axon through and beyond the lesion site (Fig. 19A). This type of growth is 
very characteristic of PNS axons, while in the CNS it is very limited (Lee and 
Zheng, 2012; Tuszynski and Steward, 2012). Sprouting accounts for the capacity 
of axons to grow new small branches to establish new connections. This 
phenomenon can happen both in injured and non-injured (spared) axons. In the 
proximal side of an injured axon, when it faces a high inhibition in the injury site 
and cannot regrow beyond it, it may form a small branch that is able to establish 
a new connection with an uninjured neuron (Fig. 19B). This new connection may 
allow the indirect reconnection of the injured axon to its former target. This kind 
of regrowth is known as regenerative sprouting (Tuszynski and Steward, 2012). 
Injury can also induce sprouting of spared axons. In this case, spared axons are 
able to establish new connections that can reinnervate the targets that lost their 
connections (Fig. 19C). This process is known as collateral sprouting (Lee and 
Zheng, 2012). 
 
Figure 19. Axonal regeneration and sprouting. Injured axons can regenerate through the glial scar 
(A), or extend lateral sprouting to form new connections (B). Spared axons may also form sprouts 
that may reinnervate axons that lost their connections (C). Adapted from (Giger et al., 2010). 
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If the correct models and methodology are not used, the distinction 
between regeneration and sprouting becomes challenging to do. If some axons 
are inadvertently spared and they are able to sprout, this may lead to the wrong 
notion that an increased regeneration has taken place. 
Regeneration through long distances in the CNS is a daunting task. Not 
only the environment of the CNS is not favorable, but also CNS neurons do not 
have the proper tools for such a long regrowth. As such, sprouting is probably 
more promising as a mechanism to improve functional recovery. 
 
6.2. Injury models to study CNS axonal regeneration. 
The spinal cord is composed of several axonal tracts with different functions and 
regeneration abilities. In this chapter I will discuss the different tracts that can be 
used to study axonal regeneration as well as their main advantages 
/disadvantages. 
 
6.2.1. Dorsal column fibers 
The dorsal column fibers are ascending sensory fibers. They originate in the 
dorsal root ganglia where their cell body is. These are pseudo-unipolar neurons 
with one axon going to the PNS and the other ascending through the dorsal white 
matter in the spinal cord (Fig. 20) to the nucleus gracilis in the brainstem (Hebel 
and Stromberg, 1986). When a dorsal hemisection is performed, all dorsal column 
fibers are sectioned. The fibers can be labeled by a tracer injection like cholera 
toxin-β (CT-β) in the sciatic nerve. This constitutes a simple model to study the 
mechanisms underlying CNS regeneration and to test therapies to enhance axonal 
regeneration (Tuszynski and Steward, 2012). 
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Figure 20. Dorsal column fibers. Dorsal column fibers (in the red and green areas) ascend in the 
dorsal white matter. 
 
6.2.2. Raphespinal fibers 
The raphespinal tract originates in the brainstem raphe nuclei and is composed of 
motor descending fibers. They descend through the spinal cord as dispersed 
bundles of axons surrounding the central gray matter (Fig. 21). These fibers are 
one of the most plastic fibers in the CNS with high ability to regenerate. Due to 
their sparse localization within the spinal cord, only a complete transection is 
able to injure all raphespinal fibers. These are the only serotonergic fibers 
present in the spinal cord. As such an immunohistochemistry to serotonin 
(antibody against 5-hydroxytyptamine-5HT) labels the raphespinal fibers in the 
spinal cord (Lee et al., 2010). Several studies reported improvements in 
raphespinal fiber regeneration using models of incomplete injury, however such 
models do not exclude the possibility that the increased fiber number below the 
injury site is due to sprouting of spared fibers. The correct conclusion that 
applies to this case is that an increase in axonal growth was found instead of an 
increase in axonal regeneration (Cafferty et al., 2010; Hellal et al., 2011). 
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Figure 21. Raphespinal fibers. The raphespinal fibers descend in the spinal cord as dispersed 
bundles of fibers in the gray matter. Lumbar spinal cord cross section immunostained for 5HT. 
 
6.2.3. Rubrospinal fibers 
The rubrospinal fibers originate in the red nuclei of the midbrain and are 
composed of motor fibers that descend through the dorsal part of the lateral 
column. Their regeneration can be studied with a model of lateral hemisection by 
labeling the fibers with tracer injection in the brainstem. But again, if only a 
lateral hemisection is performed, the possibility of sprouting of spared axons 
cannot be excluded. This tract is much more prone to regenerate than the other 
motor tract, the CST. However the fact that in humans it is residual makes it 
unattractive to study (Tuszynski and Steward, 2012). 
 
6.2.4. Corticospinal tract (CST) 
The CST is the most important tract for voluntary motor function. It originates in 
the sensory motor cortex and in rodents it descends mainly in the dorsal white 
matter (Fig. 22), with a small number of fibers descending through the lateral 
white matter. In humans, the lateral tract is the major CST tract. The CST is one of 
the most refractory tracts to regeneration. It can be labeled by tracer injection, 
like biotin dextran amine in the layer 5 of the sensorimotor cortex. Usually, the 
dorsal hemisection is used as a model in rodents since it injures almost all axons. 
Nevertheless the sparing of the lateral fibers cannot be excluded in this model. 
Due to its lower ability to regenerate, the use of a complete transection, where 
the glial scar formed is much bigger than after a hemisection, and where a gap of 
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millimeters may occur, is not advisable. There are no studies showing 
convincingly that there is CST regeneration following a complete transection. A 
contusion injury constitutes an alternative to the complete injury, since the tissue 
retraction is avoided. However even using a severe contusion, some CST fibers 
are spared (Tuszynski and Steward, 2012). 
 
Figure 22. Corticospinal tract. The corticospinal fibers (in the red and green areas) descend in the 
dorsal white matter close to the gray matter. 
 
6.2.5. Optic nerve 
Although it is not a spinal cord tract, the optic nerve is one of the most used CNS 
tracts to study both regeneration (Park et al., 2008; Smith et al., 2009) and 
guidance/elongation during development (Mann and Holt, 2001; van Horck et al., 
2004; Jung et al., 2012). The retinal ganglion cells are located in the inner surface 
of the retina and their axons form the optic nerve. The optic nerve has a simple 
structure with an easy access to perform crush and where regenerating axons can 
be labeled by intravitreal injection of a tracer. These characteristics make it a 
good and easy model to study axonal regeneration in the CNS. Moreover, with the 
increased use of transgenic mice, it became an even more powerful tool. 
Lentivirus expressing Cre recombinase can be injected intravitreally in animals 
with floxed genes. This model constitutes an easy, fast and economic way of 
generating conditional/tissue specific KO mice that can be used to study the 
importance of specific genes in axonal regeneration (Park et al., 2008; Smith et 
al., 2009; de Lima et al., 2012). 
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6.3. In vivo imaging, a new tool to study axonal regeneration 
Classical tools for the analysis of axonal regeneration in spinal cord injury models 
consist in the labeling of a particular axonal tract followed by measuring the 
extension of axonal regrowth through or beyond the injury site. Despite that this 
approach led to important achievements, it has several limitations. Although time 
course experiments can be performed to analyze axonal regeneration, this leads 
to several static pictures at different time points which may not allow the 
visualization and comprehension of the dynamic response to injury, and the 
regrowth process. Another important limitation is the possible variability of 
neuronal tracing due to variance in the amount and site of tracer injection. If not 
performed correctly, it may also lead to the labeling of undesired fibers. 
The inability to surpass these classical tools was due to technical 
limitations, but also to the absence of suitable mouse models. Recently several 
mouse models have been generated for use in in vivo imaging. These models 
consist in the expression of a fluorescent protein in a subset of neurons, usually 
in less than 10% of the neurons (Feng et al., 2000; Kerschensteiner et al., 2005; 
Young et al., 2008). Genetically labeled neurons also present higher expression 
than neurons infected with viruses. With the correct mouse model, superficial 
axons in the spinal cord, like dorsal column fibers, can be imaged with a basic 
epifluorescent microscope. The main advantage of in vivo imaging when 
compared to classical methods is the possibility of the direct observation of the 
response to injury. It also allows a clear distinction between regenerative and 
spared axons, or between inhibition of degeneration and increase in 
regeneration. In short it allows unraveling the mechanisms by which axons 
respond to injury (Laskowski and Bradke, 2012). 
Although powerful, in vivo imaging is still a recent technique with many 
limitations. It requires extensive expertise both in spinal cord surgery and 
imaging. The prolonged anesthesia together with the extensive and multiple 
surgeries performed increases the risk of complications like infection. Also, long 
term observations are even more demanding due to the formation of a thick glial 
scar in the injury site. Another difficult task is the choice of good landmarks like 
blood vessels that allow for the correct measurement of the axonal regeneration 
distance. Even with state of the art multiphoton microscopy, live imaging allows 
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only observation of relatively superficial axons (50µm deep), limiting the axonal 
tracts evaluated. 
Recently two methods were described for chronic imaging of spinal cord 
injury. They consist in the implantation of a homemade chamber in the vertebral 
column (Farrar et al., 2012) or of a glass window attached to the spinal cord 
(Fenrich et al., 2012). Both methods present minimal scarring enabling successful 
imaging for as much as 22 imaging sessions up to 350 days following surgery. 
The other main advantage is the possibility of visualizing chronic injury with a 
single surgery. It is exciting to see if the next developments of this technique 
fulfill its great potential. 
 
7. Possible treatments to achieve axonal regeneration following 
spinal cord injury.  
In the last two decades, methylprednisolone was the only drug administered 
following SCI. Although initially described as improving functional recovery, in 
recent studies its benefits have been questioned (Coleman et al., 2000; Hurlbert, 
2000; Bracken, 2001; Miller, 2008), which led to abandon methylprednisolone as 
a treatment to SCI. Nowadays the only treatment available following SCI is 
rehabilitation. The main goal of rehabilitation is to prevent further complications 
and maximize physical function. As such, there is a total absence of therapies to 
promote axonal regeneration and functional recovery of patients with acute or 
chronic SCI. 
The limitations for axonal regeneration in the CNS are well identified. The 
lack of an intrinsic regenerative ability, together with the formation of a thick glial 
scar, where injured axons are exposed to several inhibitors poses a great 
challenge to achieve axonal regeneration. As such, most pre-clinical strategies 
consist in overcoming these two main obstacles, either by stimulating neurons to 
increase the intrinsic ability to regrow their axons or by modulating the injury site 
environment so that it becomes less inhibitory. 
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7.1. Modulation of the injury site environment 
Modulation of the injury environment was the first strategy used successfully in 
animal models. The neutralization of the inhibitors present in the spinal cord 
following injury is an attractive strategy for treatment. Initial studies using IN-1, 
an antibody produced against myelin components showed promising results, 
promoting axonal regeneration following SCI (Schnell and Schwab, 1990). As 
described above, IN-1 recognizes Nogo-A, the most studied regeneration inhibitor 
(Chen et al., 2000), but it is not specific for Nogo-A (Caroni and Schwab, 1988). 
Other antibodies produced against Nogo showed less pronounced improvements 
(Liebscher et al., 2005). Even when neutralizing Nogo, several other inhibitors are 
still present. Many of the inhibitors like other MAIs or CSPG share a common 
receptor, NgR. The blockage of NgR should then have a broader effect since it 
may block the effect of several inhibitors. Indeed peptide blocking of NgR was 
reported to improve axonal regeneration (GrandPre et al., 2002; Li and 
Strittmatter, 2003; Cao et al., 2008). However, the use of the blocking peptide 
was re-assessed and no relevant improvements were found (Steward et al., 2008). 
Besides Nogo, antibody blocking of other inhibitors like RGMa (Hata et al., 2006) 
and proteoglycan NG2 (Tan et al., 2006) also diminishes the inhibitory 
environment following injury promoting axonal regeneration. 
CSPGs are one of the most important inhibitory components of the glial 
scar. The degradation of the glycosaminoglycan chains by chondroitinase ABC 
diminishes the inhibitory effect of CSPGs and its use in vivo has led to significant 
functional improvements in CNS regeneration (Moon et al., 2001; Bradbury et al., 
2002; Yick et al., 2003; Caggiano et al., 2005; Tester and Howland, 2008). 
Although blocking a particular inhibitor may lead to improvements, the reality is 
that several other inhibitory molecules are still present and may take the place of 
the inhibitor neutralized. Multi-targeting several inhibitory classes should 
promote better outcomes. 
Another important approach to overcome the inhibitory environment at the 
lesion site is to provide “bridges” that provide axons an alternative path without 
contacting the inhibitors. The first bridge successfully used was a peripheral 
nerve graft which allowed for regeneration of CNS axons (Richardson et al., 1980; 
David and Aguayo, 1981). Transplant of fetal spinal cord to the injury site also 
promotes the growth of axons within the injury site (Jakeman and Reier, 1991). 
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The use of cell transplantation has caught most of the attention in an attempt to 
“build bridges” in the injury site. The main goal is to have cells that integrate well 
within the injury and form a cellular matrix capable of linking the rostral and 
distal injury borders (Lu and Tuszynski, 2008). The successful use of PNS graft by 
(David and Aguayo, 1981), raised the possibility that Schwann cells could 
ameliorate the environment following SCI improving functional recovery. Indeed it 
has been shown that Schwann cell transplantation produces functional recovery 
(Pinzon et al., 2001; Takami et al., 2002).  In fact, the studies with cell 
transplantation following SCI to improve recovery have been growing extensively. 
In this respect, bone marrow stromal cell (MSC) transplantation has been widely 
used to facilitate the bridging following injury. When used in combination with 
other treatments that increase the intrinsic regeneration ability of neurons, MSCs 
have a synergistic effect (Lu et al., 2004; Kadoya et al., 2009). Transplantation of 
olfactory ensheating cells (OEC) has also been reported to promote improvements 
following SCI. It has been shown that OEC transplantation improves both survival 
and regeneration following SCI by producing neurotrophic factors, as well as by 
reducing the CSPG production by astrocytes (Tohda and Kuboyama, 2011). One of 
the most attractive features of MSC and OEC transplantation is the possibility of 
autologous transplant. Besides trophic support, cell transplantation can be used 
to replace the lost cells following injury. In this case, stem cell transplantation 
becomes important in doing so. Both embryonic stem cells (ESCs) and neural 
stem cells (NSCs) have been used successfully, improving functional recovery and 
being able to differentiate in oligodendrocytes and neurons (Pego et al., 2012). 
Recently, the implantation of embryonic neural stem cells following spinal cord 
injury has been shown to increase regeneration and functional recovery 
remarkably. The implanted cells were able to extend axons and build new circuits 
that led to improved function (Lu et al., 2012). 
 
7.2. Increase of the intrinsic regeneration ability of CNS neurons 
cAMP is one of the most important intracellular signals. It is synthesized from 
ATP by adenylyl cyclase at the plasma membrane and it is degraded by 
phosphodiesterase. For the past 15 years, cAMP got most of the attention in the 
axonal growth and regeneration field. Young CNS neurons have high ability to 
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elongate. This ability is lost during development due to a decrease in cAMP levels 
(Cai et al., 2001). The high levels of cAMP during development also make axon 
growth cones attracted to guidance cues like netrin-1 and SEMA-3, that are 
repellent to adult neurons (Ming et al., 1997; Song et al., 1998). Two of the most 
relevant findings were that cAMP can prompt neurons to overcome myelin 
inhibition in vitro (Cai et al., 1999; Qiu et al., 2002), and that treatment with db-
cAMP, a cell permeable analog of cAMP increases the regeneration of dorsal 
column fibers following SCI (Neumann et al., 2002; Qiu et al., 2002). This led to 
the notion that the manipulation of cAMP levels in neurons could allow them to 
overcome the inhibitory environment following SCI. The use of phosphodiesterase 
inhibitor drugs like rolipram increases cAMP levels by preventing its degradation 
(Udina et al., 2010), leading to increased axonal regeneration and functional 
recovery (Nikulina et al., 2004; Bretzner et al., 2010). However, the use of such 
drugs induces disabling nausea making them unsuitable for treatment. 
Furthermore, the robust effects of cAMP initially reported have been questioned 
by recent studies (Han et al., 2004; Blesch et al., 2012). 
Besides cAMP, some of its downstream targets such as Arg-1 or IL-6 have 
been tested as possible enhancers. IL-6 was identified as being able to induce 
regeneration (Cafferty et al., 2004; Cao et al., 2006) and daidzein (a soy 
isoflavone) has been identified as a potent inducer of Arg-1 expression that can 
induce axonal protection and growth (Ma et al., 2010). However, none of them 
has shown enough potential to be relevant in an in vivo human condition. 
Recently, the regeneration field has been focused on PTEN and SOCS-3. 
These 2 proteins were identified as potent regeneration inhibitors, as their 
removal promotes a robust increase in regeneration (Park et al., 2008; Sun et al., 
2011; de Lima et al., 2012). Despite the robust effects described so far, further 
studies are needed to strengthen their role in axonal regeneration. 
Neurotrophins are a class of small molecules that are important for the 
regulation of neuronal functions. NGF was the first neurotrophin identified. After 
NGF, many others were identified: BDNF, neurotrophin 3 and 4 (NT-3/4) and 
GDNF. They regulate neuronal survival and the interaction of neurons with their 
targets (Kirstein and Farinas, 2002). Moreover, they are also capable of inducing 
axonal growth and RAG expression (Gillespie, 2003) and to suppress myelin 
inhibition by increasing cAMP levels (Cai et al., 1999; Gao et al., 2003). When 
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applied following SCI, neurotrophins lead to functional improvements and to 
axonal regeneration of different tracts. NGF, BDNF and NT-3 are the most used 
ones with reports of all of them showing increased axonal regeneration (Schnell 
et al., 1994; Oudega and Hagg, 1996; Bregman et al., 1997; Bradbury et al., 
1999; Oudega and Hagg, 1999; Song et al., 2008). The injection of lentivirus 
expressing NT-3 distally to the injury site was shown to create a chemoattractant 
gradient allowing axonal bridging of the injury site (Taylor et al., 2006). 
Inflammation is a crucial step following injury encompassing the 
production of pro-inflammatory cytokines like TNF-α and IL-1β, and leukocyte 
recruitment.  Usually its effects are seen as deleterious, and as discussed above, 
methylprednisolone a potent anti-inflammatory drug was previously seen as the 
only treatment available. Although it was reported initially as improving 
functional recovery, later studies questioned such evidences. The use of the anti-
inflammatory cytokines interleukin 10 (IL-10) and IL-6 has shown improvements 
in recovery following SCI. IL-10 has a neuroprotective effect and its use promotes 
neuronal survival of injured neurons (Zhou et al., 2009), while IL-6 increases the 
axonal growth ability of neurons and overcomes myelin inhibition (Cafferty et al., 
2004; Cao et al., 2006). Its use following injury promotes functional recovery by 
increasing axonal regeneration (Cafferty et al., 2004; Cao et al., 2006; Yang et al., 
2012). Another evidence that the inflammatory response could be modulated to 
improve axonal regeneration is the ability of activated macrophages to promote 
regeneration of retinal ganglion cells following optic nerve injury. Activated 
macrophages are able to produce oncomodulin that increases the ability of 
neurons to grow their axons (Yin et al., 2006). However, in the context of SCI, the 
use of zymosan, a yeast cell wall preparation known for its ability to activate 
macrophages, leads to improvements by reducing the injured area and not by 
improving the ability of neurons to regenerate (Benowitz and Popovich, 2011). 
Injured CNS axons usually fail to form a growth cone and instead originate 
a non-regenerative structure called retraction bulb. The formation of a growth 
cone instead of a retraction bulb is absolutely essential to start regeneration 
(Bradke et al., 2012). Recent studies have focused on promoting regeneration by 
the direct action on the injured axon tip, increasing the possibility of growth cone 
formation. Cytoskeleton components are the strongest candidates to promote the 
formation of a growth cone. Indeed, the use of taxol stabilizes microtubules and 
promotes the formation of growth cones which can overcome the myelin 
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inhibitory effect (Erturk et al., 2007). The use of taxol was also shown to improve 
axonal regeneration following SCI (Hellal et al., 2011). 
Most of the therapies referred so far require local administration at the 
injury site, either by local injection of cells, or by the implantation of osmotic 
pumps to deliver antibodies or drugs. This type of treatment, involves at least 
one invasive procedure, increasing the risk of complications in patient’s recovery. 
As such, the use of electrical stimulation in a non-invasive manner for treatment 
poses an attractive alternative. However, the effects of electrical stimulation are 
not consensual, although it has been reported as beneficial following SCI being 
able to promote regeneration of dorsal column fibers by increasing their intrinsic 
ability to regenerate (Udina et al., 2008). 
 
7.3. Combined therapies 
Although many single therapies are able to improve recovery following SCI in 
animal models, the effects produced are usually minimal. The use of multiple 
approaches might be able to combine all the small improvements and in many 
instances have a synergistic effect on regeneration. Usually combinatorial 
therapies are constituted at least by one method to improve the intrinsic 
regeneration ability of neurons and a therapy to reduce the inhibitory effects 
within the injury site.  
The use of tissue or cell transplantation for bridging, together with 
phosphodiesterase inhibitor to increase the levels of cAMP promote recovery to 
levels higher than any individual therapy (Nikulina et al., 2004; Pearse et al., 
2004). MSC transplantation together with NT-3 treatment was also reported to 
promote robust regeneration within the glial scar (Lu et al., 2007). Other methods 
to decrease the inhibitory effect of the glial scar like the use of chondroitinase 
ABC together with other therapies like zymosan or neurotrophins act 
synergistically to promote regeneration (Tropea et al., 2003; Steinmetz et al., 
2005; Garcia-Alias et al., 2011). 
The use of combinatorial therapies provides a wide range of possibilities 
without a limit to the number of therapies that can be used at the same time. Two 
recent studies show cumulative benefits of using four different therapies: 
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increase the intrinsic growth capacity of axons by dcAMP delivery or conditioning, 
MSC transplantation together with NT3 delivery and the creation of a 
chemoattractive gradient of NT-3 across the injury site (Lu et al., 2004; Kadoya et 
al., 2009) (Fig. 23). 
 
Figure 23. Combined approach to treat SCI. Example of a combined approach using lentivirus 
expressing NT-3 rostral to the injury, together with MSC and NT-3 at the injury site to form bridges 
and conditioning injury to increase the intrinsic growth ability of DRG neurons. Adapted from 
(Kadoya et al., 2009). 
 
In the last two decades, the axonal regeneration field had important 
developments that allowed us to understand novel mechanisms on how the 
environment interferes in axonal regrowth and on how the intrinsic ability of 
neurons to regenerate is controlled. Despite all these improvements, the study of 
axonal regeneration of CNS neurons still did not lead to the development of any 
effective clinical treatment. As such, further knowledge is needed to improve 
either axonal regeneration or sprouting to an extension that may have meaning 
on the human scale. 
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Although neurons execute a cell intrinsic program of axonal
growth during development, following the establishment of con-
nections, the developmental growth capacity declines. Besides
environmental challenges, this switch largely accounts for the fail-
ure of adult central nervous system (CNS) axons to regenerate.
Here, we discuss the cell intrinsic control of axon regeneration,
including not only the regulation of transcriptional and epigenetic
mechanisms, but also the modulation of local protein translation,
retrograde and anterograde axonal transport, and microtubule
dynamics. We further explore the causes underlying the failure of
CNS neurons to mount a vigorous regenerative response, and the
paradigms demonstrating the activation of cell intrinsic axon
growth programs. Finally, we present potential mechanisms to
support axon regeneration, as these may represent future thera-
peutic approaches to promote recovery following CNS injury and
disease.
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Introduction
During development, by implementing a transcription-dependent
program relying on multiple signaling pathways, neurons display
robust elongation capacity that allows them to reach their targets.
Following this initial phase, with the establishment of connections
the developmental axon elongation ability declines. The view that
neurons in the adult CNS permanently lose their intrinsic ability to
grow axons was challenged by seminal studies by the Albert Aguayo
group, showing that the use of peripheral nerve “bridges” in the
spinal cord permits CNS axons to grow for considerable distances
following injury [1]. These studies demonstrated that adult CNS
neurons can activate a cell intrinsic program that supports axonal
regrowth, provided that a permissive environment is created. These
initial reports fueled efforts to characterize the extrinsic cues that
inhibit axon growth in the CNS, while the cell intrinsic mechanisms
that govern axon regeneration remained poorly understood. Several
decades later, the body of knowledge gathered supports the view
that counteracting or removing the extracellular inhibitory mole-
cules results in incomplete axon regeneration in vivo and that a bet-
ter understanding of cell intrinsic mechanisms regulating axon
growth following injury is needed [2].
In contrast to the CNS, adult peripheral nervous system (PNS)
axons can spontaneously regrow to a significant extent and are
often used as a model to identify the players that promote axon
regeneration. The regenerative capacity of the PNS is supported by
the combination of extrinsic and intrinsic factors that generate a
growth-permissive milieu where the execution of a cell intrinsic pro-
gram leads to successful axonal regrowth. Cell intrinsic changes
induced by a PNS injury can be observed in vitro and in vivo, as will
be discussed in the context of the conditioning lesion paradigm. In
CNS neurons, the combined action of repressors of axonal growth,
the limited injury signaling mechanisms, and the lack of robust
expression of regeneration-associated genes (RAGs) results in a
restricted potential to regenerate. Here, we will provide a critical
perspective of our understanding of the intrinsic mechanisms con-
trolling axonal regeneration in the adult nervous system. With the
term cell intrinsic, we refer to mechanisms that do not strictly
depend on external cues, although external cues can influence their
activity. As such, this review is not restricted to the discussion of
changes in the expression of the neuronal genetic program, that is,
transcriptional and epigenetic mechanisms and regulation of transla-
tion, but is extended to the analyses of intracellular pathways and
mechanisms—including axonal transport and microtubule dynamics
—that regulate axon growth and regeneration.
Cell intrinsic mechanisms of axonal regeneration in
the PNS
Calcium influx into the axoplasm is one of the first signals caused by
injury, and the depolarization triggered by the inversion of the
calcium/sodium flux travels along the axon to the cell body.
Calcium influx is here discussed in the context of the cell intrinsic
factors that govern axon regeneration as it elicits various cell auton-
omous mechanisms necessary for successful axon growth, ranging
from the regulation of intracellular pathways to the generation of
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epigenetic changes. In Caenorhabditis elegans sensory neurons, the
amplitude of the axonal calcium waves correlates with the extent of
regeneration, and conversely, inhibition of voltage-gated calcium
channels, or of calcium release from internal stores, reduces the
regenerative growth of axons [3]. Although the consequences of
electrical stimulation produce conflicting results, possibly due to dif-
ferences in stimulation paradigms, a weak stimulus may improve
the regeneration of rat motor [4] and sensory neurons [5]. However,
a strong electrical pulse mimicking the physiological activity of adult
rodent dorsal root ganglia (DRG) neurons strongly inhibits axon out-
growth, and loss of electrical activity following PNS injury promotes
axonal regeneration in the PNS [6].
Independently of the electrical activity generated by calcium
influx, the calcium transient activates intracellular signaling
required for resealing the axonal membrane in giant squid axons
[7], for local protein synthesis after optic nerve crush in rats [8,9]
and for the assembly of a competent growth cone after axotomy of
Aplysia buccal neurons [8,9]. Besides, calcium influx activates
calcium-dependent enzymes including adenylate cyclase, leading to
increased cAMP levels that signal to the downstream dual leucine
zipper kinase (DLK-1) promoting the local transformation of the
cytoskeleton needed for growth cone assembly in C. elegans sensory
neurons [3] (Fig 1). In mouse sensory neurons, the calcium wave
requires calcium release from internal stores in addition to voltage-
gated calcium channels [10]. Importantly, this back-propagating
calcium wave invades the soma causing protein kinase Cl (PKCl)
activation followed by nuclear export of histone deacetylase 5
(HDAC5), thereby increasing histone acetylation and activating the
proregenerative transcription program [10] (Fig 1). This epigenetic
mechanism controls the switch from non-elongating to growth-
competent axons [10]. This early and fast calcium-dependent phase
of injury signaling has been suggested to prime the neuronal cell
body to the signals that will be conveyed later, after microtubule-
dependent retrograde transport along the axon [10].
The importance of increasing histone acetylation to induce
axonal regeneration has also been demonstrated using the HDAC
inhibitor valproic acid, which improves the outcome in a rat model
of spinal cord injury [11]. Further reinforcing the link between
increased axon growth and histone acetylation, in mouse DRG neu-
rons triggered into a growth state, as is the case following condition-
ing lesion (this model is discussed below), histone 4 acetylation is
restored and RAG transcription is initiated [12]. During this epige-
netic reprogramming, histone-modifying enzymes together with
Smad1 facilitate the transcriptional activation of RAGs, including
neuropeptide Y (NPY), vasointestinal peptide (VIP), Sprr1a, and
galanin, thus providing a link between transcription factors and
RAGs through epigenetic regulation [12]. Importantly, the Smad1
pathway has been recently shown to be central for promoting rat
sensory axon regeneration [13]. Several other epigenetic mecha-
nisms have been reported in the context of axon regrowth [14]. The
histone acetyltransferases CBP/p300 acetylate histone 3 at K9-14
and the transcription factor p53, thereby initiating a proregenerative
transcriptional program that regulates RAG expression in rodents
[15–17]. In this context, p300 directly occupies and acetylates
histones in the promoters of the growth-associated protein 43
(GAP-43), coronin 1 b, and Sprr1a driving the expression of several
RAGs [17]. The importance of this mechanism is highlighted by the
observation that, in the model of optic nerve crush, overexpression
of p300 promotes axonal growth [17]. Besides, axonal regeneration
in the rodent CNS after spinal cord injury is dependent on the folate
pathway through DNA methylation [18]. A thorough comparison of
the epigenetic landscape in regenerative and non-regenerative
conditions is required to translate the knowledge gathered in this
field into novel therapeutic approaches [19].
Retrograde transport of locally activated injury signals
In addition to calcium-mediated signaling, studies using Aplysia
neurons described the first injury signals capable of communicating
lesion from the injury site to the cell body [20,21]. In Aplysia, injec-
tion of axoplasm from injured nerves into na€ıve neurons triggers an
injury-like behavior accompanied by increased growth. The model
proposed to explain this behavior has been that phosphorylation of
injury signals exposes hidden nuclear localization signals (NLS),
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targeting them to the nucleus [22]. The importance of retrograde
transport of NLS-containing proteins has been demonstrated later in
rats, as injection of an NLS synthetic peptide into the injured nerve
competes with the activation of intrinsic growth programs by
preventing the retrograde transport of injury signals [23]. NLS-
containing proteins bind with low affinity to importin-a, the only
importin present in intact nerves, but with high affinity to importin-
a/b heterodimers. Following injury, local translation of importin-b
at the injury site leads to the formation of importin-a/b hetero-
dimers, which bind to NLS-containing proteins and are retrogradely
transported to the cell body [23]. In fact, axonal localization of
importin-b mRNA is essential for the correct assembly of the retro-
grade transport machinery of injury signals as demonstrated in
rodent DRG neurons [24]. In the case of ERK, its binding to the
retrograde transport machinery is not dependent on an NLS signal.
Instead, ERK is linked to the retrograde transport machinery through
locally synthesized vimentin [25] (Fig 2), as further discussed
below. Besides importin-b, Ras-related nuclear protein binding pro-
tein 1 (RanBP1) is also synthesized locally after injury, allowing the
binding of importin-a/b heterodimers to dynein in rat DRG neurons
[26]. Below, the importance of local protein translation in axon
regeneration will be further discussed.
Several injury signals locally activated and retrogradely trans-
ported to the cell body have been identified using mostly rat or
mouse DRG neurons and sciatic nerve injury as a model: extra-
cellular signal-regulated kinase (ERK) [25], c-Jun N-terminal kinases
(JNK) [27], and signal transducer and activator of transcription 3
(STAT3) [28] (Fig 1). In the case of ERK, the use of MEK1,2 inhibi-
tors following peripheral nerve injury reduces the regenerative
response, suggesting that MEK may phosphorylate ERK at the injury
site [25]. To overcome the challenge of transporting phosphorylated
signals from the injury site to the cell body, protection mechanisms
HDAC5
Synthesis and anterograde
transport of RAGs
Arg1, NPY, VIP, IL-6, GAP-43
Activation and retrograde
transport of injury signals
ERK, JNK, STAT3
Negative injury signals
     Target-derived molecules
     Electrical activity
Calcium wave
Calcium influx
cAMP PKA DLK-1
Figure 1. The injury response of a PNS neuron.
Repression of axonal elongation can be relieved upon injury through the interruption of target-derived negative injury signals and electrical activity. Calcium influx into the
axoplasm activates cAMP and PKA, signaling to DLK-1 and promoting growth cone formation, local protein synthesis, and resealing of the axonal membrane. The calcium
wave back-propagates to the cell body, leading to HDAC5 nuclear export, activating the proregenerative transcription program. Following the calcium-dependent early
phase, retrograde transport of injury signals including ERK, JNK, and STAT3 occurs. In the cell body, RAGs (Arg1, NPY, VIP, IL-6, GAP-43, among others) that are necessary to
mount a regenerative response are expressed. cAMP, cyclic adenosine monophosphate; DLK-1, dual leucine zipper kinase 1; ERK, extracellular signal-regulated kinase;
HDAC5, histone deacetylase 5; JNK, c-Jun amino-terminal kinase; RAG, regeneration-associated gene.
Figure 2. Injury induces profound changes in axonal transport and local protein synthesis.
Following injury, local protein synthesis is activated. Axotomy triggers the translation of importin b1 and vimentin mRNAs. Vimentin links pERK to the importin–dynein
complex such that the injury signal is retrogradely transported to the cell body. ZBP1 is required for the axonal localization of b-actin and GAP-43mRNAs that are translated
after injury. Increased anterograde transport of mitochondria is also elicited by injury. GAP-43, growth-associated protein-43; pERK, phosphorylated extracellular signal-
regulated kinase; ZBP1, zipcode-binding protein 1.
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are in place. As discussed above, vimentin, for example, binds to
phosphorylated ERK, which enables not only linkage to the retro-
grade transport machinery but also hinders ERK dephosphorylation
[25] (Fig 2). Although pERK is involved in the retrograde signal that
initiates regeneration, it is probably not required during subsequent
outgrowth [25]. Also, the formation of the JNK-Sunday Driver com-
plex allows the signal to be transported on vesicular structures
linked to the transport machinery, possibly protecting it from
dephosphorylation [29]. Importantly, JNK signaling has been impli-
cated in the reorganization of the axonal cytoskeleton and in neurite
regeneration [30]. In the case of STAT3, it is interesting to note that
besides contributing to axonal regeneration [31], its activation is
also important for neuronal survival after injury [28].
The response to nerve injury relies on the activation of numerous
transcription factors. Some of the transcription factors are activated
by the above injury signals. ERK activates ETS domain-containing
protein (Elk-1) [26], while JNK activates c-Jun and activating tran-
scription factor 3 (ATF3) [32]. Other transcription factors involved in
the regenerative response have also been identified in assays using
rat and mouse DRG neurons, including cAMP response element-
binding protein (CREB) [31], SRY-related HMG-box (Sox11) [33],
phosphatidylinositol 3-kinase (PI3K), and Smad1 [13,34]. Together,
they alter the transcriptional profile of injured neurons contributing
to their survival and regeneration [33]. In this context, and integrat-
ing previous data, it has been demonstrated that PNS injury activates
PI3K signaling, leading to the inactivation of glycogen synthase
kinase 3 (GSK3) and suggesting that the PI3K-GSK3-Smad1 pathway
is central for promoting sensory axon regeneration [13]. The
activated transcription factors also induce the expression of several
RAGs including arginase-1 [34], NPY, VIP [35], interleukin-6 (IL-6)
[36], GAP-43, and CAP-23 [37], among others (Fig 1).
As a result of injury, the interruption of retrograde transport of
negative injury signals, possibly target-derived molecules, might
release neurons from the repression to elongate, allowing regenera-
tion to take place. In this context, it has been demonstrated that fol-
lowing lesion, reduction in nerve growth factor (NGF) levels in
sympathetic and sensory neurons contributes to the increased levels
of neuropeptide expression [38]. Likewise, cessation of electrical
activity after peripheral lesion contributes to the regenerative
response [6]. As such, both target-derived NGF and electrical activ-
ity are seen as negative injury signals. In summary, in addition to
the presence of regeneration-promoting injury signals, in adult na€ıve
PNS neurons repression of axonal elongation might be relieved
upon injury.
Anterograde axonal transport for an effective
regenerative response
As neurons are highly polarized cells, proteins synthesized as a
response to injury signaling need to travel from the cell body to the
distant axon tip. Thus, the control of anterograde axonal transport
is an intracellular mechanism of pivotal importance for axon regen-
eration. Anterograde axonal transport is divided into the slow com-
ponent a (SCa) that transports neurofilaments, tubulin, and
microtubule-associated proteins; the SCb that transports cytoplasmic
proteins, such as glycolytic enzymes and actin; and the fast compo-
nent that transports vesicles and membranous organelles [39].
Surprisingly, the motors of both slow and fast components are simi-
lar, and the different average rates are due to the pausing behavior
of cargoes during transport [40]. The flux of anterograde axonal
transport elicited by injury needs to supply the axon with structural
components (tubulin, actin, and neurofilaments), synaptic and cyto-
solic proteins, vesicles, and organelles. Interestingly, the speed of
axonal regeneration is similar to the one of SCb, supporting the rele-
vance of anterograde transport in sustaining regrowing axons [41].
Of note, following sciatic nerve injury in mice, anterograde trans-
port of mitochondria in the proximal nerve increases by more than
80% and declines only slightly subsequently [42], which may
support the increased metabolic demand of regenerating peripheral
axons (Fig 2). Whether the transport of other organelles or cytoplas-
mic proteins is also increased remains to be clarified.
Despite the discussed evidence suggesting that axonal transport
plays a central role during axonal regeneration, the modulation of
transport by injury is not well understood. Specifically, the mecha-
nisms that underlie the increase in axonal transport after PNS injury
remain to be established, and future studies should determine
whether molecular motors are affected by lesion or, if alternatively,
microtubule tracks are modified.
Zipcodes and local protein synthesis during
axonal regeneration
The relevance of local protein synthesis in axons remained obscure
until recently. To date, as a consequence of several studies per-
formed mainly in rodents, it is widely accepted that the first building
blocks of regenerating axons are obtained by local protein synthesis
along the axon and in the growth cone. In the adult PNS, axons con-
tain ribosomes distributed unevenly along the axoplasm [43], and
Schwann cells may also provide axonal ribosomes following injury
[44]. In contrast, in the CNS, axons synthesize proteins during
development in the growth cone, but polysomes are restricted to the
axon initial segment in adult rodent axons [45]. Besides the correla-
tion between the different capacities of PNS and CNS axons to
locally synthesize proteins and regenerate, local protein synthesis
generally decreases with axonal aging, which again coincides with a
reduced regeneration potential [46]. Further supporting a critical
role for local protein synthesis during axonal regeneration, applica-
tion of inhibitors of protein synthesis to cut rat axons, including
axons whose cell bodies were removed, decreases the number of
transected axons that reform a growth cone [45]. In fact, growth
cone formation after axotomy depends on local protein synthesis
and degradation, controlled by the mammalian target of rapamycin
(mTOR), p38MAPK, and caspase-3-dependent pathways [45].
The identification of axonally localized mRNAs has been facili-
tated considerably with the development of more sensitive tech-
niques. Genome-wide microarray analyses revealed that several
mRNAs are localized axonally in rat sensory axons and that this rep-
ertoire changes substantially from development to adulthood
[47,48]. Axonal mRNAs need to be actively transported, stored, and
protected from degradation at their final destination. The b-actin
zipcode, a conserved sequence present at the beginning of its
3′ UTR, is the sequence for mRNA axonal targeting identified in
mice. [49]. This sequence interacts with the RNA-binding protein
zipcode-binding protein 1 (ZBP-1), which mediates the axonal
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localization of b-actin [50] (Fig 2). Reinforcing the importance of
this mechanism for axonal regrowth, mice with reduced ZBP1 levels
show decreased axon regeneration after sciatic nerve injury [51].
Additionally, the overexpression of b-actin’s 3′ UTR was shown to
compete in vivo with other ZBP1 cargo mRNAs such as GAP-43
[52]. It has now been demonstrated that axonal translation of
b-actin supports axon branching, while that of GAP-43 promotes the
elongation of rodent sensory neurons during normal axon growth
[53]. These growth-promoting pathways might be relevant for
regenerating axons as well. As already addressed, data supporting
the local axonal translation of importin b1 have been obtained and
an axon-localizing region in the 3′ UTR of importin b1 has been
identified [24]. Mice lacking the axon-localizing region in the 3′ UTR
of importin b1 displayed a delay in axonal regeneration of sensory
neurons [24]. In summary, the above findings support the conclu-
sion that the ability of axons to locally synthesize proteins is impor-
tant for their capacity to regenerate.
Why are CNS neurons unable to mount a robust
regenerative program?
In contrast to the PNS, injured CNS axons have a limited ability to
regenerate. Besides the formation of a highly inhibitory glial scar,
several differences can be put forward to explain this lack of regen-
erative capacity, including inefficient Wallerian degeneration, possi-
ble defects in injury signaling, lack of a robust response to injury,
limited capacity to locally synthesize proteins, and the existence of
inhibitors of axonal regrowth. Indeed, rat CNS neurons fail to effec-
tively activate many of the genes necessary for axonal regeneration
to occur [54]. Interestingly, the calcium changes in the cell body
have a higher amplitude and duration in rat DRG when compared to
cortical neurons [55], and DRG neurons can survive long periods of
high calcium, whereas these are deleterious for CNS neurons [56].
Besides, increased histone acetylation fails to occur in retinal gan-
glion cells (RGCs) [10]. Together, these differences might contribute
to the failure in activating a proregenerative program (Fig 3).
Significant advances have been made with the identification of
intrinsic inhibitors of axon regrowth in the adult CNS in studies
mainly performed by gene targeting in mice. In adult RGCs, deletion
of phosphatase and tensin homolog (PTEN) promotes robust axon
regeneration after optic nerve injury [57]. In the PNS, following
nerve transection, adult sensory neurons depleted of PTEN also
show increased axon regeneration [58]. PTEN antagonizes the
action of PI3K, leading to the inactivation of protein kinase B (AKT)
and of mTOR signaling. In contrast to the CNS, mTOR has been sug-
gested to be dispensable for sensory axon regeneration [58], where
instead, the PI3K-GSK3-Smad1 pathway operates [13]. However, the
importance of mTOR in PNS regeneration remains to be clarified as
in contrast to CNS neurons, which downregulate mTOR activity
after injury, PNS neurons activate mTOR and deletion of tuberous
sclerosis complex 2 (TSC2), another negative regulator of mTOR,
increases sensory axon regeneration in vivo [59]. It is noteworthy
that the observation that mTOR might be dispensable for sensory
axon regeneration under physiological conditions does not necessar-
ily contradict the result that ectopic activation of mTOR (as occurs
after the deletion of TSC2) promotes axon regeneration.
Through the analysis of axon regeneration in different mutant
mouse lines, deletion of the suppressor of cytokine signaling 3
(SOCS3), an inhibitor of the JAK-STAT3 pathway, has been shown
to promote robust regeneration of injured optic nerve axons [60]. Of
note, simultaneous deletion of PTEN and SOCS3 further increases
Embryonic neuron
Cell-intrinsic program 
leading to axonal elongation 
Adult CNS neuron
Limited intrinsic growth capacity
Adult PNS neuron
High intrinsic growth capacity
Low calcium changes
No increase in histone acetylation
Lack of robust synthesis of RAGs
Limited local protein synthesis
Inhibitors of axon regrowth (PTEN, SOCS3, EFA-6)
Activation of regeneration-specific program
Recapitulation of developmental-related pathways
Figure 3. Increased growth capacity of PNS versus CNS neurons.
During development, through a cell intrinsic program composed of multiple pathways, neurons display a robust elongation capacity. After the establishment of connections,
adult CNS neurons have a limited regenerative ability as the consequence of decreased calcium changes, no increase in histone acetylation, lack of robust synthesis of RAGs,
limited local protein synthesis, and presence of inhibitors of axon regrowth (PTEN, SOCS3, and EFA-6). Adult PNS neurons have, however, a high intrinsic growth capacity as a
consequence of the activation of a regeneration-specific program and probably also through the recapitulation of developmental-related pathways. CNS, central nervous
system; EFA-6, exchange factor for Arf6; PNS, peripheral nervous system; PTEN, phosphatase and tensin homolog; RAG, regeneration-associated gene; SOCS3, suppressor of
cytokine signaling 3.
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axon regeneration, as these signals regulate two independent path-
ways that act synergistically [61]. In summary, the mTOR and
STAT3 pathways emerged as key regulators promoting long-
distance axon regeneration in the adult CNS. Reinforcing this view,
PTEN or SOCS3 deletion improves regeneration of distinct CNS
axons [57,60,62,63], and sustained activation of STAT3 promotes
corticospinal remodeling and functional recovery after spinal cord
injury [64]. Recently, in C. elegans mechanosensory neurons, the
conserved Arf guanine nucleotide-exchange factor EFA-6 has been
reported to be an intrinsic inhibitor of axon regrowth that operates
by affecting axonal microtubule dynamics, acting downstream of
and/or in parallel with DLK-1 [65].
Together, these studies indicate that axon regeneration is
restrained not only by extrinsic inhibitory cues but also by intrinsic
factors. As such, the manipulation of intrinsic growth control path-
ways is actively being pursued as a therapeutic approach to promote
axon regeneration after CNS injury.
The cell intrinsic growth capacity of adult CNS neurons
can be activated
Despite the general inability of CNS axons to regenerate, regrowth
can be activated under specific conditions, for example the condi-
tioning lesion effect. DRG neurons possess a peripheral axon branch
that regenerates when injured, and a central axon branch that enters
the spinal cord (forming the dorsal column fibers) and does not
regenerate upon injury. However, when the peripheral branch is
lesioned prior to lesioning the central branch (conditioning lesion),
the central axon can overcome the glial scar inhibitory effect, regen-
erating to a significant extent both in vivo and in vitro [66,67], when
plated on inhibitory substrates, including myelin [68]. The condi-
tioning effect is probably due to the activation of the regenerative
machinery prior to CNS lesion. Studies performed in rodents have
shown that the increase in regeneration capacity encompasses RAG
expression [33,69] and possibly changes in axonal transport [70]. In
fact, the response to injury starts as soon as 1 day following lesion
[68] and has a long-lasting effect, as RAGs are still expressed
2 months following the priming injury [71]. Although a peripheral
lesion performed subsequently to the CNS injury does not improve
axonal regeneration due to the assembly of a thick glial scar, it still
increases the intrinsic regenerative ability of DRG neurons [71].
The conditioning effect certainly represents a good model to
identify the mechanisms underlying the cell intrinsic regenerative
capacity. Numerous molecular pathways have been shown to be
regulated by a conditioning lesion, in accordance with the robust
and broad transcriptional change that conditioning causes in DRG
neurons. The initial unifying concept was that the conditioning
effect was mediated by increased cAMP levels induced by injury
[68]. cAMP prompted neurons to overcome myelin inhibition in
vitro, and treatment with dibutyryl-cAMP, a cell-permeable analog
of cAMP, increased the regeneration of dorsal column fibers fol-
lowing spinal cord injury [68,72]. Further supporting the pivotal
role of cAMP, the phosphodiesterase inhibitor rolipram increases
cAMP levels, leading to enhanced regeneration of serotonergic
axons and functional recovery following spinal cord injury in rats
[73]. However, the robust effect of cAMP in axon regeneration
has been questioned by recent studies, as the use of cAMP
analogs has failed to reproduce the full effect of a conditioning
lesion [74]. Increased levels of cAMP appear to promote axon
regeneration by overcoming myelin-based inhibitors rather than
by modulating the intrinsic ability of neurons to support axon
regeneration. It has been shown that elevation of cAMP fails to
increase the SCb of axonal transport, the rate-limiting step of axon
growth [75].
Besides cAMP, several studies have identified broad changes in
gene expression in rodent conditioned neurons [36,69], regulated
by the activation of multiple transcription factors [76]. Down-
stream, the expression of traditional RAGs such as GAP-43 and
CAP-23 [77] is induced and novel RAGs have been identified using
this model, including arginase-1 [34] and IL-6 [36]. However, none
of the identified transcription factors or RAGs reproduces the entire
conditioning effect [74], suggesting that conditioning cannot be
mimicked by manipulating a single pathway. Supporting this view,
epigenetic changes elicited by HDAC5 nuclear export partially
reproduce the conditioning lesion effect [10]. Several questions
remain open, including the differences in injury-induced signaling
that allow a peripheral injury to elicit a strong regeneration
response, whereas a central lesion to the same neuron fails to do so
(Sidebar A).
Manipulating axonal microtubule dynamics to
promote regeneration
Among the multiple processes involved in the generation of a
new growth cone, cytoskeleton reorganization is crucial for the
intrinsic ability to regenerate. While upon injury CNS axons form
a retraction bulb with a disorganized network of microtubules,
PNS axons form a growth cone with stable microtubules in the
backbone and dynamic microtubules in the tip [78]. Pharmaco-
logical destabilization of microtubules converts a growth cone into
a retraction bulb, and taxol-induced stabilization generates growth
cones that can overcome myelin inhibition [78] and regenerate
following spinal cord injury [79]. Also, HDAC6 inhibition in
rodents results in increased levels of acetylated/stable micro-
tubules and enhances the growth of sensory neurons on myelin
[80]. It has been recently suggested that instead of inducing the
normal mode of repair, where the axon tip might behave more
dynamically, taxol might promote axonal regeneration by enabling
the axon tip to become more forceful [81]. In rodent sensory neu-
rons, HDAC5 accumulates at the tip of injured axons where local
tubulin deacetylation induces growth cone microtubule dynamics
and axon regeneration [82]. The varying effects that microtubule
stability might have on axon regeneration do not allow for a clear
causal relationship between axon regeneration and microtubule
stability. Moreover, at this point, the available literature does not
provide sufficient detail to allow for a comparison between the
effects of HDAC5, HDAC6, and taxol on tubulin dynamics in the
axon shaft versus axon tip. Although the results obtained with
studies using taxol and HDAC6 seem contradictory to the data
reported for HDAC5 and the kinesin family member KIF3C [83],
previous studies have shown that efficient developmental axon
growth requires an optimal level of microtubule dynamics. Thus,
destabilizing or overstabilizing microtubules could both impair
axon growth.
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Many of the pathways that contribute to cell intrinsic control of
regeneration participate in the remodeling of the axonal cytoskeleton,
specifically by modulating microtubule dynamics. As such,
potential therapeutic strategies intervening at the level of micro-
tubule-related proteins have been actively pursued. In this respect,
and besides those already discussed in this review including HDAC5
and 6, several other possible targets have been identified, including
GSK3b, as many of its substrates are microtubule-interacting
proteins [84].
Members of the kinesin family have also been put forward as
important players in regulating microtubule dynamics during axonal
regeneration. KIF3C has been shown to be an injury-specific kinesin
with microtubule-destabilizing function, playing a key role during
axon regrowth [83]. Depletion of KIF3C in adult neurons leads to an
increase in stable and looped microtubules and delays axonal regen-
eration after injury [83]. In addition to KIF3C, in C. elegans
mechanosensory axons, the depolymerizing kinesin-like protein
family member 7 (KLP-7) restricts microtubule growth in the steady
state [85]. After axon injury, the number of growing microtubules is
increased at the injury site, simultaneously with the downregulation
of KLP-7, in a cascade coordinated by DLK-1 [85]. This mechanism
has been proposed to allow the stable microtubule cytoskeleton of a
mature neuron to be converted into the dynamically growing micro-
tubule cytoskeleton of a regenerating axon.
Besides the importance of identifying microtubule-interacting
proteins that participate in either the formation of a retraction bulb
or of a growth cone, further analysis of the regulation of post-
translational microtubule modifications following injury is needed,
as these control microtubule dynamics and may also interfere with
axonal transport, therefore impacting on axonal regrowth.
Conclusions and outlook
Recent evidence obtained by systematic genetic screening in
C. elegans shows that besides triggering developmental programs
that may be repressed in mature neurons, regenerative growth
involves specific pathways that sense and specifically respond to
damage [65] (Fig 3). Although axonal regeneration cannot be
viewed as mere recapitulation of axonal elongation during develop-
ment, some of the operating mechanisms are shared. Axon growth
during development occurs in two different phases: an initial phase
of growth and a later phase that takes place during pruning [86].
Axon growth during developmental remodeling appears to be mech-
anistically distinct from initial axon outgrowth. Interestingly,
common pathways, for example mTOR signaling, operate during
developmental axon regrowth and axonal regeneration [86].
The ubiquitin ligase Cdh1-anaphase-promoting complex
(Cdh1-APC) pathway is also a critical cell intrinsic mechanism that
regulates axon growth in the rodent developing cerebellar cortex
[87]. The inhibition of Cdh1-APC in primary neurons enhances
axonal growth and also overrides myelin inhibition of axon
regrowth [87]. Conceivably, Cdh1-APC might therefore potentially
limit axonal growth in the adult CNS. In key follow-up studies, the
transcriptional regulator SnoN has been identified as a critical sub-
strate of Cdh1-APC in neurons [88], operating in a pathway that is
regulated by transforming growth factor b-Smad2 signaling [89].
Smad2 knockdown also overrides myelin inhibition of axon growth
[89]. More recently, expression of a mutant SnoN resistant to degra-
dation has been shown to enhance axonal regeneration following
spinal cord injury in rats [90]. Together, these findings raise the
exciting prospect that pathways operating during development
might also drive axonal regeneration following injury. Therapeutic
strategies aiming at the reactivation of these pathways in injured
CNS neurons might be successful in enhancing our capacity to
regenerate neurons in response to injury or disease.
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Research goals 
 
The main focus of this work was to dissect mechanisms controlling axonal 
regeneration. As such, the following specific objectives were covered: 
 
- Most of the known inhibitory components in the CNS are myelin associated 
proteins. We used the shiverer mouse that has an almost complete absence 
of compact myelin in the CNS, to study the impact of myelin absence in 
CNS axonal regeneration (chapter 1). 
 
- The ability of PNS axons to signal injury underlies their strong response to 
promote regeneration. Using the dorsal root injury as model of CNS lesion, 
I evaluated if the CNS inability to promote regeneration could be due to 
differential activation of injury signals (chapter 2). 
 
- The conditioning injury paradigm was used to identify novel regeneration 
enhancers that could be anterogradely transported and increase axonal 
regeneration (chapter 3). 
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Prologue – Characterization of transthyretin as an axonal 
regeneration enhancer in the PNS 
 
My interest in axonal regeneration came from my initial involvement in a project 
that characterized transthyretin (TTR) as an axonal regeneration enhancer in the 
peripheral nervous system. That work was published (Fleming et al., 2009) and I 
contributed as the second author. 
In this publication that is displayed in the following pages, I performed the 
experiments described in Fig. 2A, Fig. 6C and Fig. 8C. I have also performed the 
retrograde labeling of DRG neurons with cholera toxin B (page 3226). 
In summary, the experiments that I conducted were pivotal to show that: 
- TTR can be delivered to the sciatic nerve following injury. 
- TTR KO mice have decreased axonal retrograde transport. 
- TTR internalization by DRG neurons is megalin-dependent 
- TTR endocytosis by DRG neurons is clathrin-mediated 
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Transthyretin Internalization by Sensory Neurons Is Megalin
Mediated and Necessary for Its Neuritogenic Activity
Carolina E. Fleming,1,3 FernandoMilhazes Mar,1 Filipa Franquinho,1Maria J. Saraiva,1,2 andMo´nica M. Sousa1
1Instituto de Biologia Molecular e Celular–IBMC, Nerve Regeneration Group and Molecular Neurobiology Group, 4150-180 Porto, Portugal, 2Instituto de
Cieˆncias Biome´dicas Abel Salazar, Universidade do Porto, 4099-003 Porto, Portugal, and 3Programa Doutoral em Biologia Experimental e Biomedicina,
Universidade de Coimbra, 3004-517 Coimbra, Portugal
Mutated transthyretin (TTR) causes familial amyloid polyneuropathy, a neurodegenerative disorder characterized by TTRdeposition in
the peripheral nervous system (PNS). The origin/reason for TTR deposition in the nerve is unknown. Here we demonstrate that both
endogenous mouse TTR and TTR injected intravenously have access to the mouse sciatic nerve. We previously determined that in the
absence of TTR, bothneurite outgrowth in vitro andnerve regeneration in vivowere impaired.Reinforcing this finding,wenowshow that
local TTR delivery to the crushed sciatic nerve rescues the regeneration phenotype of TTR knock-out (KO) mice. As the absence of TTR
was unrelated to neuronal survival, we further evaluated the Schwann cell and inflammatory response to injury, as well as axonal
retrograde transport, in the presence/absence of TTR. Only retrograde transport was impaired in TTR KOmice which, in addition to the
neurite outgrowth impairment,might account for thedecreased regeneration in this strain.Moreover,we showthat in vitro, indorsal root
ganglia neurons, clathrin-dependent megalin-mediated TTR internalization is needed for TTR neuritogenic activity. Supporting this
observation, we demonstrate that in vivo, decreased levels of megalin lead to decreased nerve regeneration and that megalin’s action as
a regeneration enhancer is dependent onTTR. In conclusion, ourworkunravels themechanismofTTRactionduringnerve regeneration.
Additionally, TTR presence in the nerve, as is here shown, may underlie its preferential deposition in the PNS of familial amyloid
polyneuropathy patients.
Introduction
Whenmutated, transthyretin (TTR) is related to familial amyloid
polyneuropathy (FAP) (Saraiva 2001), a neurodegenerative dis-
order characterized by extracellular deposition of TTR aggregates
and amyloid fibrils, particularly in the peripheral nervous system
(PNS) (Andrade, 1952). As a consequence of TTR deposition,
axonal degeneration arises, ending up in neuronal loss. Several
clues have emerged as to the molecular mechanisms of TTR-
mediated cellular toxicity leading to neurodegeneration in FAP
(Sousa and Saraiva, 2003). The origin of TTR deposited in the
PNS of FAP patients is however unknown. TTR ismainly synthe-
sized by the liver and the choroid plexus that are respectively the
sources of TTR in the plasma andCSF. TTRwas reported as being
expressed in the PNS, namely by glial cells of dorsal root ganglia
(DRG) (Murakami et al., 2008). However, this issue was clarified
in a subsequent study showing that TTR synthesis does not occur
inDRG cells (Sousa and Saraiva, 2008). Under physiological con-
ditions serum-free human and rat nerve endoneurial fluid dis-
play TTR immunoreaction (Saraiva et al., 1988). TTR may have
access to the nerve through the blood-nerve barrier (BNB),
and/or through contact between peripheral nerve roots and CSF,
where TTR is present in high levels. In fact, in recipients of FAP
livers, i.e., after domino liver transplantation, TTR deposits are
found within the nerve of the recipients, suggesting that plasma
TTR (synthesized in the liver) can cross the BNB (M.M. Sousa et
al., 2004).
Apart from being a transporter of thyroxine (T4) and retinol,
TTR has been described as having functions related to the ner-
vous system, namely to be involved in cognition (Brouillette and
Quirion, 2008), behavior (J. C. Sousa et al., 2004), and neuropep-
tide processing (Nunes et al., 2006). In the case of the PNS, it was
demonstrated that TTR enhances peripheral nerve regeneration
(Fleming et al., 2007). In that study, TTR knock-out (KO) mice
presented delayed functional and morphological recovery after
nerve injury, as assessed from a decreased number of myelinated
and unmyelinated axons in the course of regeneration. TTR ca-
pacity to enhance nerve regeneration was unrelated to neuronal
survival as the absence of TTRwas not accompanied by increased
neuronal loss. In transgenic mice expressing human TTR in neu-
rons, in a TTR KO background, the delayed regeneration of TTR
KO mice was rescued, reinforcing that TTR enhances nerve re-
generation (Fleming et al., 2007). Additionally, absence of TTR
was found to be related to a decreased ability of DRG neurons to
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grow neurites in vitro: cells grown without TTR displayed a re-
duced number of neurites, as well as a decreased size of the long-
est neurite (Fleming et al., 2007). This TTR neuritogenic effect
was demonstrated to be independent of its major ligands, retinol
andT4. The newly described TTR role in peripheral nerve biology
might explain why, when mutated, the protein preferentially ac-
cumulates in the PNS. Yet, the means through which TTR in-
creases regeneration is unknown.
In the current work, we aimed at finding the mechanism
through which TTR enhances nerve regeneration and neurite
outgrowth.
Materials andMethods
Mice. Mice were handled according to European Union and National
rules.WTandTTRKO(Episkopou et al., 1993) littermates (in the 129/Sv
background), as well as megalin heterozygous [MEG (/), kindly pro-
vided by Dr. Thomas Willnow, Max-Delbrueck Center for Molecular
Medicine, Berlin, Germany] and TTR KO/MEG (/) littermate mice
(in the 129/Sv background), were obtained from the offspring of het-
erozygous breeding pairs. All animals were maintained under a 12 h
light/dark cycle and fed with regular rodent’s chow and tap water ad
libitum. Genotypes were determined from tail extracted genomic DNA.
Unless otherwise stated, all comparisons comprised groups of 6 animals
per genotype, age- and sex-matched. For TTR detection in the nerve and
nerve injury experiments, either 3 or 6 months old animals were used.
For DRG neuron cultures, animals with 1–4 weeks of age were used. All
experiments were performed with the observer blinded to the animal’s
genotype.
Nerve injury. Mice were anesthetized with medetomidine/ketamine
and a 4-mm-long incision was made in the shaved thigh skin. For nerve
crush, the sciatic nerve was exposed and crush was performed using Pean
forceps, twice during 15 s. To standardize the procedure, the crush site
was maintained constant for each animal at 35 mm from the tip of the
third digit. A single skin suture, immediately above the crush site, served
as an additional reference. After surgery, animals were allowed to recover
for 5, 15, 30, or 75 d. For chronic constriction injury (CCI), the sciatic
nerve was exposed and one ligature was tied around the nerve using 4/0
silk suture material (Braun). Skin was sutured and mice were allowed to
recover for 24 h. Mice were perfused for 20 min with PBS through the
vena cava at a flow rate of 2 ml/min and the sciatic nerve was subse-
quently collected.
Assessment of mouse TTR presence in the nerve after nerve crush. WT
mice underwent nerve crush and were allowed to recover for 3 d. Mice
were perfused for 20min with PBS through the vena cava at a flow rate of
2 ml/min and the distal nerve segments were subsequently collected.
Western blot was performed as described below. The primary antibody
used was a custom made rabbit anti-mouse TTR antibody (produced
against recombinant mouse TTR, 1:500). Electronic microscopy using
WT distal nerve segments was performed as described below.
Assessment of TTR access to the nerve. TTR was produced as previously
described (Liz et al., 2004), and 1 mg of recombinant human TTR was
conjugatedwithAlexa 488 using theAlexa Fluor 488 labeling kit (Invitro-
gen), according to the manufacturer’s instructions. hTTR-Alexa 488 was
separated from free Alexa 488 by fine size exclusion chromatography in
Bio-Rad BioGel P-30 resin columns. Subsequently, 1 g of hTTR-Alexa
488 was run in a 15% SDS polyacrylamide gel and, after electrophoresis,
hTTR-Alexa 488was visualized in a Typhoon 8600 (Amersham) to check
labeling efficacy. hTTR-Alexa 488 (100g) was injected intravenously in
the tail vein ofWT and TTRKOmice. The next day, mice were subjected
to unilateral nerve crush as described above. The following day, mice
were killed, and both crushed and contralateral sciatic nerves were col-
lected and cryoprotected with a 1.2% L-lysine solution containing 2%
formalin. For immunohistochemistry using the primary rabbit anti-
human TTR (Dako; 1:1500), and rabbit anti-mouse TTR (1:2000) poly-
clonal antibodies, 10 m-thick sections were incubated in 0.1% sodium
borohydride (Sigma) for 5 min. Sections were then blocked in blocking
buffer (1% bovine serum albumin and 4% fetal bovine serum in PBS) for
1 h at room temperature, and incubatedwith primary antibody diluted in
blocking buffer overnight. As a negative control, slides were left over-
night at 4°C with either anti-mouse (TTR previously adsorbed with re-
combinant mouse TTR, produced as previously described (Liz et al.,
2004), or with blocking buffer alone. The adsorption of anti-mouse TTR
was performed by incubation of 200g of recombinantmouse TTRwith
1 l of anti-mouse TTR overnight at room temperature with agitation.
After centrifugation at 16,000 g, the supernatant, diluted 1:2000 in block-
ing buffer, was used to perform immunohistochemistry. Subsequently,
slide incubation with the anti-rabbit IgG-Alexa 568 secondary antibody
(Invitrogen, 1:1000) diluted in blocking buffer was performed for 1 h at
room temperature. Coverslips were mounted with VectaShield Mount-
ing Medium with DAPI (Vector), and images were taken using a Leica
SP2 AOBS SE (Leica) confocal laser scanning microscope.
Local delivery of TTR to the crushed nerve. WT and TTR KO mice
underwent bilateral nerve crush as described above. Immediately after
crush and before suturing, 80l ofMatrigel BasementMembraneMatrix
(BD Biosciences) was applied to the left sciatic nerve crush site; the right
sciatic nerve crush site received 80 l of Matrigel Basement Membrane
Matrix supplemented with 60 g of recombinant WT TTR, produced as
previously described (Liz et al., 2004). Ten minutes after Matrigel appli-
cation, when it had already gelled, skin was sutured. The animals were
allowed to recover for either 15 or 30 d. Mice were killed using a lethal
anesthesia dosage, and the left and right nerve distal stumps were col-
lected and processed for morphometric analysis as described below. To
assess for the presence of TTR in the nerve after Matrigel application,
similar experiments were performed where 80 l of Matrigel supple-
mented with 60 g of hTTR-Alexa 488 (produced as described above)
were applied to the right sciatic nerve crush site of TTR KO mice; to the
left sciatic nerve crush site, Matrigel supplemented with free Alexa 488
(equivalent to the amount of fluorophore present in 60 g of hTTR-
Alexa 488) was applied. As an additional negative control, a group of
animals receivedMatrigel alone in the sciatic nerve crush site. Mice were
killed 1 d after Matrigel application and the nerve (3–4 mm upstream
and downstream of the crush site) was collected, cryoprotected with a
1.2% L-lysine solution containing 2% formalin and sectioned at 8 m.
The presence of hTTR-Alexa 488 was detected using a using a Leica SP2
AOBS SE (Leica Microsystems) confocal laser scanning microscope.
Morphometric analysis. The 3 mm segments immediately distal to the
crush site were fixed overnight in 1.25% glutaraldehyde in 0.1 M sodium
cacodylate, washed in 0.1 M sodium cacodylate for 30 min, postfixed in
1% osmium tetroxide in 0.2 M sodium cacodylate for 60 min, washed
again in 0.1 M sodium cacodylate for 30min, dehydrated using a series of
graded alcohols and propylene oxide, and embedded in epon. Transverse
sections (1.0 m thick) were cut with a SuperNova, Reichest, Leica ul-
tramicrotome, and stained with 1% toluidine blue in an 80°C heating
plate for 20 s. For each animal, the total number of myelinated fibers
present in one semithin section was determined by counting 50 mag-
nified photographs covering the whole nerve area. To determine the
density of unmyelinated fibers, ultrathin transverse sections were cut and
stainedwith uranyl acetate and lead citrate. For each animal, 20 nonover-
lapping photomicrographs (7000 amplification) corresponding to
9000 m2 of each ultrathin section were taken using a transmission
electron microscope (Zeiss 10C) and analyzed. To assess possible differ-
ences in nerve total areas between strains, these were determined from
10magnified photos of sciatic nerve transverse sections.
Analysis of Schwann cell proliferation. WT and TTR KO mice under-
went bilateral nerve crush and were allowed to recover for 5 d. To label
dividing cells, 100g/g bodyweight of BrdU (5-bromo-2-deoxyuridine,
Sigma) was injected intraperitoneally 4 and 2 h before kill. Labeling of
proliferating cells was performed 5 d after injury, since at this time point,
Schwann cells reach their maximum proliferative activity in injured sci-
atic nerves (Cheng and Zochodne, 2002). Mice were killed using a lethal
anesthesia dosage and the sciatic nerves were collected and processed for
immunohistochemistry. Nerves were excised, fixed in 4% neutral buff-
ered formalin and embedded in paraffin. Sections (5 m thick) were
deparafinated in histoclear (National Diagnostics) and hydrated in a
descendent alcohol series. Antigen unmaskingwas done by incubation in
2N HCl for 20 min at 37°C, followed by neutralization with 0.1 M
Na2B4O7, and incubation with trypsin-EDTA (Invitrogen) for 10 min at
Fleming et al. • Transthyretin Internalization Is Megalin Mediated J. Neurosci., March 11, 2009 • 29(10):3220–3232 • 3221
37°C. Immunohistochemistry using the primary anti-BrdUmonoclonal
antibody (1:1000, Sigma) was performed with the MOM kit (Vector)
according to the manufacturer’s instructions, using diaminobenzidine
(Sigma) as substrate. Slides were counterstained with hematoxylin
(Merck). Two longitudinal nerve sections per animal were immuno-
stained; four 50magnified photographs per section distal to the crush
site were taken, covering an area of 0.5 mm2, and the number of
BrdU-labeled nucleus was determined, as well as the total number of
nucleus stained with hematoxilin. The percentage of BrdU-labeled nu-
cleus was then calculated for each animal.
Assessment of apoptosis by TUNEL analysis. The comparison of apo-
ptotic cells in crushed nerves fromWT andTTRKOmice was performed
with the ApopTag Peroxidase In Situ Apoptosis Detection Kit (Millipore
Bioscience Research Reagents), according to the manufacturer’s instruc-
tions, using diaminobenzidine (Sigma) as substrate. Slides were counter-
stained with hematoxylin (Merck). Eight 10 magnified photographs
per section near the crush site were taken, covering an area of 0.15
mm2. For each animal, the number of labeled nucleuswas determined, as
well as the total number of nucleus stained with hematoxilin. The per-
centage of apoptotic nucleus was then calculated for each animal.
Determination of macrophage number. Semithin sections stained with
toluidine blue of WT and TTR KO sciatic nerve distal segments were
obtained as described above formorphometric analysis. For each animal,
the density of macrophages present in one semithin section covering the
whole nerve area was determined by observation of 20magnified pho-
tographs 15, 30, and 75 d after nerve crush.
Western blot. Intact and CCI nerves were sonicated in 0.5% Triton
X-100 (Sigma) containing protease inhibitor mix (Amersham). Protein
(12 g total per lane) was run in 15% SDS polyacrylamide gels. After
electrophoresis, samples were transferred to a nitrocellulose membrane
(Amersham), blocked with blocking buffer (5% nonfat dried milk in
PBS), and incubated overnight at 4°C with primary antibodies diluted in
blocking buffer, namely, rabbit polyclonal anti-p75NTR (Santa Cruz Bio-
technology, 1:200), and mouse monoclonal anti--actin (Sigma;
1:5000). Subsequently, incubation with horseradish peroxidase (HRP)-
labeled secondary antibodies diluted in blocking buffer, namely either
anti-rabbit IgG-HRP (The Binding Site; 1:10,000) or anti-mouse IgG-
HRP (The Binding Site; 1:5000), was performed for 1 h at room temper-
ature. Blots were developed using the ECL PlusTM Western blotting
reagents (Amersham) and exposed to Hyperfilm ECL (Amersham).
Quantitative analysis of Western blots was performed using the Image-
Quant software (Amersham). Results are shown as the ratio between p75
NTR and -actin signals.
Primary cultures of DRG neurons. Primary cultures of DRG neurons
were performed as described previously (Lindsay, 1988). Briefly, DRG
were dissected aseptically fromWT or TTR KO mice, freed of roots and
treated with 0.125% collagenase (Sigma) for 3 h at 37°C. After enzyme
treatment, a single-cell suspension was obtained by trituration with a
fire-polished Pasteur pipette. The cell suspension was centrifuged into a
15% albumin gradient for 10 min at 200 g. The obtained pellet was
resuspended in Neurobasal medium supplemented with B27, penicillin-
streptomicin, glutamine, fungizone (all from Invitrogen) and 50 ng/ml
NGF (Sigma), plated in poly-L-lysine coated 13mmcoverslips andmain-
tained at 37°C.
Transferrin transport assay. The use of human transferrin conjugated
with Texas red (Tf-TR, Invitrogen) as a tracer to examine retrograde
transport in cultures of DRG neurons has been previously documented
(Liu et al., 2003). WT and TTR KO DRG neurons were cultivated as
described above. After 3 d in culture, cells were incubated with medium
containing 50 g/ml Tf-TR for 2 h at 37°C to allow uptake. Cells were
then washed and incubated with Neurobasal medium supplemented
with B27, penicillin-streptomicin, glutamine, fungizone (all from In-
vitrogen), and 50 ng/ml NGF (Sigma). Twenty-seven hours later, neu-
rons were fixed in 2% neutral buffered formalin for 30min, washed with
PBS, and kept at 4°C until use. Slides were mounted in VectaShield
MountingMediumwithDAPI (Vector). Images were taken using a Leica
SP2 AOBS SE (LeicaMicrosystems) confocal laser-scanningmicroscope.
For the quantification of Tf-TR labeling in DRG neurons, a semiquanti-
tative scale ranging from 1 to 5 was used as follows: 1, Tf-TR present in
100% of the neurites; 2, Tf-TR present in50% of the neurites; 3, Tf-TR
present in 50% of the neurites; 4, Tf-TR present in50% of the neurites;
5, Tf-TR absent from neurites (i.e., only present in the cell body).
In vivo analysis of retrograde transport using cholera toxin B. The sciatic
nerve of WT and TTR KO mice was exposed and transected at the mid-
tight level; a solution of the retrogradely transported cholera toxin B
subunit (0.5 mg/ml, List Biological) was applied to the proximal end of
the transected sciatic nerve for 35 min. The skin was subsequently su-
tured and mice were allowed to recover for 72 h, after which the L4–6
DRGwere collected and fixed in 4%neutral buffered formalin. To detect
retrogradely labeled sensory neurons, serial 4-m-thick DRG sections
were cut and processed for anti-cholera toxin immunohistochemistry.
Briefly, sections were blocked in blocking buffer (1% bovine serum al-
bumin and 4% fetal bovine serum in PBS) for 30 min at 37°C and incu-
bated with anti-cholera toxin antibody (Calbiochem; 1:1000) diluted in
blocking buffer overnight at 4°C. Antigen visualization was performed
with the biotin-extravidin-peroxidase kit (Sigma). For each animal, to
determine the percentage of retrogradely labeled sensory neurons, the
total number of DRG neurons, as well as the number of labeled DRG
neurons presenting visible nuclei, were counted every 24 m.
Analysis of TTR endocytosis by DRG neuron cultures. Primary cultures
of DRG neurons were performed as described above (Lindsay, 1988).
Cells were maintained for 96 h at 37°C. After this period, DRG neurons
were supplemented with 300 g/ml recombinant human TTR conju-
gatedwith Alexa 488 (hTTR-Alexa 488, produced as described above) for
3 h at 4°C or 37°C. When mentioned, neuronal cells were additionally
incubated with 50 g/ml transferrin conjugated with Texas red (Tf-TR,
Invitrogen) or with 5 g/ml cholera toxin subunit B conjugated with
Alexa Fluor 647 (CT-B, Invitrogen). Cells were fixed in 2% neutral buff-
ered formalin for 30 min, washed with PBS and kept at 4°C until immu-
nostaining. For immunocytochemistry, DRG neurons were permeabil-
izedwith 0.2%TritonX-100 (Sigma) andwere then incubatedwith 0.1%
sodium borohydride (Sigma). For immunocytochemistry using the pri-
mary antibody rabbit anti-PGP 9.5 (1:500, Ab Serotec), coverslips were
blocked inMOM IgG Blocking reagent (Vector) for 1 h at room temper-
ature, and incubated with primary antibody diluted in MOM diluent
(Vector) overnight at 4°C. Subsequently, incubation with the secondary
antibody anti-rabbit IgG-Alexa 568 (1:1000, Invitrogen) diluted in
MOM diluent was performed for 1 h at room temperature. Coverslips
were mounted with VectaShield Mounting Medium containing DAPI
(Vector), and images were taken using a Leica SP2 AOBS SE (Leica Mi-
crosystems) confocal laser scanning microscope.
Analysis of TTR endocytosis by transfected DRG neurons. Primary DRG
neurons were obtained as already detailed. After DRG neuron isolation
and prior plating, 250,000 neurons were transfected with 10 g of
GFP-tagged Eps15 constructs (a kind gift from Dr. Benmerah, Institut
Cochin, Paris, France), isolated using the Endofree Plasmid Maxi kit
(Qiagen, Portugal). Transfection was performed in a Amaxa Nucleofec-
tor (Amaxa Biosystems), using program A-033 and the Mouse Neuron
Nucleofector kit (Amaxa Biosystems). Transfected cells were subse-
quently plated in 24-well plates at a density of 30,000 cells/well. Cells
were maintained for 48 h at 37°C after which they were supplemented
with 300 g/ml recombinant human TTR conjugated with Alexa 568
(hTTR-Alexa 568, produced similarly as described above for hTTR-
Alexa 488) for 3 h at 37°C. Cells were then processed for PGP 9.5 immu-
nocytochemistry, as described above, using as secondary antibody anti-
rabbit IgG-Alexa 647 (1:1000, Invitrogen). For quantification of hTTR-
Alexa 568 internalization, images of randomly selected PGP 9.5 labeled
cells were taken along the z-axis in a Leica SP2 AOBS SE confocal laser
scanning microscope, using the same laser intensity for all conditions.
hTTR-Alexa 568 internalization in cells photographed in each of the
conditions was then determined using the ImageJ software (http://rs-
bweb.nih.gov/ij/) and calculated as total brightness intensity in the 568
channel (expressed as arbitrary units)/cell.
Measurement of neurite outgrowth using TTR coupled to FluoSpheres.
Recombinant WT TTR (2 mg) was covalently bound to 1 m-diameter
carboxylate- or amine-modified FluoSpheres (Invitrogen), using a car-
bodiimide cross-linking method, according to the manufacturer’s in-
structions. FluoSpheres bound to TTRwere washed three times with PBS
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and the efficacy of themethodwas evaluated by running the three washes
containing free uncoupled WT TTR in a 15% SDS polyacrylamide gel;
90% of WT TTR was bound to the FluoSpheres and no detectable free
TTR was found within the last wash. PC12 cells (European Collection of
Cell Cultures), a rat adrenal cell line with a neuronal-like phenotype,
were grown in six-well plates in DMEM (Invitrogen) supplemented with
10% fetal bovine serum (Invitrogen). When cells reached 50% conflu-
ence, fetal bovine serum was withdrawn and cells were supplemented
with either: (1) 10%of eitherWTorTTRKOmouse serum, (2) 10%TTR
KOmouse serum containing 300g/ml recombinantWT TTR, (3) 10%
of TTRKOmouse serum containing 0.12% of free FluoSpheres, (4) 10%
of TTR KO mouse serum containing 300 g/ml free recombinant WT
TTR and 0.12% of free FluoSpheres, and (5) 10% of TTR KO mouse
serum containing 300 g/ml recombinant WT TTR coupled to 0.12%
FluoSpheres. Fifty hours later, PC12 cells were fixed in 2% neutral buff-
ered formalin for 30 min, washed with PBS and kept at 4°C until further
analysis. Neurite size was determined from 50magnified fields. At least
150 cells were analyzed for each condition. To check whether TTR was
biologically active when coupled to FluoSpheres, its ability to bindT4was
evaluated. Briefly, a 100l suspension of either free FluoSpheres (0.12%)
or 8.25 g/ml TTR coupled to FluoSpheres (0.12%) was incubated with
50,000 cpm of [125I]T4 (Perkin-Elmer) in triplicates overnight at 4°C. As
an internal control to ascertain the specificity of T4 binding to TTR, 100
l suspension of the same samples were coincubated with 50,000 cpm of
[ 125I]T4 and nonradioactive T4 in molar excess. Subsequently, Fluo-
Spheres were washed three times with PBS and radioactivity of the pel-
lets, corresponding to T4 bound to TTR, was counted in a gamma-
spectrometer (Wallac).
Analysis of TTR endocytosis in DRG neurons blocked with sheep anti-rat
megalin antibody. After DRG neuron isolation, cells were plated in 24-
well plates at a density of 10,000 cells/well. Cells were maintained for
96 h at 37°C afterwhich theywere preincubated for 2 h at 37°Cwith sheep
anti-rat megalin (1:200, kindly provided by Dr. Pierre Verroust, CHU
Saint Antoine, Paris, France) or nonimmune sheep serum (using an
equal volume as the one used in the case of sheep anti-rat megalin).
Subsequently, DRG neurons were supplemented with 300 g/ml hTTR-
Alexa 488 in the presence of sheep anti-ratmegalin or nonimmune sheep
serum (in the same conditions as used for the preincubation) for 3 h at
37°C. It is noteworthy that this anti-megalin antibody has been used
previously to successfully inhibit megalin-dependent internalization
(Klassen et al., 2004). DRG neurons were then processed for PGP 9.5
immunocytochemistry as described above using as secondary antibody
anti-rabbit IgG-Alexa 568 (1:1000, Invitrogen). For quantification of
hTTR-Alexa 488 internalization, images of randomly selected PGP 9.5
labeled cells were taken along the z-axis in a Leica SP2 AOBS SE confocal
laser scanning microscope, using the same laser intensity for all condi-
tions. The intensity of internalized hTTR-Alexa 488 in DRG neurons
treated with either sheep anti-rat megalin or nonimmune sheep serum
was then determined using the ImageJ software (http://rsbweb.nih.gov/
ij/), as described above.
Measurement of neurite outgrowth in the presence of TTR and anti-rat
megalin. TTR KO DRG neurons were maintained for 48 h at 37°C, after
which DRG neurons were supplemented with (1) B27 or B27 containing
either (2) 300g/ml recombinant TTR, (3) 300g/ml recombinant TTR
and 200 g/ml sheep anti-rat megalin (kindly provided by Dr. Pierre
Verroust), (4) 200 g/ml sheep anti-rat megalin, and (5) 300 g/ml
recombinant TTR and 200 g/ml IgG (IgG, Sigma). As an additional
control, in an independent experiment, DRG neurons were supple-
mentedwith B27 containing a volume of nonimmune sheep serum equal
to the one of sheep anti-rat megalin used in condition (5). Fifty hours
later, cells were fixed in 2%neutral buffered formalin for 30min, washed
with PBS and kept at 4°C until further analysis. Neurite size was deter-
mined from 50 magnified fields. At least 180 cells were analyzed for
each condition.
Megalin immunohistochemistry and RT-PCR. For RT-PCR, total RNA
from mouse DRG and kidney was isolated using Trizol (Invitrogen).
cDNA was obtained using the Superscript II kit (Invitrogen). PCR was
performed using the following sense and antisense primers: for mouse
megalin, 5-CCTTGCCAAACCCTCTGAAAAT-3 and 5-CACAAG-
GTTTGCGGTGTCTTTA-3 and for mouse HPRT, 5-GTAAT-
GATCAGTCAACGGGGGAC-3 and 5-CCAGCAAGCTTGCAAC-
CTTAACCA-3. Ethidium bromide-stained gels were scanned using a
Typhoon 8600 (Amersham). For immunohistochemistry using the sheep
anti-megalin primary antibody (1:2000, kindly provided by Dr. Pierre
Verroust), antigen unmasking was done by boiling 3 in 0.5 mM EDTA
10 mM Tris pH 9.0 solution. Sections were blocked in blocking buffer
(1% bovine serum albumin and 4% fetal bovine serum in PBS) for 30
min at 37°C and incubated with primary antibody diluted in blocking
buffer overnight at 4°C. Antigen visualization was performed with the
biotin-extravidin-peroxidase kit (Sigma). Slides were counterstained
with hematoxylin (Merck).
Statistical analysis. Statistical analysis was performed using the Stu-
dent’s t test. Results were expressed as average	 SEM.
Results
TTR is detectable within the endoneurium of both control
and crushed nerves
We recently determined that TTR enhances nerve regeneration
(Fleming et al., 2007). Upon nerve injury, disruption of the BNB
occurs, leading to the exposure of the nerve to plasma proteins.
To verify the disruption of the BNB by nerve crush, ultrathin
nerve sections were analyzed, 3 d after crush; blood residues were
observed near the crush site (Fig. 1A). To checkwhether TTRwas
present in the nerve 3 d after crush, mouse TTR immunoblotting
of crushed nerves from perfused WT mice was performed. As
illustrated in Figure 1B, TTR is indeed present in the nerve after
crush, in the course of regeneration. As positive and negative
controls, CSF fromWTmice (WT CSF) and nerve extracts from
TTR KOmice (TTR KO nerve) were used, respectively (Fig. 1B).
To further unveil the presence of TTR in the nerve in the
settings of nerve injury, we performed immunohistochemistry
against mouse TTR (mTTR) in crushed nerves from WT mice.
mTTR was readily detected within the nerve, along nerve fibers
(Fig. 1Ca). To confirm the specificity of mTTR immunohisto-
chemistry, three different negative controls were performed:
mTTR immunohistochemistry of (1) TTR KO crushed nerves
(Fig. 1Cb), (2)WT crushed nerves using the anti-mTTR primary
antibody previously adsorbed with recombinant mTTR (Fig.
1Cc), and (3) WT crushed nerves in the absence of primary anti-
body (Fig. 1Cd). As expected, no reactivity was present in the
negative controls. Considering the prompt detection of TTR in
the crushed nerve, we followed by investigating whether TTRwas
detectable in the nerve under physiological conditions. mTTR
immunohistochemistry of WT intact nerves revealed that TTR is
readily detectable in the nerve (Fig. 1Da) with a similar immu-
nostaining pattern as the one observed after nerve crush (Fig.
1Ca). The analysis of transverse sections of WT intact nerves
stained for mTTR suggests that TTR is probably present in the
extracellular matrix surrounding nerve fibers, as visualized by
colocalization with brightfield images (Fig. 1Db–d).
To further understand howTTR gains access to the nerve after
injury, hTTR-Alexa 488 was injected intravenously 1 d before
nerve crush; 1 d after crush, nerves were collected and cryopre-
served. Subsequently, crushed nerves were screened for green
fluorescence. Interestingly, hTTR-Alexa 488 was found within
the nerve, along fibers (Fig. 1Eb). The same pattern was found in
WT and TTR KO nerves (data not shown). To verify that the
green fluorescence corresponded to injected hTTR-Alexa 488,
immunohistochemistry against human TTR (hTTR) was per-
formed, showing that both signals colocalized (Fig. 1Eb–d), con-
firming that plasma TTR enters the sciatic nerve after crush.
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Local TTR delivery to the crushed nerve rescues the
regeneration phenotype of TTR KO mice
In TTR KO mice, nerve regeneration is impaired: after 15 d of
regeneration, the number of myelinated fibers is 20% lower,
whereas 30 d after injury, the density of unmyelinated fibers is
40%decreased in this strain (Fleming et al., 2007). This impair-
ment is recovered when TTR KO mice are backcrossed to mice
expressing human TTR in neurons (Fleming et al., 2007). To
determine if additionally, local TTR delivery to the injury site is
sufficient to rescue the TTR KO phenotype, TTR was locally ad-
ministrated to the crush site andmice were allowed to recover for
either 15 or 30 d. Matrigel, the chosen vehicle, although contain-
ing other extracellular matrix components such as growth fac-
tors, ismainly constituted by laminin, that enhances nerve regen-
eration per se (Madison et al., 1985). To verify whether TTR
released from Matrigel could be found at the nerve crush site,
Matrigel supplemented with hTTR-Alexa 488 was initially used.
As is shown in Figure 2A, hTTR-Alexa 488 could readily be found
in the nerve crush site 1 d after Matrigel application (left); in
nerves where free Alexa 488 was applied, no labeling was found,
as expected (Fig. 2A, right).
Fifteen days after injury, the addition of Matrigel per se was
Figure 1. TTR presence in the nerve. A, B, TTR presence in the nerve 3 d after nerve crush as assessed by evaluation of ultrathin sections from a WT sciatic nerve near the crush site (asterisk
highlights blood accumulation) (A), and anti-mouse TTRWestern blot ofWTmouse CSF (WT CSF), crushed nerves fromWT (WTnerve), and TTR KOmice (TTR KO nerve) (TTRmonomer and dimer are
indicated by arrows) (B). C,mTTR presence in the nerve after injury detected by immunohistochemistry inWT crushed nerves (a), TTR KO crushed nerves (b), andWT crushed nerves using anti-mTTR
preincubatedwith recombinantmTTR (c), and in theabsenceof primary antibody (d); scale bars, 10m.D,mTTRpresence in intact nerves: (a)mTTR immunohistochemistry in a longitudinal section
of an intact WT nerve and (b–d) mTTR immunohistochemistry of a transverse section of an intact WT nerve. BF, Brightfield. Scale bar, 10m. E, Intravenously injected hTTR-Alexa 488 was found
within WT crushed nerves along fibers: (a) DAPI immunostaining in blue, (b) hTTR-Alexa 488 in green, (c) hTTR immunostaining in red, and (d) merged image. Scale bar, 10m.
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not able to overcome the effect of lack of
TTR, as TTR KO mice presented a 24%
decreased density of myelinated fibers
when compared with WT littermates (Fig.
2B,C). However, the addition of TTR to
Matrigel was sufficient to rescue the regen-
eration delay of TTR KO mice, as their
density of myelinated fibers reached WT
levels (Fig. 2B,C).
Regarding unmyelinated fibers, at 15 d
of regeneration no differences were found
between the two strains (data not shown)
which is in agreement with what was pre-
viously described at this time point after
crush (Fleming et al., 2007). To further ad-
dress whether TTR delivery to crushed
nerves ofWT and TTRKOmice could res-
cue the regeneration of unmyelinated fi-
bers, their density was determined 30 d af-
ter injury. Similarly to what was observed
for myelinated fibers, the addition of Ma-
trigel per se was not able to overcome the
lack of TTR, as 30 d after injury TTR KO
mice presented a 30% decreased density of
unmyelinated fibers when compared with
WT littermates (Fig. 2D). However, the
addition of TTR to Matrigel was able to
rescue the regeneration impairment of
TTR KOmice, as their density of unmyeli-
nated fibers reached WT levels (Fig. 2D).
In TTR KOmice, after nerve crush, the
Schwann cell response is unaffected
while the inflammatory response
reflects their delayed regeneration
Given that no effect of TTR on neuronal
survival was found after nerve crush
(Fleming et al., 2007), we assessed whether
the delayed regeneration of TTR KO mice
was associated with a differential response
to injury by Schwann cells, by determining
the percentage of proliferating and apo-
ptotic cells in the nerve 5 d after crush. No
differences in the number of BrdU-labeled
cells were found betweenWTandTTRKO
littermates (data not shown). Also, no dif-
ferential cell survival was observed, as no
differences were found between strains
when the percentage of apoptotic cells was
determined (data not shown). As no sig-
nificant differences were found in the sur-
vival of either neurons or Schwann cells
that could underlie the regeneration im-
pairment in the absence of TTR, the per-
sistence of macrophages was addressed in
the distal stumps of regenerating nerves
from WT and TTR KO mice 15, 30, and
75 d after nerve crush. Recruitment of
macrophages is essential for rapid myelin
clearance and therefore for regeneration to
occur (Hirata and Kawabuchi, 2002);
macrophages infiltrate the lesion site
within 2 d and spread into the entire distal
Figure 2. Local delivery of TTR to the crushed nerve. A, Detection of green fluorescence in the sciatic nerve crush site 1 d after
delivery of hTTR-Alexa 488 (left) or free Alexa 488 (right) in Matrigel. Scale bars, 100m; DAPI in blue. B, Semithin sections of
distal nerve stumps 15 d after nerve crush from WT mice (a, c) and TTR KO mice (b, d), in which Matrigel either alone (a, b) or
supplemented with TTR (c, d) was added. Scale bars, 10m. C, Corresponding density of myelinated fibers. WT: n 6 and n
7; TTR KO: n 5 and n 7, respectively, for each setting.D, Density of unmyelinated fibers 30 d after nerve crush inWT and TTR
KOmice, in which Matrigel either alone or supplemented with TTR was added. WT: n 6 and n 5; TTR KO: n 8 and n 8,
respectively, for each setting; Matrigel alone (matrigel), Matrigel supplemented with TTR (matrigelTTR). *p 0.05, **p
0.01.
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stump after day 4 (Perry et al., 1987). At later time points, an
increased macrophage number is recognized as an indicator that
regeneration is compromised, as has been shown in othermodels
of delayed axonal regeneration (Triolo et al., 2006). In both
strains, as expected, the number ofmacrophages diminishedwith
increased time of recovery (Fig. 3). Moreover, TTR KO mice
presented a 30% increase in the density ofmacrophages after 15 d
of regeneration, when compared with WT littermates; 30 and
75 d after nerve crush, this difference reached 45%. Such a per-
sistence ofmacrophages in latter time points of regeneration is an
additional indicator thatmyelin debris still exist in the nerves, i.e.,
that regeneration is delayed in TTR KO mice.
TTR KOmice present a compromised retrograde transport
To further understand the reason for the delayed regeneration in
TTRKOmice, the capacity ofWT and TTRKO axons to perform
retrograde transport was assessed. In the case of impaired retro-
grade transport, the transmission of signals from the injury site to
the cell body, that would allow the regrowth of fibers, might be
compromised. p75NTR is a receptor that, upon binding to neuro-
trophins at axonal terminals, undergoes retrograde transport
along the axon to the cell body (Curtis et al., 1995). Previous
studies have shown that ligated nerves accumulate p75NTR in the
distal side of the ligation, making this approach reliable for ret-
rograde transport evaluation (Johnson et al., 1987, Taniuchi et
al., 1988). Chronic constriction injury (CCI) was performed in
WT (n 6) and TTR KO (n 5) mice and the accumulation of
p75NTR in the distal side was determined 24 h after. TTRKOCCI
nerves revealed a 26% decrease in the accumulation of p75NTR in
the distal side of the ligation when compared with WT nerves
( p  0.001). To ensure that this decrease was not due to differ-
ential p75NTR expression, the levels of this protein were deter-
mined in WT and TTR KO intact nerves. No differences were
observed between the two strains.
To further confirm that in vivo the absence of TTR is related to
decreased levels of retrograde transport,WT (n 6) andTTRKO
(n 5) sciatic nerveswere retrogradely labeledwith cholera toxin
B. In agreement with the results obtained for the accumulation of
p75NTR, a decrease of 30% was observed in the percentage of
retrogradely labeled DRG neurons of TTR KO mice when com-
pared with WT littermates ( p 0.05).
The relation between the absence of TTR and the lower levels
of retrograde transport was additionally corroborated in vitro.
For that, DRGneurons were cultivated and incubatedwith trans-
ferrin conjugated with Texas red (Tf-TR). Transferrin, a mono-
meric serum glycoprotein, binds iron for cell delivery through
receptor-mediated endocytosis (Dautry-Varsat, 1986). When
conjugated to Texas Red, transferrin functions as a tracer for
retrograde transport (Liu et al., 2003). Twenty-seven hours after
incubation, Tf-TR was only found in close proximity to the cell
body in mostWTDRG neurons (Fig. 4, top), while in the major-
ity of TTR KO cells a more diffused labeling was found as Tf-TR
was still present along neurites (Fig. 4, bottom). These differences
in staining pattern are indicative of a slower retrograde transport
in TTR KO DRG neurons. In fact, after quantification of the
presence of Tf-TR in neurites and cell bodies, we determined that
TTR KO DRG neurons presented a 20% decrease in the amount
of retrogradely transported Tf-TR ( p  0.001). These in vitro
findings correlate with the decreased accumulation of p75NTR in
the distal portion of ligated TTR KO nerves, as well as with the
decreased number of retrogradely labeled DRG neurons of TTR
KOmice found in vivo, and suggest that lack of TTR is associated
not only with decreased neurite outgrowth, but also with im-
paired retrograde transport.
In vitro, TTR is internalized by neurons through a
clathrin-dependent mechanism
Since, in vitro, neurite outgrowth is increased by the presence of
TTR (Fleming et al., 2007), we aimed at understanding how TTR
action is exerted. For that, primary cultures ofDRGneuronswere
incubated with hTTR-Alexa 488 for 3 h at 37°C. Confocal images
along the z-axis showed that hTTR-Alexa 488 (in green) was
internalized byDRGneurons. For visualization of cell bodies and
neurites, the neuron specific protein PGP 9.5 (in red) was used.
hTTR-Alexa 488 was prominently found in neurites (Fig. 5A, top
panels, highlighted by arrows) but was also found within cell
bodies (Fig. 5A, bottom panels, highlighted by arrows). More-
over, TTR internalization presented a punctate-like pattern (Fig.
5A), compatible with its presence within vesicles.
To establish whether TTR internalization was receptor-
mediated, DRG neurons were incubated with hTTR-Alexa 488
for 3 h at 4°C, as at this temperature receptor-mediated endocy-
tosis is inhibited. TTR internalization did not occur at 4°C, as
Figure 3. Macrophage response after nerve injury. Density of macrophages in regenerating
nerves fromWT and TTR KOmice 15, 30, and 75 d after nerve crush; *p 0.05, **p 0.01.
Figure 4. Retrograde transport in the presence and absence of TTR. Confocal images of WT
and TTR KO DRG neurons 27 h after exposure to Tf-TR: in blue, DAPI staining, and in red, Tf-TR
labeling. Scale bars, 10m.
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hTTR-Alexa 488 was never found within DRG neurites or cell
bodies (Fig. 5B), suggesting that TTR entry in neurons occurs
through receptor-mediated endocytosis.
To further understand the mechanism through which TTR
enters neurons, DRG neuron cultures were coincubated with
hTTR-Alexa 488 and Tf-TR (in red), as transferrin endocytosis is
known to be clathrin-dependent (Booth and Wilson, 1981). As
shown in Figure 6A, hTTR-Alexa 488 vesicles partially colocalize
with Tf-TR vesicles, suggesting that TTR endocytosis is clathrin-
dependent. Reinforcing this finding, TTR did not colocalize with
lipid rafts as shown by CT-B staining (in red) (Fig. 6B). In
clathrin-coated pits, one of the major components, AP-2, is con-
stitutively associated with Eps15, an accessory protein essential
for early stages of clathrin-mediated endocytosis (Benmerah et
al., 1998). To have additional proof that TTR endocytosis by
DRG neurons is clathrin-dependent, GFP-tagged dominant neg-
ative constructs of Eps15 were transfected in DRG neurons. The
two dominant-negative Eps15 mutants were: DIII and E
95/295
(Benmerah et al., 1998, 1999). As a control, DIII
2 was used
(Benmerah et al., 1998, 1999). The inhibition of transferrin up-
take by both DIII and E
95/295 and the lack of effect of DIII
2
are well described (Benmerah et al., 2000). Given its toxicity (A.
Benmerah, personal communication), transfection of DRG neu-
rons with the mutant E
95/295 resulted in high levels of cell
death and as such only results obtained with the DIII dominant-
negative Eps15 construct are described. In support of clathrin-
mediated endocytosis, neurons transfected with the GFP-DIII
construct displayed a reduced uptake of hTTR-Alexa 568 (Fig.
6C, top) when compared with DRG neurons transfected with the
control construct GFP-DIII
2 where TTR was taken up into the
cytoplasm presenting the characteristic punctuate-like staining
(Fig. 6C, bottom, arrowheads). Quantification of internalized
hTTR-Alexa 568 using confocal images along the z-axis, revealed
that in fact DRG neurons transfected with the GFP-DIII con-
struct internalized 65% less hTTR-Alexa 568 than DRG neurons
transfected with the control construct GFP-DIII
2 ( p 0.05).
TTR internalization is required for neurite
outgrowth enhancement
Similarly to DRG neurons, PC12 cells grown in the absence of
TTR, i.e., with TTR KO serum, were previously shown to display
a 30% decreased size of the longest neurite per cell, when com-
pared with cells grown with WT serum (Fleming et al., 2007).
Moreover, addition of TTR to TTR KO serum was able to rescue
this phenotype. To understand whether TTR internalization is
needed for the ability of TTR to enhance neurite outgrowth, ad-
ditional experiments were performed where TTR KO serum was
supplemented with TTR coupled to 1 m-diameter polystyrene
beads, FluoSpheres, which prevent TTR internalization due to
their size. It is noteworthy that similar strategies using Fluo-
Spheres were previously applied to address NGF internalization
by neurons (Riccio et al., 1997; MacInnis and Campenot, 2002).
Figure 5. TTR internalization by DRG neurons.A,B, Confocal images of DRG neurons incubatedwith hTTR-Alexa 488 (in green) at 37°C (A, top shows a neurite and bottom shows a cell body) and
at 4°C (B); anti-PGP 9.5 in red; internalized TTR highlighted by arrows. Scale bars, 10m.
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As a control, cells were also exposed to
TTR KO serum supplemented with either
FluoSpheres only or with FluoSpheres and
free TTR. First, the efficacy of TTRbinding
to FluoSpheres was assessed:90%ofWT
TTRwas bound to the FluoSpheres and no
detectable free TTR was found within the
last wash (data not shown). Second, the
biological activity of TTR coupled to Fluo-
Spheres was assessed. TTR is a homotet-
rameric protein where the arrangement of
the four subunits forms a central hydro-
phobic channel where T4 binds (Blake et
al., 1974). Given that the four TTR sub-
units need to be correctly structured so
that T4 binding is accomplished, this prop-
erty of the protein was chosen to evaluate
its structural integrity after conjugation to
FluoSpheres. TTR coupled to FluoSpheres
was efficient in binding T4 (data not
shown). As such, although it cannot be to-
tally ruled out, it is unlikely that the results
obtained with TTR conjugated to Fluo-
Spheres might be the consequence of loss
of function on sensory neurons caused by
structural changes in the protein. Regard-
ing neurite outgrowth, as previously de-
scribed, absence of TTR in the cell culture
medium (KO) was related to decreased
size of the longest neurite, and addition of
free TTR (KO  free TTR) was able to
rescue this phenotype (Fig. 7). Addition of
FluoSpheres to TTR KO serum did not al-
ter neurite outgrowth (KO FluoSpheres
only). When PC12 cells were exposed to
TTR KO serum supplemented with TTR
coupled to FluoSpheres (KO  TTR cou-
pled to FluoSpheres), neurite size was sim-
ilar to the situation where cells were ex-
posed to TTR KO serum alone (KO) (Fig.
7). Moreover, the addition of FluoSpheres
and free TTR (KO FluoSpheres free TTR) rescued this phe-
notype, suggesting that the mechanism by which TTR enhances
neurite outgrowth requires the internalization of the protein. To
ascertain that the phenotype found was due to the inhibition of
TTR internalization and not to the inactivation of specific resi-
dues of the protein, amine- and carboxylate-modified Fluo-
Spheres were used in these assays. The results obtained were
equivalent and independent of the type of FluoSpheres used (data
not shown). This experiment was performed using PC12 cells as
DRG neurons revealed to be sensitive to FluoSpheres which, un-
der the conditions used, lead to the inhibition of neurite out-
growth independently of protein coupling.
Megalin is expressed by DRG neurons and is necessary for
TTR neuritogenic effect
Given that one endocytic TTR receptor, megalin, has been iden-
tified, being important for preventing TTR filtration through the
glomerulus (Sousa et al., 2000) and since megalin was recently
implicated in metallothionein uptake by neurons (Fitzgerald et
al., 2007; Ambjørn et al., 2008), we hypothesized that megalin
might be involved in the uptake of TTR. To verify whether DRG
neurons express megalin, RT-PCR and immunohistochemistry
were performed. Kidney was used as a positive control since
megalin is abundantly expressed in this organ. As shown in Fig-
ure 8A and B, both methodologies demonstrate that megalin is
expressed in DRG neurons. To demonstrate that a sheep anti-rat
megalin antibody blocks TTR entrance in DRG neurons, simi-
larly to what has been previously demonstrated for metallothio-
nein uptake by kidney cells (Klassen et al., 2004), we performed
the analysis of hTTR-Alexa 488 uptake in DRG neurons incu-
bated with either nonimmune sheep serum or sheep anti-rat
megalin. DRG neurons treated with the anti-megalin antibody
(Fig. 8C, right) displayed less hTTR-Alexa 488 internalized when
compared with DRG neurons incubated with nonimmune sheep
serum (Fig. 8C, left). Quantification of internalized hTTR-Alexa
488 using confocal images along the z-axis, showed that DRG
neurons where megalin was functionally blocked by the anti-
megalin antibody revealed50% decreased hTTR-Alexa 488 en-
try relatively to DRG neurons incubated with nonimmune sheep
serum ( p 0.05), similarly to what has previously been demon-
strated for TTRuptake by kidney cells (Sousa et al., 2000). In light
of these results, neurite outgrowth induced byTTRwasmeasured
after megalin blocking by anti-megalin. As previously described
(Fleming et al., 2007), TTR KODRG neurons grown in the pres-
Figure 6. TTR internalization by DRG neurons is clathrin mediated. A, Coincubation of DRG neurons with hTTR-Alexa 488
(green) and Tf-TR (red). B, Coincubation of DRG neurons with hTTR-Alexa 488 (green) and CT-B (red). Scale bar, 10m. C, z-axis
stacking of hTTR-568 (red) uptake by DRG neurons transfected with either GFP-tagged DIII (green) (top) or DIII
2 constructs
(green) (bottom); DAPI staining in blue. Scale bar, 10m.
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ence of TTR (TTR) presented increased size of the longest neu-
rite when compared with cells grown in TTR-free medium (Fig.
8D). TTR action was not affected by the addition of IgG (TTR
 IgG) (Fig. 8D). However, when DRG neurons were coincu-
bated with TTR and anti-megalin (TTR   megalin), TTR
enhancement of neurite size was no longer observed (Fig. 8D),
showing that TTR internalization by neurons, which is needed
for the protein to exert its neuritogenic activity, is megalin-
dependent. As a control, the anti-megalin antibody was added to
the culture medium (  megalin) and no difference was ob-
served relatively to cells grown with culture medium alone. As an
additional control, sheep serum was added to TTR KO DRG
neurons, and again no differencewas foundwhen comparedwith
cells grown with culture medium alone.
In vivo, decreased megalin leads to decreased nerve
regeneration and its action is TTR-dependent
To assess the influence of megalin in the action of TTR in vivo,
nerve crush of WT, TTR KO, megalin heterozygous (MEG (/
)) and TTR KO/MEG (/) animals was done and mice were
allowed to recover for 15 d. This experiment was performed with
megalin heterozygous instead of megalin KOmice as most of the
latter animals die within minutes after birth (Willnow et al.,
1996). We started by determining that MEG (/) mice ex-
pressed50% lessmegalin in theDRGwhen comparedwithWT
littermates (Fig. 9A) ( p 0.05). MEG (/) mice, producing a
reduced amount of the receptor in the DRG, presented a 28%
decrease in the density of myelinated fibers 15 d after crush when
compared with WT animals (Fig. 9B). As previously described
(Fleming et al., 2007), TTR KO mice also presented a 30% de-
crease in the density of myelinated fibers (Fig. 9B), emphasizing
the role of TTR in nerve regeneration, and suggesting that in the
absence of TTR, other megalin ligands have no influence in the
progression of regeneration in the sciatic nerve. These findings
additionally suggest that megalin is an important player in the
course of nerve regeneration as its partial absence is sufficient to
impair TTR-mediated enhancement of this process. Supporting
this hypothesis, TTR KO/MEG (/) animals presented a sim-
ilar regeneration impairment to both TTR KO and MEG (/)
mice (Fig. 9B).
Discussion
In the present work we describe the mechanism of TTR action in
neurons by showing that its neuritogenic effect is dependent on
megalin-mediated internalization. We previously demonstrated
that TTR enhances and accelerates regeneration (Fleming et al.,
2007): 15 d after injury, the total number of myelinated fibers is
20% decreased in TTR KOmice (reachingWT levels after 30 d of
regeneration), whereas in the case of unmyelinated fibers, differ-
ences are observed later, at 30 d after injury, when mice lacking
TTR show a 40% decrease. More importantly, these differences
have consequences at the functional level as TTR KO mice
present a decreased locomotor activity andmotor nerve conduc-
tion velocity throughout regeneration, clearly demonstrating
that TTR enhances and accelerates this process. Such an effect is
relevant in the scenario of nerve regeneration as timely target
innervation is crucial for regain of functional capacity. Here, the
impact of TTR in nerve regeneration was further established
through the demonstration that local TTRdeliverywas successful
in abolishing the differences between WT and TTR KO mice.
Regarding the cellular response to nerve injury, TTR KO mice
present no significant differences in both Schwann cell prolifer-
ation and survival when compared withWT littermates, suggest-
ing that these mechanisms are not responsible for their delayed
regeneration.Moreover, after nerve crush, no differences in the g
ratio between strains were reported (Fleming et al., 2007), ruling
out an impairment in myelination. The fact that TTR KO mice
present an increased number of macrophages in the nerve after
injury is probably an indicator that regeneration is compromised
and that the removal of debris is delayed. Regarding the neuronal
response to injury, the absence of TTR is not related to increased
neuronal death after nerve crush that could underlie the dimin-
ished number of axons undergoing regeneration, but is instead
related to delayed axonal growth (Fleming et al., 2007). Addition-
ally to a decreased axonal growth, our present results demon-
strate that TTR KO axons have lower levels of retrograde trans-
port both in vitro and in vivo. Being the transmission of signals to
the cell body a key process in nerve regeneration, the compro-
mised retrograde transport of TTRKO axonsmight be, at least in
part, responsible for the delayed regenerative capacity of TTRKO
mice and decreased neurite outgrowth in the absence of TTR.
Our results show additionally that WT TTR is readily detect-
able within the peripheral nerve which is in agreement with the
previous demonstration of TTRpresence in the endoneurial fluid
of human and rat nerves (Saraiva et al., 1988). The fact that TTR
is present in the nerve under physiological conditions, as is here
shown, further elucidateswhy, whenmutated, TTRpreferentially
deposits in FAP peripheral nerves. In recipients of FAP livers,
TTR deposits were found within the nerve, suggesting that
plasma TTR can cross the BNB (M. M. Sousa et al., 2004). Our
studies using intravenous injection of hTTR-Alexa 488 show that
plasmaTTR is in fact able to enter intact nerves through the BNB,
which is effective in slowing but not in preventing the entry of
proteins into the endoneurium (Wadhwani and Rapoport,
1994). This is in agreement with previous studies showing that
intravenously injected albumin was conspicuously found
Figure 7. Neurite outgrowth in the presence of FluoSpheres. Average size of the longest
neurite of PC12 cells after exposure to WT serum (WT), or to TTR KO serum alone (KO), or
supplementedwith either free TTR (KO free TTR), FluoSpheres (KO FluoSpheres only), TTR
coupled to FluoSpheres (KO TTR coupled to FluoSpheres), or FluoSpheres and free TTR (KO
FluoSpheres free TTR). ***p 0.001.
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throughout nerve connective tissue and in
basement membranes surrounding nerve
fibers (Allen and Kiernan, 1994), similarly
to what we here show for TTR. On the
other hand, when an injury takes place,
plasmaTTRhas its entrance in the nervous
tissue facilitated, as the BNB is disrupted.
In summary, our data further substanti-
ates that in vivoTTR is present in the nerve
and, as such, is able to contribute to the
enhancement of nerve regeneration and
neurite outgrowth in the settings of nerve
injury.
In vitro, DRG neurons were able to in-
ternalize TTR by a clathrin-dependent en-
docytic process. The biological signifi-
cance of TTR internalization was
confirmed by the fact that the enhance-
ment of neurite outgrowth by TTR was
only possible when free TTR was used, be-
ing abolished when the protein was pre-
vented from being internalized. Two en-
docytic TTR-related receptors have been
described, namely megalin (Sousa et al.,
2000) and an unidentified receptor-
associated protein (RAP)-sensitive recep-
tor (Sousa and Saraiva, 2001). Megalin, a
member of the LDL receptor family, is in-
volved in receptor-mediated endocytosis
in clathrin-coated pits of a wide range of
ligands, such as albumin (Zhai et al.,
2000), and was described as being impor-
tant for preventing TTR filtration through
the glomerulus (Sousa et al., 2000). Later,
it was shown that TTR internalization by
liver cells is associated to lipoprotein me-
tabolism, and that an unidentified RAP-
sensitive receptor mediates TTR uptake
(Sousa and Saraiva, 2001). Regarding the
nervous system, megalin has been de-
scribed as an important protein for the de-
velopment of the forebrain (Willnow et al.,
1996; Spoelgen et al., 2005) and spinal
cord (Wicher and Aldskogius, 2008). Fur-
thermore, megalin was thought to be expressed exclusively by
epithelial cells; however, very recently, several reports have
shown that megalin is expressed by other cell types, namely oli-
godendrocytes (Wicher et al., 2006), astrocytes (Bento-Abreu et
al., 2008), and neurons, including retinal ganglion cells (Fitzger-
ald et al., 2007), cortical neurons (Chung et al., 2008), and cere-
bellar granule neurons (Ambjørn et al., 2008).We now show that
DRG neurons also express megalin and that TTR neuritogenic
activity depends on its internalization by this receptor. Interest-
ingly, it was recently reported thatmetallothionein stimulation of
neurite outgrowth in retinal ganglion cells (Fitzgerald et al., 2007)
and cerebellar granule neurons (Ambjørn et al., 2008) is medi-
ated by megalin. Considering that TTR interacts with metallo-
thionein (Gonc¸alves et al., 2008) and that the present work dem-
onstrates that TTR neuritogenic effect is megalin dependent, the
relationship between these molecules and neurite outgrowth
should be further studied. The present work also reveals that, in
vivo, decreased levels of megalin lead to decreased nerve regener-
ation, further substantiating the importance of this receptor in
the nervous system and particularly in the course of nerve regen-
eration. Although MEG (/) mutants are generally described
as lacking a major phenotype, a semidominant effect through
haplo-insufficiency resulting in decreased levels of megalin has
been shown to cause progressive hearing loss in these animals
(Ko¨nig et al., 2008). In support of diminished levels of megalin in
MEG (/)mice, these were shown to present transferrin excre-
tion in the urine, in contrast to WT mice (Kozyraki et al., 2001).
Here we show that similarly to the latter tissues, MEG (/)
DRGhave a decreased expression of the receptor when compared
with WT littermates. The importance of megalin in the nerve is
supported by the fact that its partial absence is sufficient to impair
TTR-mediated enhancement of nerve regeneration. Our data ad-
ditionally suggests that, in the case of sciatic nerve regeneration,
other megalin ligands have no influence, as TTR KOmice have a
similar decrease in nerve regeneration as MEG (/) mice. This
further suggests that megalin and TTRmay act in the same path-
way. It is worth mentioning that it is possible that additionally,
TTR may generate its effect via signal transduction pathways ac-
Figure 8. TTR internalization by DRG neurons is megalin mediated. A, Megalin and HPRT RT-PCR of kidney () and DRG. B,
Megalin immunohistochemistry of kidney (left), and DRG in the absence (, middle) and presence (, right) of primary anti-
body. Scale bar, 5m. C, z-axis stacking of hTTR-Alexa 488 (green) uptake by DRG neurons preincubatedwith either nonimmune
sheep serum (sheep serum, left) or sheep anti-rat megalin (megalin, right); red: anti PGP 9.5 staining, blue: DAPI. D, Average
size of the longest neurite of TTR KODRGneurons cells after exposure to B27 or B27 supplementedwith TTR (TTR),with TTR and
anti-megalin (TTRmegalin), with anti-megalin (megalin), or with TTR and IgG (TTR IgG). ***p 0.001.
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tivated by the NpxY motifs of the cytoplasmic tail of megalin,
which interact with signaling molecules involved in the regula-
tion of endocytosis (Qiu et al., 2006). It is also noteworthy that
megalin is part of a ligand-dependent signaling pathway by enzy-
matic processing, linking receptor-mediated endocytosis with
cell signaling (Zou et al., 2004).
In conclusion, our work further establishes the mechanism of
TTR action in the nerve by showing that it has a direct effect on
neurons, as its absence leads to impaired retrograde transport
and decreased axonal growth. Also, we show that TTR effect in
neurite outgrowth and nerve regeneration is mediated by
megalin-dependent internalization. Finally, the relevance of TTR
presence in the nerve may underlie its preferential deposition,
when mutated, in the PNS of FAP patients.
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Considering the knowledge that I have acquired since the publication of this 
paper, I propose several experiments that could be performed in order to 
understand the molecular mechanisms through which TTR increases axonal 
growth. 
- Determine whether in the adult, the effect of TTR is restricted to DRG 
neurons 
The role of TTR in the PNS has been extensively studied due to its involvement in 
familial amyloid polyneuropathy (FAP), a neuropathy characterized by the 
deposition of TTR amyloid fibrils in the PNS (Sousa and Saraiva, 2003). The 
preference for TTR accumulation in peripheral nerves led to the hypothesis that 
WT TTR may play a role in PNS physiology. TTR is important for axonal growth 
since TTR KO DRG neurons have decreased neurite outgrowth, and TTR KO mice 
present impaired retrograde transport and delayed axonal regeneration (Fleming 
et al., 2009). This novel role of TTR in nerve physiology raises the question of 
whether TTR might also be important in the CNS. In this respect, it is important to 
note that TTR is one of the most abundant proteins in the cerebrospinal fluid 
(CSF). As such, it would be interesting to know if TTR is also important for axonal 
elongation of CNS neurons, particularly in hippocampal neurons, as the presence 
and expression of TTR by this neuronal subtype has been suggested (Li et al., 
2011).  
 
- Dissect the involvement of TTR in axonal transport 
One of the most important features in TTR KO mice is that they present 
impairment in retrograde axonal transport as determined by retrograde labeling 
with cholera toxin and by analysis of transport of p75
NTR
. Nevertheless, very little 
is known about the mechanism by which TTR interferes with axonal transport. It 
is not even known if the defects in axonal transport are exclusive to retrograde 
transport or whether TTR KO mice also have defects in anterograde transport. To 
investigate this hypothesis, the accumulation of an anterogradely transported 
protein like amyloid precursor protein (APP) (Cavalli et al., 2005) could be studied 
in the proximal stump of TTR KO mice following ligation of the sciatic nerve. 
Moreover, different components of the axonal transport could be tested in vitro, 
namely organelles, vesicles and proteins to identify which components are 
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impaired in TTR KO mice. To assess organelle transport, mitochondria labeling 
could be performed with mitoTracker (Invitrogen); for vesicles, fluorescently 
labeled synaptophysin or APP transfected neurons could be used; and for protein 
transport studies with, fluorescently labeled tubulin could be performed. These 
experiments could further disclose the involvement of TTR in axonal transport. 
Additionally, whether the defects in axonal transport are a direct cause of 
the absence of TTR or are a secondary result from the lack of this protein should 
be further investigated. 
Besides, at the molecular level many questions can be raised. Are 
microtubules correctly assembled in axons of TTR KO mice? To evaluate these 
issues, microtubules could be extracted from nerves of TTR KO mice and WT 
littermates and the ratio of microtubule/tubulin monomer could be established. 
 
- Identify downstream targets of TTR that could mediate axonal growth 
The dissection of downstream targets of TTR might unravel novel 
regeneration enhancers that could be modulated to increase nerve regeneration. 
Since TTR was found to be important in axonal growth of DRG neurons (Fleming 
et al., 2009), a screening could be done on DRG neurons, from naïve and PNS 
injured TTR KO mice and WT littermates. One of two approaches could be 
performed. Either microarray to evaluate different patterns of gene expression or 
a proteomic approach such as iTRAQ or 2D gels coupled to mass spectrometry. 
The proteins/genes differentially regulated should then be validated. Moreover, 
since TTR has also been described as a protease (Liz et al., 2012), and since its 
activity is important for its ability to induce neurite outgrowth (Liz et al., 2009), it 
would be interesting to know if the identified proteins are TTR substrates. 
 
- Determine whether in FAP, loss of function (as an axonal regeneration 
enhancer) of mutated TTR aggregates/fibrils also contributes to 
neuropathology. 
In FAP, there is the accumulation of mutated TTR in peripheral nerves that leads 
to neurodegeneration. Neurodegeneration is attributed to the toxicity of TTR 
aggregates (Sousa and Saraiva, 2003). Nevertheless, it cannot be excluded that 
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loss of function of TTR fibrils, may also contribute to neuropathology. In 
particular, given that TTR is important in retrograde transport, impairment in this 
function may contribute to pathology. In fact, defects in axonal transport have 
been associated to neurodegenerative diseases (Chevalier-Larsen and Holzbaur, 
2006). This could be addressed by using animal models of FAP to check whether 
these present defects in axonal transport. It would be interesting to know if these 
putative defects precede amyloid deposition and neurodegeneration. 
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Cholesterol and sphingomyelin are axon regeneration inhibitors that can be 
counteracted by cyclodextrin delivery 
 
 
Abbreviated  title: Myelin lipids modulate axonal regeneration 
 
 
Fernando M. Mar
1,3
, Tiago Ferreira da Silva
1,3
, Marlene M. Morgado
1
, Lorena G. 
Rodrigues
2
, Daniel Rodrigues
2
, Ana Marques
1
, Vera F. Sousa
1,3
, João Coentro
1
, 
Clara Sá- Miranda
2
, Mónica M. Sousa
1
*, Pedro Brites
1
* 
 
 
1
Nerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC, 
University of Porto; Rua do Campo Alegre 823, 4150-180 Porto, Portugal 
2
Lysosome and Peroxisome Biology group, Instituto de Biologia Molecular e 
Celular - IBMC, University of Porto; Rua do Campo Alegre 823, 4150-180 Porto, 
Portugal 
3
Instituto de Ciências Biomédicas Abel Salazar – ICBAS, Rua Jorge Viterbo Ferreira 
228, 4050-313 Porto, Portugal   
* These authors contributed equally to this work 
 
  
Myelin lipids modulate axonal regeneration 
118 
 
Abstract 
Lack of axonal regeneration following spinal cord injury has been mainly ascribed 
to the inhibitory environment of the injury site i.e., to chondroitin sulphate 
proteoglycans and myelin-associated inhibitors. Here, we used shiverer mice to 
assess axonal regeneration following spinal cord injury in the presence of myelin-
associated inhibitors and chondroitin sulphate proteoglycans, but in the absence 
of compact myelin. Although in vitro shiverer neurons displayed a similar intrinsic 
neurite outgrowth to wild-type neurons, in vivo, shiverer fibers had increased 
regenerative ability, suggesting that the wild-type spinal cord contains additional 
inhibitors besides myelin-associated inhibitors and chondroitin sulphate 
proteoglycans. Our data shows that besides myelin protein, myelin lipids are 
highly inhibitory for neurite outgrowth and demonstrates that this inhibitory 
effect is released in the shiverer spinal cord given its decreased lipid content. 
Specifically, we identified cholesterol and sphingomyelin as novel myelin-
associated inhibitors with activity in multiple neuron types. We further 
demonstrated the inhibitory action of cholesterol and sphingomyelin in vivo, by 
showing that delivery of 2-hydroxypropyl-β-cyclodextrin, a drug that reduces the 
levels of lipids in the injury site, leads to increased axonal regeneration following 
spinal cord injury. In summary, our work shows that myelin lipids are important 
modulators of axonal regeneration that should be considered together with 
protein myelin-associated inhibitors as critical targets in strategies aiming at 
improving axonal growth following injury. In this respect, our study provides the 
initial preclinical data needed to evaluate the possible use of 2-hydroxypropyl-β-
cyclodextrin in clinical trials with spinal cord injury patients. 
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Introduction 
The inability of adult vertebrate CNS axons to regenerate is seen as a 
consequence of the highly inhibitory environment at the injury site (Silver and 
Miller, 2004), and of the failure in activating a cell-intrinsic program leading to 
the expression of regeneration-associated genes (Sun and He, 2010). Upon CNS 
injury, the glial scar functions as an inhibitory barrier composed of multiple 
components, generally divided in 3 categories: myelin associated inhibitors 
(MAIs), namely Nogo, myelin associated glycoprotein (MAG) and oligodendrocyte 
myelin glycoprotein (OMgp) (Lee and Zheng, 2012); canonical axon guidance 
molecules, such as semaphorin 3A, ephrin B3, netrin-1 and repulsive guidance 
molecule A (RGMa) (Giger et al., 2010); and chondroitin sulfate proteoglycans 
(CSPGs), produced by astrocytes (Jones et al., 2003).  
 Studies from different groups using triple knockout mice for MAG, Nogo 
and OMgp produced conflicting results ranging from limited (Lee et al., 2010) to 
extensive  regeneration abilities (Cafferty et al., 2010). Although the field has 
largely concentrated on MAIs, other inhibitors play important roles in vivo: 
blocking CSPG or RGMa or deleting ephrinB3 increases axonal regeneration 
following spinal cord injury (SCI) (Bradbury et al., 2002; Hata et al., 2006; Duffy et 
al., 2012). As such, the wide variety of inhibitors present in the spinal cord milieu 
is thought to underlie the absence of a robust axonal regeneration when blocking 
either single or a limited combination of inhibitors. Despite the structural 
differences, several MAIs share receptors and an inhibitory mechanism dependent 
on RhoA/ROCK activation (Yiu and He, 2006), as demonstrated mainly through 
the use of RhoA/ROCK inhibitors (Kubo and Yamashita, 2007). 
 To further explore the importance of myelin in the inhibition of axonal 
regeneration, we used shiverer (shi) mice which lack myelin basic protein (MBP), a 
key player in myelin compaction in the CNS (Boggs, 2006). In the shi CNS, the 
absence of MBP results in a complete lack of compact myelin (Rosenbluth, 1980) 
which is accompanied by a severe phenotype comprising shivering, convulsions 
and early death. Here we show that in shi mice, despite the presence of canonical 
MAIs and of axonal abnormalities generally related to decreased regeneration 
capacity, CNS axons have an increased ability to regenerate through the spinal 
cord glial scar. This increase in regeneration was ascribed to a decreased 
abundance of myelin lipids, namely cholesterol and sphingomyelin. Moreover we 
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show that delivery of 2-hydroxypropyl-β-cyclodextrin (HPβCD), reduces the levels 
of cholesterol and sphingomyelin in the SCI site, leading to increased axonal 
regeneration. In summary, our work demonstrates that myelin lipids are 
important modulators of axonal regeneration that can be targeted through 
HPβCD delivery. 
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Materials and methods  
Animals. Mice were handled according to European Union and National rules. All 
procedures were approved by the IBMC Ethics Committee and by the Portuguese 
General Veterinarian Board. Six week-old-WT and shi (Jackson laboratories) 
littermates of either sex, on a Swiss Webster:C3HeB/Fe5 background, were 
obtained from heterozygous breeding pairs. For drug-delivery studies 8 weeks-
old C57BL/6 mice of either sex were used. 
Electron microscopy. The thoracic spinal cord of WT and shi littermates (11 
weeks-old) was embedded in Epon. Semi-thin 1µm-thick sections were stained 
with p-phenylene-diamine to visualize myelin and white matter tracts. 60nm-thick 
sections of the dorsal funiculus were stained with uranyl acetate and lead citrate 
and examined in a JEOL JEM-1400 transmission electron microscope. 
Western blotting. Twenty five μg of thoracic spinal cord protein from naïve (6 
weeks-old) or injured (11 weeks-old) WT and shi littermates were separated in 3-
8% Tris-Acetate gels (Bio-Rad) and transferred to nitrocellulose. Antibodies used: 
mouse anti-MAG (Dr. Richard Quarles, NINDS, Bethesda, 1:1,000), rat anti-OMgp 
(R&D Systems, 1:250), rabbit anti-Nogo-A (Dr. Stephen Strittmatter, Yale 
University, New Haven, 1:10,000), rabbit anti-Ephrin B3 (Santa Cruz 
Biotechnology, 1:200), rabbit anti-RGMa (Immuno-Biological Laboratories, 1:200) 
and mouse anti-GAPDH (Santa Cruz Biotechnology, 1:2,000). 
MAG and Nogo immunohistochemistry. Paraffin-embedded spinal cords from WT 
and shi littermates (6 weeks-old) were used for immunohistochemistry against 
MAG (1:500) or Nogo-A (1:5,000) using ABC Vectastain and DAB (Vector labs).  
Spinal cord injury (SCI). Animals were anesthetized with ketamine 
(75mg/kg)/medetomidine (1mg/kg) and a laminectomy was performed at the T9 
level. Complete transection, dorsal hemisection or left lateral hemisection were 
done using a micro feather ophthalmic scalpel. Analgesia was performed for 72h 
with buprenorphine (0.08mg/kg). 
Assessment of the lesion area following SCI. Five weeks after complete SCI, 10µm 
sagittal spinal cord cryosections were immunostained for CSPG (Sigma-Aldrich, 
1:200) and GFAP (DAKO, 1:500). Collagen was visualized with Masson trichrome 
staining (Sigma-Aldrich). The injury area was measured using Photoshop CS3. 
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Regeneration of dorsal column fibers. Animals with dorsal hemisection were 
allowed to recover for 4 weeks. Four days before sacrifice, animals were 
anesthetized as described above and 2µl of 1% cholera toxin B (CT-B, List 
Biologicals) were injected in the left sciatic nerve. Fifty µm sagittal free floating 
sections were immunostained for CT-B (List Biologicals, 1:30,000). From each 
animal, the section displaying the highest number of regenerating axons was 
selected. Axonal regeneration was quantified by counting the number of CT-B 
labeled axons within the glial scar and by measuring the length of the longest 
fiber found rostrally to the injury border. All quantifications of axonal 
regeneration were performed with the researcher blinded for genotype and 
experimental group. 
Regeneration of raphespinal fibers. Five weeks after complete spinal cord 
transection, free floating sections were immunostained for serotonin (5-HT) 
(1:20,000, Immunostar). Only animals where a complete injury was present in all 
sections were analyzed. Axonal regeneration was quantified by counting 5-HT 
positive fibers caudally to the injury site. Raphespinal fiber sprouting was 
assessed 4 weeks after lateral spinal cord hemisection by 5-HT immunostaining in 
cross-sections of the lumbar enlargement. 5-HT immunoreactivity was quantified 
in 4 sections/animal using FeatureJ software. Compensatory sprouting was 
quantified by 5-HT immunoreactivity in the ipsilateral ventral horn. For each 
genotype, 5-HT immunoreactivity was normalized against 5-HT immunoreactivity 
in the naïve spinal cord. All quantifications of axonal regeneration were 
performed with the researcher blinded for genotype. 
Crude membrane isolation. Crude membranes were isolated from the spinal cord 
of 6 weeks old WT and shi littermates, as described (Shen et al., 1998). Briefly, 
tissues were homogenized in 0.32M sucrose, and nuclei removed by 
centrifugation at 500g for 30 min. Membranes were pelleted by centrifugation at 
100,000g for 1 h, resuspended in H2O and protein concentration was 
determined. 
Myelin isolation. Myelin was isolated from the spinal cord of 16 weeks-old WT 
mice as detailed (Norton and Poduslo, 1973). Briefly, the tissue was homogenized 
in 0.32M sucrose and after centrifugation at 900g, the post-nuclear supernatant 
was collected and carefully overlaid on an ultracentrifuge tube containing a 0.85M 
sucrose solution on top of a 50% (w/v) sucrose cushion. After centrifugation for 1 
  Chapter I 
123 
 
h at 37,000g at 4ºC, the interphase between sucrose solutions was transferred to 
a new ultracentrifuge tube. Two rounds of osmotic shocks were performed by 
adding ice-cold water and centrifugation at 20,000g. The final myelin pellet was 
stored at -80ºC until further use. Before use, myelin was sonicated and the 
protein concentration determined. 
Lipid isolation. Lipids were isolated from myelin and spinal cord extracts by a 
modified Folch two solvent system (Mirza et al., 2007). Briefly, 150µg of protein 
extract (from either myelin or total spinal cord extract) were dissolved in 
methanol:water (1:1) and lipids were separated by liquid extraction with 
chloroform (Merck). The chloroform layer containing the lipids was then dried 
under nitrogen stream and stored at -20°C. Absence of proteins in the lipid 
fraction was confirmed by western blotting against Nogo, MAG, Ephrin B3 and 
RGMa. The aqueous layer containing the protein sample was precipitated with 
0.2M perchloric acid following Folch extraction. Following centrifugation the 
protein was resuspended in H2O, sonicated and its concentration was 
determined. 
Lipid extraction and thin layer chromatography. Thoracic spinal cords from WT 
and shi littermates were collected and lipids were extracted as described (Folch et 
al., 1957). The spinal cord injury site and a rostral uninjured region of WT spinal 
cord treated with artificial CSF (aCSF) or HPβCD was also collected for lipid 
extraction. Acidic and neutral lipids were further separated by reverse-phase 
chromatography (Vance and Sweeley, 1967; Seyfried et al., 1978; Rodrigues et al., 
2009). All lipids were analyzed by high-performance thin-layer chromatography 
(HPTLC) as detailed (Rodrigues et al., 2009) alongside with lipid standards. The 
lipids analyzed were: ceramide (Cer), phosphatidylserine (PS), cholesterol (CO), 
sulfatide (GS), galactocerebroside (GalCer), phosphatidylcholine (PC), triglycerides 
(TG), sphingomyelin (SpH), cholesteryl esters (CE), phosphatidylethanolamine (PE), 
globotetrahexosylceramide (Gb4), lactocerebroside (Lac), phosphatidylinositol (PI) 
and GM1 ganglioside (GM1). 
Neuron cultures and inhibition assays. Primary cultures of DRG neurons from P6 
mice were performed as described (Miranda et al., 2011). Glass coverslips were 
coated with poly-L-lysine (20µg/mL) and laminin (0.5µg/mL) followed by crude 
membranes (0.1µg protein), myelin (0.5µg protein), myelin protein fraction 
(0.5µg), MBP (Upstate, 0.9µg) or total protein from spinal cord extracts (3µg). To 
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test the effect of lipids, the myelin lipid fraction (corresponding to 0.5µg of 
protein) and lipids extracted from the spinal cord of either WT or shi mice 
(corresponding to 2µg of protein) were used. Coverslips were coated with poly-L-
lysine followed by lipids in chloroform/methanol/water (2:1:0.1) and laminin 
(0.5µg/mL). The amount of individual lipids present in 2µg protein from WT 
spinal cord lysates was determined by HPTLC and is referred to as 1x (PI= 2 ng, 
GalCer= 200ng, CO= 120ng, GS= 120ng, Gb4= 24ng, SpH= 50ng, GM1= 0.6ng, 
Lac= 20ng, PE= 40ng). In the analysis of single lipids, 1x, 10-fold less (0.1x) or 
10-fold more (10x) were used per coverslip. Gb4, PE, SpH and Lac were from 
Matreya LLC and CO, GalCer, GS, GM1 and PI were from Sigma-Aldrich. GalCer, GS 
and PI were dissolved in chloroform/methanol (2:1), and CO, PE, SpH, Gb4, GM1 
and Lac in chloroform/methanol (1:2). For each lipid, the corresponding solvent 
was used as control. To confirm the presence of lipids following coating, lipid 
extraction of the coverslip was performed, and lipid content was quantified. Lipid-
coating efficacy was measured by HPTLC and approximately 90% of the coated 
lipids were present in the coverslips. For each condition, 5,000 cells/coverslip 
were plated in triplicate and immunostained 12h later against βIII-tubulin 
(Promega, 1:2,000). In at least 100 neurons/condition, the longest neurite was 
traced using NeuronJ. Similar experiments were performed with cortical and 
hippocampal neurons isolated from E17.5 WT and shi embryos as described (Dent 
et al., 1999; Kaech and Banker, 2006), respectively. For cortical neurons, 50,000 
cells/coverslip were maintained for 48 h and for hippocampal neurons, 16,500 
cells/coverslip were maintained for 72 h.  
Evaluation of toxicity. DRG neurons were plated on top of either laminin, solvent, 
CO or SpH. Twelve hours later, cells were washed and incubated with 1µg/mL 
calcein (Invitrogen) for 30 min followed by 10µg/mL propidium iodide for 5 min. 
Cells were then washed and 10x magnification pictures were taken. The 
percentage of viable cells (cells where nonfluorescent calcein AM is converted to a 
green-fluorescent calcein) was determined.  
Rho inactivation assay. WT DRG neurons were plated onto coverslips coated with 
laminin, myelin, solvent, CO or SpH, as described above. Thirty minutes before 
plating, cells were incubated with 1 µg/mL of C3 transferase (Cytoskeleton, Inc.), 
a Rho inhibitor that was maintained during the entire experiment. Twelve hours 
later, cells were fixed and neurite outgrowth was evaluated. 
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ROCK activation assay. 16,500 hippocampal neurons/coverslip were plated onto 
coverslips coated with either solvent or SpH (10x and 100x), as described above. 
A pool of 12 wells/condition was used. Seventy two hours after plating, cells were 
lysed in 62.5mM Tris pH 6.8 containing 2% SDS, 12.5% glycerol and 5% β-
mercaptoethanol. Lysates were then immunobloted against phospho-Ser19-
myosin light chain (Cell Signaling, 1:1,000), the primary phosphorylation site of 
MLC by ROCK, and against β-actin (Sigma-Aldrich, 1:5,000). 
HPβCD treatment. C57BL/6 mice (n=24) were subjected to SCI dorsal hemisection 
as described above. At the time of injury, osmotic minipumps (Alzet 2006) were 
placed subcutaneously with a tube allowing perfusion of the injury site at a rate 
of 0.15μl/hour with either 27μg/g/day of HPβCD in aCSF (128mM NaCl, 2.5mM 
KCl, 0.95mM CaCl2, 1.9mM MgCl2; n=12), or vehicle (aCSF; n=12). Besides 
delivery at the injury site, 4mg/g of HPβCD were injected subcutaneously twice a 
week. Five weeks following injury, the SCI site was collected and lipids were 
extracted and quantified as described above (n=6, HPβCD-treated mice; n=6, 
aCSF-treated mice). In n=6 HPβCD-treated mice and n=6 aCSF-treated mice, dorsal 
column fibers were labeled with CT-B, and axonal regeneration was assessed as 
previously described. 
Data analysis. Data is shown as mean±SEM. Statistical significance was 
determined by Student’s t test or Tukey’s test (One-way ANOVA) for multiple 
comparisons.  
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Results  
Axonal regeneration inhibitors are present in the shi spinal cord and a standard 
glial scar is formed upon SCI 
In shi mice, the absence of MBP leads to an almost complete absence of compact 
myelin in the CNS, including the spinal cord (Supplementary Fig. 1A). Despite that 
several axonal regeneration inhibitors are myelin components, western blot of 
spinal cord extracts showed that all canonical inhibitors are present in the shi 
spinal cord (Fig. 1B). Besides a 10- and 2.5-fold decrease in the levels of MAG and 
OMgp, respectively, either similar (Ephrin B3 and RGMa) or increased (Nogo-A) 
levels of inhibitors were found (Fig. 1B,C). Immunohistochemistry against MAG 
and Nogo-A showed a normal distribution of the inhibitors in the shi spinal cord 
(Fig. 1D). Following complete spinal cord transection, wild-type (WT) and shi mice 
displayed an equivalent glial scar as evaluated by Masson trichrome staining and 
CSPG and GFAP immunostaining (Fig. 1E,F). Moreover, following SCI, all axonal 
regeneration inhibitors were present in shi spinal cords (Fig. 1B) being that MAG 
was the only for which decreased levels (40% decrease) were found. Interestingly, 
following injury, increased levels of the inhibitors Nogo, OMgp and EphB3 were 
present in the shi spinal cord (Fig. 1B,G). In summary, despite the absence of 
compact myelin, the shi spinal cord contains axonal regeneration inhibitors and 
forms a regular glial scar following SCI. 
  Chapter I 
127 
 
 
Figure 1. Shiverer mice have increased axonal regeneration and sprouting. A, p-phenylene-diamine 
staining in thoracic spinal cords of WT and shi mice (upper panels; scale bar = 200 µm). Higher 
magnification of the dorsal funiculus of WT and shi spinal cord (middle panels; scale bar = 100 µm). 
Electron microscopy images of the white matter of WT and shi mice (lower panels; scale bar = 1 
µm). B, Western blot of  Nogo, MAG, OMgp, EphB3, RGMa and GAPDH in spinal cord extracts of WT 
and shi littermates from naïve mice and mice with SCI. Representative results are shown. C, 
Quantification of results obtained for naïve spinal cords shown in B (n = four mice/genotype). D, 
Immunohistochemistry of MAG and Nogo in the dorsal funiculus of spinal cords from WT and shi 
littermates (scale bar = 100 µm). E, Masson trichrome staining and immunostaining against CSPG 
and GFAP in the spinal cord of WT and shi littermates 5 weeks following complete spinal cord injury 
(scale bars = Masson trichrome 200 µm, GFAP and CSPG 50 µm). F, Quantification of the injury area 
following Masson trichrome staining and immunohistochemistry against CSPG and GFAP (n = seven 
mice/genotype). G, Quantification of the results obtained following SCI shown in B (n = four 
mice/genotype). Results represent the mean ± SEM. *p<0.05, **p<0.01 and ***p<0.001. 
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Axonal regeneration and sprouting are increased in shi mice  
Although the shi spinal cord contains all the canonical axonal regeneration 
inhibitors, we asked whether the absence of compact myelin could have an 
impact in axonal regeneration in vivo. Following dorsal hemisection, and in 
contrast to WT axons, shi dorsal column tract axons entered the lesion site (Fig. 
2A,B) and regenerated for longer distances (Fig. 2A,C). In the raphespinal tract, 
following complete spinal cord transection, shi 5-hydroxytryptamine (5-HT)-
positive fibers found caudally to the injury site were more frequent and were 
capable of regenerating for longer distances (Fig. 2D,E). The ability of 
contralateral non-lesioned fibers to sprout in the ipsilateral injury side following 
lateral hemisection was used as a measure of plasticity (Lee et al., 2010). In the 
shi spinal cord, a 1.7-fold increase in 5-HT positive fibers was found in the 
ipsilateral side (WT: 33±3%; shi: 56±8%; p<0.05; Fig. 2F). The correlation with a 
functional improvement was not possible to evaluate given the severe shi 
phenotype. Of note, MAG was the only MAI decreased in the shi spinal cord 
following SCI (Fig. 1G). However, as MAG ablation is insufficient to increase 
axonal regeneration (Bartsch et al., 1995), decreased MAG levels are unlikely to 
underlie the increased axonal regeneration of shi mice. Combined, our data 
shows that following SCI, shi axons have increased axonal regeneration and 
sprouting. 
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Figure 2. Shiverer mice present increased axonal regeneration. A, Cholera toxin B (CT-B) 
immunohistochemistry in sagittal spinal cord sections of WT and shi littermates, 4 weeks following 
dorsal hemisection. Arrowheads highlight regenerating CT-B positive dorsal column axons in shi 
spinal cords. R: rostral; C: caudal; D: dorsal; V: ventral. Lower panels are higher magnifications of 
the selected boxed regions (scale bar = 100 µm). B, Number of CT-B positive dorsal column axons 
able to regenerate through the glial scar in WT and shi animals (n = six mice/genotype). C, Length 
of the longest regenerating CT-B positive dorsal column axon in WT and shi animals (n = six 
mice/genotype). D, Serotonin (5-HT) immunohistochemistry in shi and WT spinal cords 5 weeks 
following complete spinal cord transection showing regenerating  raphespinal fibers. R: rostral; C: 
caudal; D: dorsal; V: ventral. Lower panels are higher magnifications of the selected boxed regions 
(scale bar = 100 µm). E, Quantification of regenerating raphespinal fibers (WT, n = 5; shi, n = 7). F, 
5-HT immunohistochemistry of the ventral white matter of spinal cord cross sections from WT and 
shi littermates (WT n = 6, shi n = 7) 4 weeks following lateral hemisection to assess sprouting (scale 
bar = 100 µm). Results represent the mean ± SEM. *p<0.05. 
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Myelin lipids inhibit neurite outgrowth 
Despite the alterations described in shi axons (Brady et al., 1999; Kirkpatrick et 
al., 2001; Andrews et al., 2006) that are generally related to decreased 
regeneration capacity (Hellal et al., 2011), neurite outgrowth of WT and shi dorsal 
root ganglia (DRG) and cortical neurons was compared and no differences were 
found (Fig. 3A). This data suggests that the intrinsic growth capacity of shi 
neurons does not underlie their increased regeneration in vivo. To evaluate 
whether the shi spinal cord environment might be less inhibitory than that of WT 
mice, and as myelin cannot be isolated from the shi CNS, we tested the effect of 
crude membranes prepared from spinal cords of both strains. Although DRG 
neurons were inhibited in the presence of both WT and shi membranes, the 
inhibition produced by shi membranes was lower (Fig. 3B), suggesting that the 
shi spinal cord environment presents less inhibitory cues to axonal growth. The 
decreased inhibitory environment of the shi spinal cord was unrelated to the lack 
of MBP as no effect on neurite outgrowth was produced when WT DRG neurons 
were plated on MBP (Fig. 3C). To further confirm that the decreased inhibitory 
environment of the shi spinal cord was unrelated to a protein component, WT 
DRG neurons were grown on top of protein extract from either WT or shi spinal 
cords. Both extracts were equally inhibitory (Fig. 3D).  
 Given that lipids account for approximately 75% of myelin dry weight, we 
asked whether myelin lipids would contribute to the inhibitory properties of 
myelin. When WT DRG neurons were grown on myelin protein or myelin lipids as 
substrates, a decreased neurite outgrowth was observed for both, demonstrating 
that myelin lipids also play a role as axonal regeneration inhibitors (Fig. 3C). To 
further demonstrate that the different lipid content of the shi spinal cord creates 
a more permissive environment to axonal growth, WT DRG neurons were grown 
on spinal cord lipids extracted from either WT or shi mice. In contrast to lipids 
from WT spinal cords, lipids from shi spinal cords did not inhibit neurite 
outgrowth (Fig. 3E,F). These data demonstrate that neurite outgrowth of WT DRG 
neurons can be modulated by exposure to different lipid milieus.  
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Figure 3. Myelin lipids inhibit neurite outgrowth. A, Neurite outgrowth of DRG and cortical neurons 
from WT and shi littermates (n = 3). B, Neurite outgrowth of WT DRG neurons grown on 0.1 µg of 
protein from WT and shi crude membranes (n = 3). C, Neurite outgrowth of WT DRG neurons grown 
on 0.9 µg MBP, 0.5 µg WT myelin, 0.5 µg WT myelin protein or myelin lipids corresponding to 0.5 
µg of WT myelin (n = 3). D, Neurite outgrowth of DRG neurons grown on 3 µg of total protein from 
either WT or shi spinal cords (n = 3). E, Neurite outgrowth of WT DRG neurons grown on lipids 
extracted from either WT or shi spinal cords (n=3). F, Representative βIII-tubulin 
immunocytochemistry of E (scale bar 25 = µm). Results represent the mean ± SEM. *p<0.05, 
**p<0.01 and ***p<0.001. 
 
Cholesterol and sphingomyelin inhibit axonal growth through a Rho-dependent 
mechanism 
To identify the lipids that might underlie the increased axonal regeneration in the 
shi spinal cord, we compared the lipid composition of WT and shi spinal cords. 
Among others, the most abundant myelin lipids were analyzed, namely: CO, Cer, 
phospholipids (PE, PC, PI, PS and SpH), GM1 and GalCer (Norton and Poduslo, 
1973). In the shi spinal cord we observed a decrease of most lipids (namely CO, 
GS, GalCer, SpH, PE, Gb4, Lac and GM1), an increase of CE and PI, and normal 
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amounts of Cer+PE, PS, PC and TG (Fig. 4A). From all the lipids with abnormal 
concentrations in the shi spinal cord, only CO and SpH inhibited DRG neurite 
outgrowth in a dose-response manner (Fig. 4B,C). This effect was unrelated to 
toxicity as no dead cells were found in any condition, as examined by calcein 
viability assay (Supplementary Fig. 4D). The effect of both CO and SpH was not 
restricted to DRG neurons as these lipids also produced a dose-dependent 
inhibitory effect in neurite outgrowth of hippocampal (Fig. 4E) and cortical 
neurons (Fig. 4F). Interestingly, when hippocampal neurons were grown on CE, 
that shares the same backbone structure as CO, the esterification of CO reduced 
its ability to inhibit neurite outgrowth (Fig. 4E), suggesting a specific inhibitory 
effect of unesterified CO.  
 The RhoA/ROCK pathway is the major mediator of myelin inhibition (Yiu 
and He, 2006), and the inhibitory effect of myelin can be reverted by the Rho 
inhibitor C3 transferase (Winton et al., 2002).  To assess whether myelin lipids 
share similar pathways to block axonal regeneration than those described for 
myelin proteins, DRG neurons were grown on the inhibitory substrates myelin, CO 
and SpH and in the presence of C3 transferase. As expected, C3 was able to 
overcome myelin inhibition (Fig. 4G). Inhibition by both CO and SpH was also 
relieved by C3 treatment (Fig. 4G) suggesting that lipid inhibition of axonal 
growth occurs, at least in part, through a Rho-dependent mechanism. Despite 
that treatment with C3 improved neurite outgrowth in DRG neurons plated onto 
CO and SpH, given that the rescue was complete in neurons plated on SpH, we 
evaluated the Rho-mediated signaling cascade by measuring the levels of 
phosphorylated myosin light chain (p-MLC). Increased p-MLC is the downstream 
outcome of the activation of the effector molecule of Rho, Rho-kinase (ROCK) 
(Mueller et al., 2005). In the presence of SpH, p-MLC was increased (Fig. 4H,I), 
further supporting a lipid-based Rho-mediated inhibition.  
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Figure 4. Cholesterol and sphingomyelin inhibit neurite outgrowth through a Rho dependent 
mechanism. A, Quantification of lipids extracted from WT and shi spinal cords analyzed by high 
performance thin layer chromatography (n = three mice/genotype). B, Effect of individual lipids in 
neurite outgrowth of DRG neurons (n = 3). C, Representative βIII-tubulin immunocytochemistry of 
DRG neurons grown on top of solvent (control), CO and SpH coated coverslips (scale bar = 50µm). 
D, Representative images of live/dead assay of DRG neuron cultures grown on top of solvent, CO or 
SpH. Green- calcein, red- Propidium iodide (scale bar = 100 μm). E, Neurite outgrowth of 
hippocampal neurons plated on CO, CE and SpH (n = 3). F, Neurite outgrowth of cortical neurons 
plated on CO and SpH (n = 3). G, Neurite outgrowth of DRG neurons plated on top of myelin, CO or 
SpH in the presence or absence of the Rho inhibitor C3 transferase (n = 3). H, Western blot against 
p-myosin light chain (p-MLC) and β-actin of hippocampal neurons grown on top of either solvent or 
different SpH concentrations (10x and 100x). I, Quantification of H. Results represent the mean ± 
SEM. *p<0.05, **p<0.01, ***p<0.001, ns: non statistical and ng: no growth detected. 
 
Reduction of lipid levels in the spinal cord injury site through 2-hydroxypropyl-β-
cyclodextrin delivery promotes axonal regeneration 
To further confirm the inhibitory role of CO and SpH in vivo, WT mice with SCI 
were treated with 2-hydroxypropyl-β-cyclodextrin (HPβCD), a drug capable of 
reducing the levels of CO and sphingolipids, as already demonstrated in models 
of Niemann-Pick type C (Abi-Mosleh et al., 2009; Liu et al., 2009; Aqul et al., 
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2011) and Alzheimer’s disease (Yao et al., 2012). When comparing the changes in 
lipid content induced by SCI in WT mice, SpH and CO remained unchanged (as 
well as PC, Cer+PE, Gb4+SpH and GalCer), whereas CE, PE, PI and GS+PS increased 
at the SCI site (Fig. 5A). At the SCI site and following HPβCD delivery, we observed 
decreased levels of inhibitory lipids namely CO (28% decrease), CE (26% decrease) 
and SpH (21% decrease) (Fig. 5B) and also of others (Fig. 5B), although PC levels 
were not affected (Fig. 5B). Of note, in the uninjured spinal cord, administration 
of HPβCD did not decrease the levels of either inhibitory lipids or of the other 
lipids analyzed (Fig. 5C). In HPβCD-treated mice, improved axonal regeneration of 
dorsal column fibers was obtained, with a 2.5-fold increased number of axons 
being able to enter the lesion site (Fig. 5D,E), and a 2-fold increased length of 
regenerating axons (Fig. 5D,F). Combined, this study identified CO and SpH as 
new myelin lipids that inhibit axonal regeneration through the glial scar and 
determined that HPβCD may be used to reduce the levels of inhibitory lipids in 
the injury site and improve axonal regeneration. 
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Figure 5. 2-hydroxypropyl-β-cyclodextrin delivery promotes axonal regeneration following SCI. A, 
Quantification of CO, CE, SpH, PC, PE, GalCer, Cer, PI, GS, PS and Gb4 extracted from uninjured or 
injured spinal cord by high performance thin layer chromatography (n = six mice/condition). B, 
Quantification of CO, CE, SpH, PC, PE, GalCer, Cer, PI, GS and PS in the spinal cord injury site from 
aCSF- and HPβCD-treated mice, 5 weeks following dorsal hemisection (n = six mice/condition). C, 
Quantification of CO, CE, SpH, PC, PE, GalCer, Cer, PI, GS and PS in uninjured spinal cord from aCSF- 
and HPβCD-treated mice, 5 weeks following dorsal hemisection (n = six mice/condition). D, CT-B 
immunohistochemistry in sagittal spinal cord sections of aCSF- and HPβCD-treated animals, 5 weeks 
following dorsal hemisection. Arrowheads highlight regenerating CT-B positive dorsal column axons 
in HPβCD-treated spinal cords. R: rostral; C: caudal; D: dorsal; V: ventral. Lower panels are higher 
magnifications of the selected boxed regions in the upper panels (scale bar = 100 µm). E, Number 
of CT-B positive dorsal column axons able to regenerate through the glial scar in aCSF- and HPβCD-
treated mice (n = six mice/condition). F, Length of the longest regenerating CT-B positive dorsal 
column axon in aCSF- and HPβCD-treated mice (n = 6mice/condition). Results represent the mean ± 
SEM. *p<0.05, **p<0.01 and ***p<0.001. 
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Discussion  
Our work shows that CO and SpH are myelin-associated lipid inhibitors that 
modulate axonal regeneration, and demonstrates that HPβCD delivery reduces 
the levels of lipids in the SCI site promoting axonal regrowth. Lipids represent 
75% of myelin dry weight. From these, CO is the most abundant, accounting for 
28% of the myelin lipid content, whereas SpH accounts for 4%. Although CO is an 
essential component of the plasma membrane crucial for axonal growth, CO 
accumulation in the mammalian brain is a risk factor for neurodegenerative 
diseases including Alzheimer’s disease (Puglielli et al., 2003) and Niemann-Pick 
(Aqul et al., 2011). In the scenario of injury, with the presence of myelin debris 
within the injury site, myelin-derived CO is presented to regenerating axons in a 
different form from glial-derived CO. Whereas glial-derived CO can stimulate axon 
growth by providing lipoproteins as a source of both CO and apolipoprotein E to 
regenerating axons, free CO i.e., without the context of a lipoprotein particle, as 
is the case of myelin-derived CO, fails to enhance axon extension (Hayashi et al., 
2004). In the case of SpH, its accumulation, which is the hallmark of Niemann-
Pick disease, leads to changes in plasma membrane that similarly to CO, also 
culminate in neurodegeneration (Ledesma et al., 2011). As such, we propose that 
following CNS injury, when growing axons need to elongate through an 
environment filled with myelin debris, exposure to free CO and to SpH 
contributes to axonal growth inhibition. This mechanism may also underlie, at 
least in part, the increased axonal regeneration in the PNS. Despite that 
peripheral and central myelin have similar CO and SpH content, as 
dedifferentiated Schwann cells and invading macrophages are able to phagocyte 
and clear myelin debris following PNS injury (Stoll et al., 1989), regenerating 
axons are probably not exposed to a lipid-rich environment, in contrast to the 
CNS where such clearance is not as effective. 
 Accumulation of unesterified CO and SpH is the hallmark of Niemann-Pick 
disease, which culminates in neurodegeneration (Aqul et al., 2011; Ledesma et 
al., 2011). Interestingly, cultured neurons from mice lacking Niemann-Pick type 
C1 protein (npc1 knockout mice) displayed increased rate of growth cone 
collapse that was mediated by ROCK activation and reverted by ROCK inhibition 
(Qin et al., 2010). In npc1 mice, administration of HPβCD delays the onset of 
clinical symptoms by reducing the buildup of CO and sphingolipids within the 
nervous tissue (Davidson et al., 2009; Aqul et al., 2011). HPβCD is a well-tolerated 
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FDA-approved drug used in animal models and in human clinical trials, known for 
its ability to form inclusion complexes, remove cholesterol from membranes and 
increase cholesterol trafficking (Davidson et al., 2009; Aqul et al., 2011; Matsuo 
et al., 2013). Here we show that following HPβCD delivery, decreased levels of 
inhibitory lipids, namely CO, CE and SpH are specifically obtained in the SCI site 
whereas uninjured spinal cord segments have unaltered lipid composition. Upon 
spinal cord injury, HPβCD may exert a generalized sequestering effect allowing 
the removal of lipids from the injury site, and thus relieve the inhibitory level 
within the glial scar. Although HPβCD did not seem to have a clearly defined lipid 
specificity, we did not observe any lipid changes in the treated un-injured spinal 
cord, indicating that this non-toxic agent does not lead to lipid dysregulation in 
normal tissues. In addition, HPβCD treatment led to increased axonal 
regeneration, supporting that HPβCD delivery should be considered as a 
therapeutic option in the context of SCI.  
 At the molecular level, inhibition induced by CO and SpH could be reverted 
by the Rho inhibitor C3 transferase. In the case of SpH, for which a stronger effect 
was observed with C3 transferase, we further demonstrate the downstream 
activation of ROCK as increased phosphorylated levels of its substrate, MLC, are 
generated. These data supports that both myelin proteins and lipids signal 
inhibition through similar pathways involving Rho activation. CO and SpH may act 
as ligands to induce receptor-mediated activation of the Rho signaling cascade, or 
alternatively they can augment receptor activation leading to increased Rho 
activity. Whether CO and SpH engage the same receptors (e.g. Nogo receptor and 
PirB) as several structurally unrelated myelin proteins is to be unraveled. Specific 
binding sites for CO have been identified in G-protein-coupled receptors 
(Cherezov et al., 2007; Liu et al., 2012). As such, CO and/or SpH at the 
extracellular matrix in which axons are growing may interact and engage other 
receptors eliciting a signaling cascade that impairs axonal growth. Sulfatide has 
also been identified as a lipid that specifically inhibits neurite outgrowth of retinal 
ganglion cells through a Rho-mediated mechanism (Winzeler et al., 2011), 
although the pathway by which this occurs remains poorly understood. The next 
challenge will be to further characterize the pathways by which lipids mediate the 
repression of neurite outgrowth.  
 In summary our work shows that myelin lipids are important modulators of 
axonal regeneration that should be considered as critical targets in strategies 
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aiming at improving axonal growth following injury. Moreover, we provide the 
initial data supporting that the FDA-approved HPβCD delivery could be tested in 
the context of SCI. 
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Abstract 
Following peripheral nervous system injury, besides increased cAMP, the positive 
injury signals ERK, JNK and STAT-3 are locally activated and retrogradely 
transported to the cell body, where they induce a pro-regenerative program. Here, 
we used dorsal root ganglia (DRG) neurons which comprise a central branch that 
does not regenerate and a peripheral branch that regrows after lesion, to further 
understand the importance of injury signaling for successful axon regeneration. 
Although injury to the central branch of DRG neurons (dorsal root injury-DRI) 
activates the above positive injury signals and increases cAMP levels, it does not 
elicit the gain of intrinsic growth capacity nor the ability to overcome myelin 
inhibition, as occurs after injury to the peripheral branch (sciatic nerve injury- 
SNI). Besides, by blocking ERK activation and adenylyl cyclase activity, we show 
that the gain of intrinsic growth capacity of DRG neurons after injury is 
independent of ERK and cAMP. Antibody microarray analysis of axoplasm from 
rats with either DRI or SNI following dynein immunoprecipitation revealed a broad 
differential activation and transport of signals after each injury type and further 
supported that ERK, JNK, STAT-3 and cAMP signaling pathways are probably 
minor contributors to the differences in the intrinsic axon growth capacity 
observed in these injury models. From the injury signals differentially activated 
after DRI and SNI, we specifically identified increased levels of Hsp-40, ROCK-II 
and GSK3β after DRI, not only in axons but also in DRG cell bodies. In summary, 
our work shows that activation and transport of canonical positive injury signals 
is not sufficient to promote increased axonal growth capacity, and that a limited 
regenerative response after DRI may be accounted by the differential activation of 
inhibitory injury signals including ROCKII and GSK3β.  
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Introduction 
While axon regeneration in the central nervous system (CNS) is unsuccessful, 
adult peripheral nervous system (PNS) axons can spontaneously regenerate to a 
considerable extent and are therefore generally used as a model to identify 
players that promote axon regrowth. Within the PNS, sensory dorsal root ganglia 
(DRG) neurons have been widely used in axonal regeneration studies given their 
peculiar nature. DRG neurons are pseudounipolar, possessing two branches: a 
peripheral branch that innervates sensory organs and a central branch that enters 
the spinal cord through the dorsal root and ascends to the brainstem, forming 
the dorsal column fibers (Devor, 1999). When injured, the two branches have 
different regenerative capacities. While an injury to the peripheral branch is 
followed by successful regeneration, injury to the central branch, either dorsal 
root injury (DRI) or spinal cord injury, fails to display a similar effect (Smith and 
Skene, 1997). In the case of DRI, sensory axons regenerate within the dorsal root 
but stop after contact with the dorsal root entry zone (DREZ; the transition zone 
between the spinal cord and the dorsal root), making the DRI a simplified model 
to study CNS regeneration. Initially, the inability of sensory axons to regenerate 
after DRI has been attributed to the presence of inhibitory molecules in the DREZ 
(Zhang et al., 2001; Beggah et al., 2005). However, recent reports suggest that 
the formation of new synapses when regenerating axons enter the spinal cord 
stabilizes them, inhibiting further growth (Di Maio et al., 2011). Besides 
extracellular cues, cell-intrinsic differences have been described in DRG neurons 
subjected to either DRI or peripheral injury. Whereas a peripheral injury triggers 
the expression of several regeneration associated genes (RAGs), including 
activating transcription factor 3 (ATF-3), growth-associated protein 43 (GAP-43) 
and CAP-23 among others (Schreyer and Skene, 1993; Mason et al., 2002; 
Seijffers et al., 2006), DRI fails to elicit a similar response. The reasons underlying 
the differential activation of a pro-regenerative program after SNI and DRI remain 
elusive. 
 It is widely acknowledged that injury signaling is pivotal to mount a pro-
regenerative program (Mar et al., 2014). Seminal studies done in Aplysia have 
shown that injection of axoplasm from injured nerves into naïve neurons is 
accompanied by increased growth. The hypothesis raised to explain this 
observation was that axonal injury triggers the local activation of injury signals 
that are retrogradely transported to the cell body and then imported to the 
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nucleus (Ambron et al., 1995). Later, and further supporting this hypothesis, 
extracellular-signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and 
signal transducer and activator of transcription 3 (STAT-3) have been identified as 
positive injury signals locally activated following peripheral injury and 
retrogradely transported to the cell body, playing a crucial role in mounting the 
response to injury (Cavalli et al., 2005; Perlson et al., 2006; Rishal and Fainzilber, 
2010; Ben-Yaakov et al., 2012).  Specifically, pERK is involved in the retrograde 
signal that initiates regeneration (Perlson et al., 2005); JNK signaling has been 
implicated in the reorganization of the axonal cytoskeleton and in neurite 
regeneration (Barnat et al., 2010) and  STAT-3 contributes to the initiation of 
axonal regeneration (Bareyre et al., 2011) and to neuronal survival after injury 
(Ben-Yaakov et al., 2012). Besides injury signaling, increased levels of cAMP in 
DRG neurons after PNS injury have long been associated with increased axonal 
elongation (Cai et al., 1999; Cai et al., 2001; Neumann et al., 2002; Qiu et al., 
2002; Nikulina et al., 2004). Nevertheless, recent reports have questioned the 
extension of cAMP effects (Blesch et al., 2012). Downstream of injury signaling, 
major transcriptional alterations underlie the increased regeneration ability 
following peripheral injury (Costigan et al., 2002). Some of the transcription 
factors are activated by the above injury signals: ERK activates ETS domain-
containing protein (Elk-1) (Perlson et al., 2005), JNK activates c-Jun and ATF3 
(Lindwall and Kanje, 2005) and the cAMP pathway activates cAMP response 
element-binding protein (CREB) (Gao et al., 2004).  Together, these will lead to a 
profound change of the transcriptional profile of injured neurons contributing to 
their survival and regeneration through the expression of an array of RAGs 
including neuropeptide Y (NPY), vasoactive intestinal peptide (Vip), ATF-3, 
arginase 1 (Arg-1) and GAP-43, among others (Ylera et al., 2009). 
 Here we observed that despite DRI is unable to elicit a robust increase in 
axon growth, it is accompanied by the activation and retrograde transport of the 
canonical positive injury signals ERK, JNK and STAT-3 and increased levels of 
cAMP. Besides, we identified broad signaling differences between DRI and 
peripheral injury including increased levels of signals associated with decreased 
axonal growth namely, Rho-associated kinase (ROCK-II) and glycogen synthase 
kinase 3 β (GSK3β), that may contribute to the limited regeneration capacity after 
a central branch injury. 
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Materials and methods  
Surgical procedures. Rats were handled according to European Union and 
National rules. All animals were maintained under a 12-h light/dark cycle and fed 
with regular rodent's chow and tap water ad libitum. For the animal models of 
injury 8-10 weeks old Wistar rats were used. For sciatic nerve injury (SNI), rats 
were anesthetized with ketamine (75 mg/kg)/medetomidine (0.5 mg/kg). The 
sciatic nerve was exposed at the mid-thigh and crush was then performed using 
Pean forceps, twice for 15 seconds. Analgesia (butorphanol 3 mg/kg, twice a day) 
was performed for 48 h following injury. For dorsal root injury (DRI), rats were 
anesthetized and laminectomy at lumbar vertebrae 2 was performed exposing the 
dorsal roots of DRG L4,5. The L4,5 dorsal roots were then crushed using fine 
forceps, twice for 15 seconds. Analgesia was performed as described above. 
Quantitative PCR. One week after either SNI or DRI, rats were sacrificed with an 
overdose of ketamine/medetomidine and L4,5 DRGs were collected; naïve rats 
were used as control (n=4 rats per group were used). RNA was extracted from 
DRGs (Qiagen), and cDNA was synthesized by reverse transcription (Invitrogen) 
using 1 μg of RNA. qRT PCR was then performed using iQ supermix (Bio-Rad) and 
primers designed using Beacon designer: NPY (sense: 5’-
GCTCGTGTGTTTGGGCATTCTG-3’; antisense: 5’-GTGTCTCAGGGCTGGATCTCTTG-
3’), Vip (sense: 5’-GTCACTCATTGGCAAACGAATCAG-3’; antisense: 5’-
CTCCCTCACTGCTCCTCTTCC-3’), GAP-43 (sense: 5’-
GATAACTCGCCGTCCTCCAAG-3’; antisense: 5’-CTACAGCTTCTTTCTCCTCCTCAG-
3’); Arg-1 (sense: 5’-GACATCAACACTCCGCTGACAAC-3’; antisense: 5’-
CCAGGGTCCACATCTCGCAAG-3’); ATF-3 (sense: 5’-
TCTGGAGATGTCAGTCACCAAGTC-3’; antisense: 5’-
CCTTCAGTTCGGCATTCACACTC-3’); Hypoxanthine-guanine 
phosphoribosyltransferase (Hprt) (sense: 5’-ATGGACTGATTATGGACAGGACTG-3’; 
antisense: 5’-GCAGGTCAGCAAAGAACTTATAGC-3’). 
Neurite outgrowth assays. One week after either SNI or DRI, animals were 
sacrificed with an overdose of ketamine/medetomidine and L4,5 DRGs were 
collected. DRG neuron cultures were performed as described (Miranda et al., 
2011). Briefly, DRG were collected and digested with 0.125% collagenase IV-S 
(Sigma-Aldrich) for 3 h at 37°C. A single-cell suspension was obtained by 
trituration with a fire-polished Pasteur pipette and centrifuged over a 15% 
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albumin cushion for 10 minutes at 200g. Cells were then plated in poly-L-lysine 
(20 µg/mL)/laminin (5 µg/mL; Sigma-Aldrich) or in poly-L-lysine (20 
µg/mL)/myelin-coated (2.4 µg/coverslip; myelin was isolated from the spinal cord 
of 16 weeks-old WT mice as detailed (Norton and Poduslo, 1973)) 13 mm 
coverslips and maintained at 37 °C for 12 h. Subsequently, cells were fixed, 
immunostained against βIII tubulin (1:2000, Promega) and traced with NeuronJ 
(an ImageJ plugin). The length of the longest neurite was measured in at least 
100 neurons per condition. 
Axoplasm extraction. Immediately after SNI or DRI, a knot was performed with 
4/0 suture thread proximally to the DRG to restrain the axonal transport of injury 
signals (Fig. 2A). Eight or 24 h after each injury type, rats were sacrificed and 
nerves were collected to 100 μl of PBS containing protease inhibitors (GE 
Healthcare) and 1 mM ortovanadate (Sigma-Aldrich). Nerves from naïve rats were 
used as control. Axoplasm was collected by gently squeezing the nerves with a 
pestle followed by a centrifugation at 15,000 g at 4 ºC for 10 minutes, as 
described (Hanz et al., 2003). This cycle was repeated 2 more times. After the last 
centrifugation, supernatant was collected and 25 μg of each protein sample were 
run in 12% SDS-PAGE. 
DRG protein extract. L4,5 DRG of animals with either SNI or DRI were collected 
17-20 h after lesion, respectively; naïve animals were used as a control 
(n=4/group). The tissue was then homogenized in PBS containing protease 
inhibitors (GE Healthcare), 1mM ortovanadate and 0.3% Triton X-100, sonicated 
and centrifuged for 10 minutes at 15,000 g at 4 °C. The supernatant was 
collected and 25 μg of each protein sample were run in 12% SDS-PAGE. 
Dynein immunoprecipitation. Dynein immunoprecipitation was performed as 
described elsewhere (Perlson et al., 2005). Briefly, 500 μg of axoplasm protein 
was precleared for 1 h at 4 °C with protein G magnetic beads (GE Healthcare) and 
then incubated with 10 μg of anti-dynein antibody (Millipore) overnight at 4 °C. 
The immune complex formed was collected by incubation for 2 h at room 
temperature with protein G magnetic beads (GE Healthcare), and then boiled in 
sample buffer (31.25 mM Tris-HCL pH 6.8; 1 % SDS; 12.5 % glycerol; 0.02 % 
bromophenol blue; 1.25 % β-mercaptoethanol). The immunoprecipitated samples 
were then run in 12% SDS-PAGE. 
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Immunoblots. Twenty five µg of either axoplasm, DRG extract or dynein 
immunoprecipate were immunobloted against pERK (T202/Y204) and total-ERK 
(both 1:2,000, Cell Signaling), pJNK ((T183/Y185) and total-JNK (both 1:1,000, 
Cell Signaling), pSTAT-3 (Y705) and total-STAT-3 (both 1:2,000, Cell Signaling), β-
actin (1:5,000, Sigma-Aldrich), GSK3α/β (1:2,000, Santa-Cruz Biotechnologies), C-
terminal Src kinase (Csk) (1:1,000, Santa-Cruz Biotechnologies), proto-oncogenic 
cytoplasmic tyrosine kinase (Src) (1:1,000, Signalway Antibody), Hsp-40 (1:1,000, 
Santa-Cruz Biotechnologies), mitogen-activated protein kinase kinase (MEK6) 
(1:1,000, Enzo Life Sciences), Caspase 4 (1:1,000, Enzo Life Sciences), Polo-like 
kinase 3 (Plk3) (1:500, Abgent), ROCK-II (1:1,000, Millipore), total-collapsin 
response mediator protein-2 (CRMP-2), pCRMP-2 (both 1:1,000, Kinasource) and 
GAPDH (1:1,000, Santa-Cruz Biotechnologies). Quantitative analysis of Western 
blots was performed using PDQuest (Bio-rad). 
In vitro conditioning assays. DRG from 8 weeks-old Wistar rats were collected and 
DRG cultures were performed as described above. Cells were either fixed 12 h 
after plating (naïve type of growth), or grown for 24 h and treated with trypsin-
EDTA (Invitrogen) for 5 min, replated and allowed to grow for 12 h (conditioned 
type of growth). The in vitro assay was performed in the presence of the ERK 
inhibitor U0126 (Calbiochem; 10 μM in 0.1 % DMSO), or of the adenylyl cyclase 
inhibitor 9-cyclopentyladenine monomethanesulfonate (9-CPA; 100 μM in H2O, 
Sigma-Aldrich). During the assay, cells were exposed to the drug immediately 
following tissue collection and the drug was present in all culture mediums. 
Vehicle was used as control for both drugs. ERK inhibition was confirmed by 
Western blot against pERK. The efficiency of 9-CPA was assessed by measuring 
the levels of cAMP, as described below.  
cAMP quantification and immunohistochemistry. L4,5 DRG of rats with either SNI 
or DRI were collected 1 day after lesion; naïve animals were used as control (n=4 
per group). Tissues were immediately collected to liquid nitrogen, homogenized 
in ice cold 6 % trichloroacetic acid solution and centrifuged for 15 minutes at 
2,000 g at 4 °C. The supernatant was washed 4 times with 1 ml of water saturated 
diethyl ether. The aqueous phase was then dried under a stream of Nitrogen. 
cAMP levels were measured by an enzyme immune assay according to the 
manufacturer’s instructions (GE Healthcare). For cAMP immunohistochemistry, 
L4,5 DRG of animals with either SNI or DRI were collected 1 day after lesion and 
were formalin fixed, processed and paraffin embedded; naïve animals were used 
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as control (n=4 per group). Paraffin sections were cleared, hydrated and 
incubated in blocking buffer (10 % fetal bovine serum, with 0.3 %Triton X-100) for 
1 h at room temperature and then incubated with anti-cAMP primary antibody 
diluted in blocking buffer (1:500 Millipore) overnight at 4 ºC, followed by 
incubation with biotinylated secondary antibody in blocking buffer (1:200, Vector 
laboratories) and avidin peroxidase (Elite ABC kit, Vector laboratories). Antigen 
visualization was performed using DAB (Vector laboratories). Sections were then 
dehydrated, mounted in DPX and pictures were taken at 10 x magnification 
(Olympus). 
Antibody microarray analysis. Axoplasm of L4,5 ligated nerves from rats with 
either SNI (a pool of 18 animals) or DRI (a pool of 6 animals) was collected 8 h 
after injury. Dynein immunoprecipitation was performed as described above. The 
immune complexes formed were dissociated by two incubations of 10 minutes 
with 0.1 M glycine pH 2.5, at room temperature. The solution was neutralized 
with 1 M Tris pH 9 and then incubated with protein G magnetic beads (GE 
Healthcare) to remove the IgGs. The collected supernatant (immunoprecipitation 
product without IgGs) was analyzed using the Kinex™ Antibody Microarray 
(Kinexus).  The Kinex™ Antibody Microarray tracks both protein expression (with 
~510 pan-specific antibodies) and phosphorylation (with ~340 phospho-site-
specific antibodies) using highly validated commercial antibodies. Briefly, 50 μg 
of lysate protein from each sample (axoplasm following dynein 
immunoprecipitation from animals with either DRI or SNI) was covalently labeled 
with a Kinexus proprietary fluorescent dye and loaded side by side on the same 
chip (each microarray consists of 2 identical fields). Signal quantification was 
performed with ImaGene 8.0 from BioDiscovery (El Segundo, CA). Z scores were 
calculated by subtracting the overall average intensity of all spots within a sample 
from the raw intensity for each spot, and dividing it by the standard deviations 
(SD) of all of the measured intensities within each sample. Z ratios were further 
calculated by taking the difference between the averages of the observed protein 
Z scores and dividing by the SD of all of the differences for that particular 
comparison. A short list of 46 candidates was selected based on the following 
parameters: Z-ratio = >+/- 1.0, Error Range for adjacent duplicate spots of the 
same protein <30%, Globally Normalized Median Value >254, Flags (indication of 
the quality of the spot based on its morphology and background) = 0.0. To 
validate the microarray analysis, additional samples of axoplasm of ligated nerves 
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from rats with either SNI (a pool of 14 animals) or DRI (a pool of 7 animals) was 
collected 8h after injury and validation was done by Western blot- Kinetworks™. 
DRG immunohistochemistry. L4,5 DRG of animals with either SNI or DRI were 
collected 17-20 h after lesion, formalin fixed and processed for paraffin blocks; 
naïve animals were used as controls (n=4/group). Paraffin sections were cleared 
and hydrated, antigen retrieval was performed, blocking was done with 5 % fetal 
bovine serum for 1 h at room temperature and the following primary antibodies 
were incubated overnight at 4ºC: pSTAT-3 (1:200, Cell Signaling), GSK3β (1:100, 
Cell Signaling), Csk (1:50, Santa-Cruz Biotechnologies), Src (1:200, Signalway 
Antibody), Hsp-40 (1:50, 10 mM sodium citrate, Santa-Cruz Biotechnologies), 
MEK6 (1:200, Enzo Life Sciences), Caspase 4 (1:100, Thermo Scientific) and ROCK-
II (1:100, Millipore). Sections were then incubated with anti-rabbit IgG-alexa488 
(1:1,000, Invitrogen) and mounted with vectashield (Vector laboratories). Images 
were taken in a fluorescence microscope (Zeiss Axio Imager) with a 10 x 
objective. Quantification was performed by determining the percentage of DRG 
neurons with positive staining. 
Lentivirus production and neurite outgrowth analysis. HEK293T cells were 
transfected with packaging plasmids pPAX and pLP/VSVG (Dr. Relvas, IBMC) and a 
lentiviral vector (pLKO) coding for puromycin resistance and expressing a 
scrambled shRNA (Sarbassov et al., 2005) or a shRNA for Hsp-40 (Sigma-Aldrich). 
Forty eight hours later, viral titration was done by infecting HEK 293T cells. DRG 
neuron cultures from 8-weeks-old rats were performed as described above. One 
day after plating, cells were infected with lentivirus (5,000 IU/well) for 12-16 h, 
and 24 h later treated with puromycin (5μg/mL) for 48 h. For neurite outgrowth, 
cells were trypsinized, replated for 12 h and immunocytochemistry against βIII-
tubulin (1:2,000, Promega) was conducted. At least 60 neurons/condition were 
traced using NeuronJ. 
Statistical analysis. All values are presented as mean ± SEM. Student’s t-test or 1-
way-anova with Tukey’s test was used.   
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Results 
A dorsal root injury elicits the activation and retrograde transport of positive 
injury signals to the soma 
After DRI in adult animals, sensory axons regenerate within the dorsal root but 
stop after contact with the spinal cord. Besides the inhibitory extrinsic 
environment, DRI fails to activate an intrinsic regenerative program (Seijffers et 
al., 2006). In accordance with previous findings (Seijffers et al., 2006), DRG 
neurons plated on the permissive substrate laminin collected from rats with a 
conditioning SNI had a robust 1.6-fold increased neurite outgrowth, whereas after 
DRI a marginal 1.1-fold increase was observed (Fig. 1A,B). Moreover, while DRG 
collected form rats primed with a SNI were able to overcome myelin inhibition, 
DRI was unable to generate a similar effect (Fig. 1A,C). The failure of DRI in 
increasing the growth capacity of DRG neurons and of overcoming myelin 
inhibition correlated with a decreased capacity in inducing the expression of 
RAGs, namely NPY, Vip, GAP-43, Arg-1 and ATF-3 (Fig. 1D). In summary, besides 
the extrinsic inhibitory milieu, axonal regeneration failure after DRI might also 
result from its inability to prime DRG neurons to increase their intrinsic growth 
capacity. 
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Figure 1. DRI does not elicit a robust increase in the intrinsic growth capacity of DRG neurons. A, 
Representative βIII-tubulin immunocytochemistry of L4,5 DRG neurons from naïve rats or rats with 
either SNI or DRI, grown on top of laminin or myelin; scale bar 100µm. B, Neurite outgrowth of DRG 
neurons grown on laminin. C, Quantification of the percentage of cells with neurites in cultures 
represented in A. D, qPCR of L4,5 DRGs from naïve rats, and from rats with either SNI or DRI 
(n=4/group). Results represent the mean ± SEM. *p<0.05, **p<0.01 and ***p<0.001. 
 
 Locally activated injury signals have been proposed as important 
contributors to the robust regenerative response after peripheral lesion (Hanz et 
al., 2003; Cavalli et al., 2005; Ben-Yaakov et al., 2012). To test whether the 
absence of a strong regenerative response following DRI could be due to failure 
in the activation of positive injury signals, these were tested following lesion. To 
do so, we used the crush-ligation paradigm where proximally to the cell body a 
nerve ligation is performed to trap proteins retrogradely transported from the 
injury site (Fig. 2A). Axoplasm was extracted 8 and 24h following injury and 
analyzed for the presence of injury signals. ERK activation was evaluated 
following dynein immunoprecipitation in the axoplasm. Eight h after lesion, both 
DRI and SNI lead to an increase in pERK bound to dynein (6-fold and 3-fold, 
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respectively) (Fig. 2B,C). Besides pERK, pJNK (Fig. 2B,D) and pSTAT-3 (Fig. 2B,E) 
were activated in the axoplasm after DRI to a similar extent as after SNI. These 
signals were not only activated by DRI but were also retrogradely transported and 
able to reach the cell body. In DRG extracts, following either DRI or SNI, increased 
pERK (20- and 10-fold, respectively- Fig. 2F,G) and pSTAT-3 (2.1- and 2.8-fold, 
respectively- Fig. 2H,I) were observed. Similar levels of pJNK in the DRG were also 
observed following SNI and DRI. Furthermore, immunohistochemistry of DRG 
neurons showed that pSTAT-3 is translocated to the nucleus following both injury 
types (Fig.  2J,K). In summary DRI is able to induce to a similar extent as SNI, the 
activation and retrograde transport of injury signals to the DRG cell body. 
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Figure 2. DRI activates positive injury signals that are retrogradely transported to the cell body. A, 
Schematic representation of the injury-ligation model of the rat sciatic nerve and of L4,5 dorsal 
roots. B, Representative Western blots of axoplasm collected at different time points following 
either SNI or DRI against pERK and total ERK (after dynein immunoprecipitation); pJNK and total JNK; 
pSTAT-3 and total STAT-3. C, Quantification of ERK in B (n=3/group). D, Quantification of JNK in B 
(n=6/group). E, Quantification of STAT-3 in B (n=6/group). Representative Western blots (and 
respective quantifications) against F,G, pERK, and total ERK, H,I, pSTAT-3 and total STAT-3 in L4,5 
DRGs from naïve rats and from rats with either SNI or DRI; (n=4/group). J, Immunohistochemistry 
against pSTAT-3 of L4,5 DRG of either naïve rats or rat with either SNI or DRI. K, Quantification of 
the percentage of neurons with labeled nucleus in J (n=8/group). Results represent the mean ± SEM. 
*p<0.05, **p<0.01 and ***p<0.001. 
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ERK activation is not essential for DRG neurons to trigger a regenerative response 
The fact that positive injury signals are activated by DRI in the absence of an 
increase in the intrinsic axonal growth questions their relevance as crucial injury 
signals sufficient to trigger a regenerative response. Preventing ERK activation 
with the MEK inhibitor U0126 has been shown to inhibit axonal regeneration 
following peripheral nerve injury (Perlson et al., 2005). To further clarify the role 
of ERK in the gain of axonal growth capacity, we performed an in vitro assay 
mimicking a peripheral injury by trypsin treatment and replating naïve DRG 
neurons after 24 h in culture (Saijilafu et al., 2013), grown with or without U0126. 
The efficiency of the inhibitor was confirmed by immunoblot against pERK in 
cultured DRG neurons (Fig. 3A). Trypsin treatment increased neurite outgrowth 
(Fig. 3B), similarly to the in vivo priming of DRG neurons after peripheral injury. 
Although U0126 lead to a small decrease in neurite outgrowth of naïve DRG 
neurons (Fig. 3B), trypsin-treated DRG neurons had similar increase in neurite 
outgrowth with or without U0126 treatment (Fig. 3B), suggesting that priming 
DRG neurons triggers ERK-independent mechanisms that can override its 
absence. 
 
Figure 3. ERK activation is not essential for DRG neurons to trigger a regenerative response. A, 
Western blot against pERK and total ERK in DRG neuron cultures either untreated or treated with the 
MEK inhibitor U0126. B, Neurite outgrowth of DRG neurons treated with U0126 before or after 
trypsin treatment (n=3/group). Results represent the mean ± SEM. *p<0.05 and ***p<0.001. 
 
cAMP increases after DRI and is not central for the gain of axonal growth capacity 
of conditioned DRG neurons 
High levels of cAMP following peripheral injury have been described as essential 
to increase axonal regeneration (Qiu et al., 2002). Given the importance of cAMP 
in axon growth, we next asked if a DRI could increase the cAMP levels of DRG 
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neurons. Both after DRI and SNI, a 2-fold increase in cAMP levels was present in 
DRG neurons (Fig. 4A). Immunohistochemistry against cAMP of DRG following SNI 
or DRI also confirmed this increase (Fig. 4B). We went on to further evaluate the 
relevance of cAMP in the gain of regenerative capacity of trypsin-conditioned DRG 
neurons. To block cAMP synthesis, the adenylyl cyclase inhibitor, 9-
cyclopentyladenine (9CPA) was used. Culturing DRG neurons with 9CPA decreased 
cAMP levels by more than 50%, confirming the inhibition of adenylyl cyclase (data 
not shown). In DRG neurons conditioned by trypsin, 9CPA treatment did not 
prevent the gain of neurite outgrowth capacity (Fig. 4C). Overall these data 
suggest that cAMP increase is not sufficient to promote a gain in the intrinsic 
growth capacity of DRG neurons and that this increased capacity can be achieved 
in the absence of a rise in cAMP. 
 
Figure 4. cAMP is not essential for DRG neurons to trigger a regenerative response. A, 
Quantification of cAMP levels in L4,5 DRG of naïve rats or rats with either SNI or DRI (n=4/group). B, 
Immunohistochemistry against cAMP of L4,5 DRG of naïve rats or rats with either SNI or DRI 
(n=4/group). C, Neurite outgrowth of DRG neurons treated with the adenylyl cyclase inhibitor 9-CPA 
before or trypsin treatment (n=3/group). Results represent the mean ± SEM. *p<0.05 and 
***p<0.001. 
 
DRI and SNI lead to the differential activation and transport of signals in the 
axoplasm 
Since no major variation was found in known injury signals when comparing SNI 
and DRI, we performed an antibody microarray to identify possible differences 
that could explain the fact that a SNI elicits a gain in the intrinsic growth capacity 
whereas DRI fails to do so. For that, using a ligation proximal to the DRG, we 
collected the axoplasm of dorsal roots or sciatic nerves following DRI or SNI, 
respectively. Following dynein immunoprecipitation the samples were analyzed 
using Kinex™ Antibody Microarray (Kinexus) that tracks both protein expression 
(with ~510 pan-specific antibodies) and phosphorylation (with ~340 phospho-site-
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specific antibodies). The array analysis revealed that 28 protein targets had a 
significantly upregulated signal whereas 16 were significantly downregulated 
after DRI (Table 1).  
 
Table 1: Target proteins for which a significant variation was found by microarray analysis of 
dynein-immunoprecipitated axoplasm from DRI and SNI samples. Grey- targets for which additional 
analysis was performed by Western blot of axoplasm; Red- targets for which Western blot results 
validated the microarray data. 
Full Target Protein Name 
Phospho Site 
(Human) 
Microarray    
Z-ratio 
(DRI/SNI) 
Western blot   
fold change 
(DRI/SNI) 
Acetylated Lysine Pan-specific 1,28 
 
B-cell lymphoma protein 2 alpha (Bcl2) Pan-specific 2,14 not detected 
Breast cancer type 1 susceptibility protein (BRCA1) S1497 1,29 
 
Caspase 4  Pan-specific -1,2 0,7 
Caspase 5  Pan-specific -1,26 2,2 
Caveolin 1 Y14 -1,32 not detected 
Cell division cycle 2-like protein-serine kinase 5 
(CDC2L5, CHED) 
Pan-specific -1,21 not detected 
C-terminus of Src tyrosine kinase (Csk) Pan-specific 1,05 1,9 
Cyclin-dependent protein-serine kinase 5 (CDK5) Pan-specific -1,07 1,7 
Cyclin-dependent protein-serine kinase 8 (CDK8) Pan-specific 4,35 
 
DnaJ homolog, subfamily B member 1(Hsp40) Pan-specific 1,4 1,4 
Epidermal growth factor receptor-tyrosine kinase 
(EGFR) 
Y1110 1,79 not detected 
Extracellular regulated protein-serine kinase 2 
(Erk1 + Erk2) 
Pan-specific 1,32 
 
Glycogen synthase-serine kinase 3 beta (GSK3b) Pan-specific 1,04 3,2 
Heat shock 27 kDa protein beta 1 (Hsp27) S78 2,12 0,9 
Heat shock 60 kDa protein 1 (chaperonin, CPN60) Pan-specific 1,37 
 
Histone H2A variant X S140 -1,22 
 
Histone H2B S15 -1,14 
 
Integrin-linked protein-serine kinase 1 (ILK1) Pan-specific -1,21 not detected 
Jun N-terminus protein-serine kinase (JNK1/2/3) Pan-specific -1,46 
 
Kit/Steel factor receptor-tyrosine kinase (Kit) Y936 1,7 not detected 
LIM domain kinase 1 (LIMK1) Pan-specific 1,86 not detected 
LIM domain kinase 2 (LIMK1 + LIMK2) Y504+T505 1,19 not detected 
MAPK/ERK protein-serine kinase 1 (MKK1, MEK1, 
MAP2K1) 
Pan-specific 1,09 
 
MAPK/ERK protein-serine kinase 2 (MKK2, MEK2, 
MAP2K2) 
T394 1,14 not detected 
MAPK/ERK protein-serine kinase 6 (MKK6, MEK6, 
MAP2K6) 
Pan-specific 1,11 3,0 
Mitogen-activated protein-serine kinase p38 alpha 
(p38a MAPK ) 
Pan-specific 1,21 
 
Mitogen-activated protein-serine kinase p38 
gamma (MAPK12, p38g MAPK, Erk6) 
Pan-specific 1,03 
 
NF-kappa-B p65 nuclear transcription factor 
(NFkappaB p65) 
S276 -1,03 not detected 
nucleophosmin, numatrin, nucleolar protein NO38 
(B23) 
T234/T237 1,68 not detected 
Polo-like protein kinase 3 (Plk3) Pan-specific 1,36 2,2 
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Protein-serine kinase B beta (PKBb; Akt2) Pan-specific 2,77 
 
Protein-serine kinase C beta 1/2 (PKCb1/2) T500 1,2 not detected 
Protein-serine kinase C beta 2 (PKCb2) Pan-specific 1,2 0,5 
Protein-serine kinase C eta (PKCh) T655 -5,22 not detected 
Protein-serine kinase C lambda/iota (PKCl/i) T564 1,1 1,0 
Protein-serine kinase C theta (PKCq) Pan-specific 1,32 not detected 
Protein-serine phosphatase 2A - alpha and beta 
isoforms (PP2A/Aa/b) 
Pan-specific -1,12 1,9 
Retinoblastoma-associated protein 1 S807 -2,12 not detected 
Retinoblastoma-associated protein 1 T356 -1,51 not detected 
RhoA protein-serine kinase alpha (ROCK2) Pan-specific 1,18 1,3 
Signal transducer and activator of transcription 3 
(STAT3) 
S727 1,25 
 
Sphingosine kinase 2 (SPHK2) Pan-specific -1,12 not detected 
Src proto-oncogene-encoded protein-tyrosine 
kinase (Src) 
Pan-specific -1,18 0,6 
 
 According to our previous observations related to ERK signaling, by 
microarray analysis, no differences were found between DRI and SNI in active ERK, 
nor in vimentin and Elk-1 (involved in ERK transport (Perlson et al., 2005) and 
signaling pathway) (Table 2). Of note, whereas a pan-specific antibody against 
ERK was increased after DRI (Table 1), four other pan-specific ERK antibodies did 
not reveal differences between DRI and SNI (Table 2), further supporting the 
absence of changes in ERK signaling between the two lesion types. Similar 
findings were obtained for JNK, as no differences between DRI and SNI were 
found in the active form of the protein, nor in its downstream effector c-jun 
(Table 2). Besides, confirming the absence of differences in STAT-3 signaling, 
including JAK activation, no differences were observed in phospho-Y705 pSTAT-3 
in the antibody microarray (Table 2), similarly to our previous Western blot 
analysis, despite that phospho-S737 pSTAT-3 (considered a secondary event after 
Y705 phosphorylation), was upregulated after DRI (Table 1). Besides, CREB, the 
downstream effector of cAMP was also unchanged when comparing DRI and SNI 
(Table 2). In the adult CNS, intrinsic inhibitors of axon regrowth have been 
recently identified, including phosphatase and tensin homolog (PTEN). PTEN 
antagonizes the action of PI3K, leading to inactivation protein kinase B (AKT) and 
of mammalian target of rapamycin (mTOR) signaling (Christie et al., 2010). Of 
note, the PTEN/mTOR signaling was unaltered when comparing DRI and SNI 
(Table 2), supporting that this specific pathway is not responsible for the 
differences in regeneration observed after each of the lesion types. 
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Table 2: Selected target proteins with no significant differences in dynein-immunoprecipitated 
axoplasm from DRI and SNI samples as detected by microarray analysis. Number after target protein 
name indicates number of independent antibodies present in the microarray against that target, for 
which no significant variation in SNI and DRI samples was found. 
Target Protein Name Phospho Site (Human) 
CREB1 (1) S129+S133 
CREB1 (2) S133 
Elk-1(1) Pan-specific 
Elk-1(1) S383 
Erk1 + Erk2 (5) Pan-specific 
Erk1 + Erk2 (1) T185+Y187 
Erk1 + Erk2 (2) T202+Y204 
JAK1 (2) Pan-specific 
JAK1 (1) Y1034 
JAK2 (1) Pan-specific 
JAK2 (2) Y1007+Y1008 
JAK3 (1) Pan-specific 
JNK1 (1) Pan-specific 
JNK1/2/3 (2) Pan-specific 
JNK1/2/3 (3) T183 + Y185 
JNK2 (1) Pan-specific 
JNK2/3 (2) Pan-specific 
JNK3 (1) Pan-specific 
Jun (1) Pan-specific 
Jun (1) S63 
Jun (2) S73 
mTOR (1) S2448 
PTEN (2) Pan-specific 
PTEN (1) S380+T382+S385 
STAT2 (1) Y690 
STAT3 (2) Pan-specific 
STAT3 (2) Y705 
Vimentin (1) S34 
 
 In summary, the antibody microarray analysis substantiates that DRI and 
SNI lead to a broad differential activation and transport of signals in the 
axoplasm, and that the ERK, JNK, STAT-3, cAMP and PTEN/mTOR signaling 
pathways are probably minor contributors to the changes in the intrinsic axon 
growth capacity observed in these injury models. 
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The negative injury signals ROCK-II and GSK3β are upregulated in the DRG cell 
body following DRI 
From the microarray shortlist, most of the candidates were chosen for further 
validation by immunoblot of total axoplasm collected from additional rats with 
either SNI or DRI (Table 1, highlighted in grey). Given the extensive analysis 
already described, ERK, JNK and STAT-3 were excluded from further validation. 
From the selected candidates, 17 were not detected by Western blot of axoplasm 
samples given its lower sensitivity when compared to antibody microarray 
analysis. From the remaining 14 candidates, 8 were detected with similar 
differential levels in total axoplasm as those observed by antibody microarray 
analysis of dynein-immunoprecipitated axoplasm: Hsp-40, Plk3, ROCK-II, MEK6, 
Csk and GSK3β- increased after DRI; Src and Caspase 4- decreased after SNI 
(Table 1). Although we excluded from subsequent analysis the 6 candidates 
where no consistent results were found, one should note that whereas microarray 
analysis was performed in dynein-immunoprecipitated axoplasm i.e., allowing the 
identification of proteins bound to the transport machinery, Western blot was 
done on total axoplasm samples, which may underlie the differences observed. 
From the above 8 candidates with consistent changes detected both by 
microarray analysis and Western blot, clear alterations in the DRG were found by  
immunoblot against Hsp-40 and GSK3β where a 2.0- and 1.3- fold increase 
following DRI respectively, was observed (Fig. 5A,B). Besides, by immunostaining 
of DRG, following DRI, a 1.4-, 1.6- and 2.1-fold increase in the immunostaining of 
Hsp-40, GSK3β and ROCK-II was detected when comparing to SNI, respectively 
(Fig. 5C,D). This data further supports that DRI and SNI elicit differential 
activation and transport of injury signals to the DRG. 
 Inhibition of growth cone formation and axonal regeneration is widely 
described as occurring through activation of the Rho pathway, that signals 
through its effector ROCK (Mueller et al., 2005). In this context, increased ROCK-II 
activity in the axoplasm after DRI may certainly contribute to the decreased 
intrinsic growth capacity of neurons after this type of injury. Consistent with 
increased ROCK-II activity after DRI, increased phosphorylation of the ROCK-II 
substrate myosin-light chain was found after DRI (data not shown). In the case of 
GSK3, its activation has been linked to axon growth inhibition (Dill et al., 2008; 
Alabed et al., 2010). GSK3 activity is regulated by phosphorylation; under resting 
conditions, the kinase is constitutively active following phosphorylation of its 
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Tyr216 residue and as a response to the activation of the PI3K pathway, GSK3 is 
inactivated by phosphorylation of Ser9 (Zhou and Snider, 2005). We tried to infer 
GSK3 activity on DRG by checking its phosphorylation status. Increased levels of 
both Ser9 and Tyr216 phosphorylation following DRI were detected by Western 
blot (Fig. 5A). To further determine whether increased GSK3β activity was present 
after DRI, we assessed the levels of pCRMP2, a GSK3β target. Following DRI, p-
CRMP-2 was increased supporting a higher GSK3β activity (data not shown). Hsp-
40 is a member of the heat shock protein family where in contrast to ROCK-II and 
GSK3β, limited information is available as to its role in axon growth and 
regeneration. To elucidate whether Hsp-40 plays a direct role in axon growth, we 
tested neurite outgrowth in vitro following knockdown of Hsp-40 by ShRNA. 
However, as expected from its function as a stimulator of the activity of the 
chaperone Hsp-70 (Fan et al., 2003), downregulation of Hsp-40 led to neuronal 
toxicity (data not shown). This data suggests that increased Hsp-40 following DRI 
is probably related to neuroprotection and not to a direct effect in axon growth. 
Supporting this hypothesis, it is known that induction of Hsp protein expression 
improves motoneuron survival following injury (Kalmar et al., 2002). In summary, 
upregulation of ROCK-II and  GSK3β following DRI might act as a negative injury 
signaling contributing to the inability of DRG neurons to regenerate robustly. 
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Figure 5. Hsp-40, ROCK-II and GSK3β are increased in the DRG following DRI. A, Western blot for 
Hsp-40, ROCK-II, GSK3β, pGSK3β S9, pGSK3β Y216 and GAPDH in L4,5 DRG from naïve animals or 
animals with SNI or DRI. B, Quantification of A. C, Immunohistochemistry against Hsp-40, ROCK-II 
and GSK3β in L4,5 DRG from naïve animals or animals with either SNI or DRI. D, Quantification of C. 
Results represent the mean ± SEM. *p<0.05, **p<0.01 and ***p<0.001. 
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Discussion 
CNS injury does not trigger a gain of intrinsic growth capacity, as it fails to induce 
the expression of RAGs. In the PNS, ERK, JNK and STAT-3 are activated following 
injury, and their transport to the cell body is important for the regenerative 
response (Cavalli et al., 2005; Perlson et al., 2006; Ben-Yaakov et al., 2012). Here, 
we show that after DRI, a simplified model of CNS injury, activation of the 
intrinsic growth capacity of DRG neurons fails despite that activation of injury 
signaling occurs. This observation raises intriguing questions on the relevance of 
ERK, JNK and STAT-3 as master regulators of the regenerative response. Following 
activation, ERK retrograde transport is dependent on vimentin, and further 
supporting the importance of this signal, vimentin knockout nerves, lack a 
regenerative response (Perlson et al., 2005). Nevertheless, this signaling pathway 
is not present in all DRG neurons, since 40% of DRG neurons do not express 
vimentin (Perlson et al., 2005). This evidence suggests that ERK alternative 
pathways may be important to mount the regenerative response which is further 
supported by our results since when ERK phosphorylation is inhibited, DRG 
neurons are still able to increase their intrinsic growth capacity. Given the robust 
response increase in pJNK following injury, it would be interesting to know 
whether downregulation of JNK signaling is sufficient to impair the regenerative 
response. In the case of STAT-3, its activity is inhibited by suppressor of cytokine 
signaling 3 (SOCS3), and further supporting the importance of STAT-3 signaling, 
axonal regeneration can be improved by SOCS3 deletion (Sun et al., 2011), or by 
increasing STAT-3 activity (Lang et al., 2013). However, the presence of activated 
STAT-3 following DRI, when the intrinsic growth capacity is not increased, raises 
the possibility that other inhibitory pathways may suppress its function. Although 
ERK, JNK and STAT-3 are the most studied retrograde injury signals, recent 
analysis of axoplasm following peripheral injury revealed that many other 
retrograde signals may exist, supporting the robustness and redundancy of the 
regenerative response to peripheral injury (Michaelevski et al., 2010). Inactivation 
of PKCα, and activation of ABL, AKT and p38 were identified as signaling 
pathways that improve axonal regeneration following peripheral injury 
(Michaelevski et al., 2010). In our antibody microarray, we did not find major 
differences in PKCα, ABL, AKT and p38, suggesting that regenerative differences 
between SNI and DRI are probably not due to alterations in these signaling 
pathways. 
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 In our model, by comparing the axoplasm from nerves with different 
regeneration abilities, we identified several signals upregulated and 
downregulated after DRI. From these, we show that ROCK-II, GSK3β and Hsp-40 
have an increased transport up to the cell body following DRI. Their presence in 
the cell body in conditions where there is no gain in the intrinsic regeneration 
capacity after injury suggests that they may act as axonal growth inhibitors. In 
fact, both ROCK-II and GSK3β have been widely associated to axonal growth 
inhibition. Myelin proteins, namely Nogo, MAG and OMgp, are strong inhibitors of 
axonal growth (Yiu and He, 2006). Following receptor binding, there is activation 
of the small GTPase RhoA that signals through its effector ROCK. The usage of 
RhoA/ROCK pathway inhibitors, such as the Rho inhibitor C3 transferase 
(Dergham et al., 2002) and ROCK inhibitors as Y-27632 (Dergham et al., 2002) 
and fasudil hydrochloride (Alabed et al., 2006), have been largely used to surpass 
myelin inhibition and induce axonal regeneration. Further reinforcing the 
importance of this pathway in signaling axon growth inhibition, ROCK-II dominant 
negative neurons are able to surpass myelin inhibition (Alabed et al., 2006), and 
ROCK-II KO mice present increased axonal regeneration (Duffy et al., 2009). The 
inhibitory effect produced by ROCK is attributed to local alterations in the 
cytoskeleton at the axon tip (Yiu and He, 2006). We observed that following DRI, 
increase levels of ROCK-II are also observed at the cell body. Further studies 
should unravel how ROCK-II transport to the cell body may lead to axon growth 
inhibition. Besides the RhoA/ROCK pathway, activation of GSK3β has been linked 
to axonal growth inhibition and GSK3β inhibitors were successfully used to 
promote axonal growth in the presence of inhibitory substrates in vitro, and in 
vivo following spinal cord injury (Dill et al., 2008). GSK3β is able to regulate 
axonal growth by manipulating microtubule dynamics (Zhou and Snider, 2005). In 
our model, similarly to ROCK-II, we observed that there is increased GSK3β in the 
cell body. In fact, a small fraction of GSK3β has been described as having a 
nuclear localization, with a higher kinase activity (Bijur and Jope, 2003). How this 
specific distribution of GSK3β impairs axon growth remains elusive. Hsp-40 is a 
member of the heat shock protein family, which is known to be upregulated 
under pathologic conditions such as neurodegenerative diseases where it seems 
to play a protective role (Jana et al., 2000). Following a central injury, neurons 
may require an increase in protection mechanisms such as the ones provided by 
heat shock proteins, justifying the increased levels of Hsp-40 following DRI. 
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The reasons underlying the broad differences in injury signaling response 
after lesion to the central or to the peripheral branch of a DRG neuron remain 
elusive. Whether these arise as a consequence of intrinsic differences of both DRG 
branches and/or have a contribution of their distinct extracellular environments 
should be further addressed. 
In summary, our data shows that DRI and SNI lead to a broad differential 
activation and transport of signals in the axoplasm, and that the ERK, JNK, STAT-3 
and cAMP signaling pathways are probably minor contributors to the changes in 
the intrinsic axon growth capacity observed in these injury models. Besides, we 
provide evidence supporting the existence of inhibitory injury signals that include 
ROCK-II and GSK3β, which are increased in conditions where a pro-regenerative 
program is not activated and suggest that their retrograde transport following 
DRI may work as a break to regeneration.  
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Abstract 
Despite the inability of CNS axons to regenerate, an increased regenerative 
capacity can be elicited following conditioning lesion to the peripheral branch of 
dorsal root ganglia neurons (DRGs). By in vivo radiolabeling of rat DRGs, coupled 
to mass spectrometry and kinesin immunoprecipitation of spinal cord extracts, 
we determined that the anterograde transport of cytoskeleton components, 
metabolic enzymes and axonal regeneration enhancers, was increased in the 
central branch of DRGs following a peripheral conditioning lesion. Axonal 
transport of mitochondria was also increased in the central branch of Thy1-
MitoCFP mice following a peripheral injury. This effect was generalized and 
included augmented transport of lysosomes, synaptophysin- and APP-carrying 
vesicles. Changes in axonal transport were only elicited by a peripheral lesion and 
not by spinal cord injury. In mice, elevated levels of motors and of 
polyglutamylated and tyrosinated tubulin were present following a peripheral 
lesion and can explain the increase in axonal transport induced by conditioning. 
In summary, our work shows that a peripheral injury induces a global increase in 
axonal transport that is not restricted to the peripheral branch, and that, by 
extending to the central branch, allows a rapid and sustained support of 
regenerating central axons. 
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Introduction 
Although in the adult CNS axon regeneration fails, some CNS axons can be 
prompted to regenerate. For example, the central branch of dorsal root ganglia 
neurons (DRGs) gains regenerative capacity when the peripheral branch is injured- 
a paradigm known as conditioning lesion (Neumann and Woolf, 1999). 
Numerous molecular pathways are regulated by conditioning lesion but none 
alone is able to fully replicate its effect.  
 As neurons are highly polarized, many newly synthesized regeneration-
associated genes (RAGs), and cytoskeleton proteins need to be transported 
anterogradely to the axon tip. In fact, the speed of axonal regeneration is similar 
to the rate of the slow component b (SCb) of anterograde transport, supporting 
the relevance of transport in sustaining regeneration (Wujek and Lasek, 1983). 
Anterograde axonal transport is divided into the slow component a (SCa), which 
transports neurofilaments, tubulin and microtubule-associated proteins, and SCb, 
which transports cytoplasmic proteins, such as glycolytic enzymes and actin, 
whereas vesicles and membranous organelles are transported in the fast 
component (Lasek et al., 1984). The motors of slow and fast components are 
similar, and the different rates result from intermittent pausing behavior of 
cargoes (Roy et al., 2007). Retrograde transport is also critical for regeneration, 
as it participates in injury signaling (Abe and Cavalli, 2008).  
 Despite the above evidence suggesting a central role of axonal transport 
during regeneration, the modulation of transport by injury is not well understood. 
Initial studies suggested that enhanced axonal growth after conditioning lesion 
was related to increased transport of cytoskeleton components (McQuarrie and 
Grafstein, 1982; Oblinger and Lasek, 1988; McQuarrie and Jacob, 1991). 
However, a more detailed interrogation using current approaches is missing. In 
this work we used the conditioning lesion to further understand whether axonal 
transport is regulated in conditions of increased axonal regeneration. 
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Materials and Methods 
Surgeries. 8-10 weeks-old male Wistar rats were handled according to European 
Union rules. For sciatic nerve injury (SNI), the sciatic nerve was transected at the 
mid-thigh. For spinal cord injury (SCI), a dorsal hemisection was performed at T8. 
Rats with conditioning were subjected to SNI 1 week prior SCI.  
Radiolabeling of DRG neurons. L4,5 DRGs of 8-10 weeks-old naïve rats and of rats 
with a SNI performed 1 day before (n=6 rats/group), were injected with [
35
S]-
methionine/cysteine (2 μl [22 µCi])/DRG). Six days later, SCI was performed. One 
week later, spinal cords were collected from L5 up to the injury site, and 
segmented into 6 fragments. Each fragment was homogenized and counts per 
minute of 50 μg of protein were measured. Two-dimensional gels of the spinal 
cord fragment L4,5 were performed and exposed to a phosphor screen for 5 
weeks. Radioactive spots were trypsin-digested and identified by MALDI-TOF/TOF.   
qRT-PCR. L4-5 DRGs from 8-10 weeks-old naïve rats and rats 1 day or 1 week 
following SNI were collected. qRT-PCR was performed using iQ supermix (Bio-
Rad). 
Immunoprecipitation. 8-10 weeks-old Wistar rats, with and without a conditioning 
SNI (performed 1 week before SCI), were subjected to SCI and 1 week later the 
spinal cord (T9-T12) was collected (pool of 5 animals/group). Samples were 
homogenized in PBS containing 0.3% Triton X-100, protease inhibitors (GE 
Healthcare) and 1mM sodium ortovanadate. For immunoprecipitation, anti-kinesin 
heavy chain (Millipore) was used. As negative control, mouse IgG were used. The 
immune complex was collected using protein G magnetic beads (GE Healthcare). 
For Western blots, antibodies against RhoGDI (1:2,000 Santa Cruz Biotechnology), 
CRMP-5 (1:3,000, Prof Améli-Moradi, Université Lyon1, France), pan 14-3-3 
(1:1,000, Cell Signaling) and PGP9.5 (1:1,000, AbD Serotec) were used. 
Lentivirus production. HEK293T cells were transfected with packaging plasmids 
pPAX and pLP/VSVG (Dr. Relvas, IBMC) and a lentiviral vector (pLKO) coding for 
puromycin resistance and expressing the shRNA of interest (Sigma-Aldrich). 48 h 
later viral titration was done by infecting HEK 293T cells.  
Neurite outgrowth. DRG from naïve rats were isolated as described (Miranda et 
al., 2011). One day after plating, cells were infected with lentivirus (5,000 IU/well) 
for 12-16 h, and 24 h later treated with puromycin (5μg/mL) for 48 h. To confirm 
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shRNA efficiency, qRT-PCR for RhoGDI, CRMP-5 and PGP9.5 was performed; a 
reduction of 85%, 60% and 95% was obtained, respectively. For neurite outgrowth, 
cells were trypsinized, replated for 12 h and βIII-tubulin immunocytochemistry 
(1:2000, Promega) was done. At least 150 neurons/condition were traced using 
NeuronJ. For transfection, 200,000 cells were nucleofected (Amaxa 4D) with R18-
EGFP or control plasmid (Dr. Fournier, McGill University, Canada). Cells recovered 
for 48 h, and 12 h after being trypsinized and replated, neurite outgrowth was 
measured. 
Mitochondria transport. The MitoMouse line P (mice of either sex expressing a 
mitochondrial targeting sequence fused to CFP under the neuronal thy1 
promoter) (Misgeld et al., 2007) was used. DRG explants from 8-10 weeks-old 
mice subjected to SNI were analyzed 1 day or 1 week following injury. In 
additional experiments, MitoMice were subjected to SCI and 2 weeks later a SNI 
was performed; DRG explants were analyzed 1 week later. Naïve animals served 
as controls. Explants of L4,5 DRGs with attached dorsal roots and peripheral 
branches were imaged for up to 2 h. Transport of axonal mitochondria was 
analyzed by confocal microscopy with acquisition at 0.8Hz for 5 min. The number 
of transported mitochondria was determined as described (Misgeld et al., 2007). 
The percentage of moving mitochondria was evaluated in 3 different time 
frames/axon in at least 12 axons/condition. Mitochondria moving in 10 
consecutive frames were used to calculate velocities in at least 50 
mitochondria/condition. To image DRG explants from animals with SCI, injured 
axons were labeled with 1% cholera toxin B (B)-Alexa488 (Invitrogen) by 
performing 3 injections (total volume 7 µl) in the injured dorsal caudal spinal 
cord, immediately following lesion. Four days later, CTB-Alexa488-positive axons 
in the branches of L4,5 DRGs were imaged. 
Transport in DRG neurons. Neuron cultures from L4,5 DRG of naïve or 
conditioned mice (DRG collected 1 week following SNI) of either sex were 
performed. Cells were either infected with baculovirus expressing synaptophysin-
GFP (Invitrogen), incubated with 100 nM lysotracker (Invitrogen) or nucleofected 
with APP-YFP (Dr Kaether, Leibniz Institute for Age Research, Germany). Vesicle 
velocity was measured as above, and number of moving APP-containing vesicles 
was determined as the number of vesicles crossing a vertical line in either 
direction/minute. The effect of rolipram (0.5µM in DMSO) in axonal transport was 
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tested in DRGs, by analysis of synaptophysin and lysosome transport as 
described above. 
Western blotting. One day or 1 week following SNI, mouse dorsal roots were 
collected. Naïve animals served as controls. Five animals/group were used. 
Antibodies against kinesin heavy chain (1:500, Millipore), cytoplasmic dynein 
(1:250, Millipore), β-actin (1:5,000 Sigma-Aldrich), α-tubulin (1:1,000, Sigma-
Aldrich), acetylated tubulin (1:5,000, Sigma-Aldrich), tyrosinated tubulin (1:2,000, 
Arium) and polyglutamylated tubulin (1:4,000, Adipogen) were used. 
Statistical analysis. All values are mean ± SEM. Student’s t-test was used.  
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Results 
A conditioning injury increases the expression and anterograde transport of 
newly synthesized axonal proteins 
To test whether a conditioning injury increases the intrinsic ability of DRGs to 
regenerate by eliciting the synthesis and anterograde transport of RAGs, we 
revisited radiolabeling assays used to characterize the different components of 
anterograde transport (McQuarrie and Grafstein, 1982; Wujek and Lasek, 1983; 
Lasek et al., 1984; Oblinger and Lasek, 1988), but focusing on transport in the 
central branch, and coupling radiolabeling with mass spectrometry. In rat spinal 
cords where SNI preceded SCI (conditioning lesion group), increased amounts of 
radiolabeled proteins were consistently found (Fig. 1A), suggesting increased 
synthesis and/or anterograde transport. This increase was confirmed by 2D gel 
analysis of the L4,5 spinal cord fragment, where a generalized 2 to 3-fold 
increase in radiolabeled protein content was found in spinal cords of animals with 
conditioning lesion, when compared to animals where only SCI was performed 
(Fig. 1B). In naïve spinal cords, the radiolabeled protein content was similar to 
that of spinal cords from animals with SCI, whereas that of conditioned animals 
was undistinguishable from animals with SNI only (not shown). This data shows 
that increased protein synthesis by DRGs and/or transport to the central branch 
are elicited by the priming peripheral lesion and that this increase is not 
recapitulated by a central lesion. The two most abundant proteins identified were 
cytoskeletal components, tubulin and actin (Fig. 1B, spots 2 and 5, respectively). 
Most of the proteins corresponded to metabolic enzymes (spots 1- NADH 
dehydrogenase, NDUS1; 4- catalase; 6- creatinine kinase; 8- glutamine synthase; 
11 and 12- acetyl-CoA acetyltransferase, acyl coenzyme A thioester hydrolase and 
prolyl isomerase; 14 and 15- malate dehydrogenase), amongst which several 
glycolytic enzymes were found (spots 10- fructose-bisphosphate aldolase C; 16 
and 17- glyceraldehyde-3-phosphate dehydrogenase; 9- phosphoglycerate kinase 
1; 7- α-enolase; spots 3 and 4-pyruvate kinase isozymes) (Fig. 1B). In addition, 
others included heat shock protein 70 (HSP-70- spot 1), dihydropyrimidinase-
related protein 5 (CRMP-5- spot 4), G protein subunit 2 (GNB2- spot 13), annexins 
2 and 5 (Anxa2 and Anxa 5- spots 16 and 18), sirtuin2 (Sirt2- spot 16), 14-3-3 
proteins (isoforms ζ, γ, θ, ζ/δ, η, β/α and ε- spot 19), Rho GDP-dissociation 
inhibitor 1 (RhoGDI- spot 20) and the neuron-specific ubiquitin carboxyl-terminal 
hydrolase 1 (PGP9.5- spot 20) (Fig. 1B). Of note, as our analysis was performed 
Increased axonal transport after conditioning 
178 
 
following radioactive labelling of DRGs, it was restricted to proteins contained in 
sensory axons in the spinal cord. 
 To determine whether the increase in radiolabeled proteins could arise 
from increased gene expression in DRG, we evaluated the expression of selected 
proteins identified by 2D gel analysis, namely the cytoskeleton genes βIII-tubulin 
(tubulin) and β-actin (actin), the glycolytic enzyme GAPDH and the genes coding 
for CRMP-5, 14-3-3 (ζ isoform), RhoGDI, PGP9.5, HSP-70, GNB2, Anxa2, Sirt2, 
Anxa5 and NDUS1. Most of the proteins had an increased expression 1 day after 
SNI, which in some cases was sustained at a later time point (1 week after SNI). 
Interestingly however, others, including tubulin, actin and anxa5 had unchanged 
expression following injury (Fig. 1C). To test whether proteins identified by 2D 
gel analysis could also show increased anterograde transport in central axons 
from conditioned neurons, we performed kinesin-1 immunoprecipitation. In this 
experimental setup, all the axons of the spinal cord were analyzed and not just 
sensory axons.  In spinal cords of conditioned animals, on average a 2-fold 
increase in the amounts of CRMP-5, 14-3-3, RhoGDI and PGP9.5 that co-
immunoprecipitated with kinesin-1 was found (Fig. 1D). This suggests that an 
increased association with the transport machinery occurs. 
Although metabolic enzymes and cytoskeleton components are obvious 
candidates to be transported to the injury site, many of the remaining proteins 
identified have not been related to axonal regeneration. Thus, to determine their 
relevance, the expression or activity of some of these proteins was inhibited in 
DRG neurons. We observed that neurite outgrowth was inhibited following shRNA-
mediated knock-down of RhoGDI and by blocking the 14-3-3 proteins by 
transfection with R18, a pan 14-3-3 inhibitor (Kent et al., 2010), while the knock 
down of PGP9.5 and CRMP-5 showed no significant effect (Fig. 1E). This suggests 
that at least for some of the proteins identified by 2D gel analysis, including 
RhoGDI and 14-3-3, synthesis in the DRG and anterograde transport through the 
spinal cord may contribute to the increased regenerative capacity induced by 
conditioning injury. 
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Figure 1. Conditioning lesion increases the synthesis and transport of proteins to the central branch 
of DRGs. A, Counts per minute in spinal cord fragments of rats with SCI or SCI preceded by SNI 
(conditioning). B, Representative 2D gels of the L4,5 spinal cord fragment of rats with SCI or 
conditioning. C, qPCR of DRGs from naïve rats, and from DRGs collected from rats 1 day or 1 week 
following SNI (SNI 1d and SNI 1w, respectively); n=4 naïve, n=5 SNI 1d and n=10 SNI 1w. D, 
Representative Western blots of CRMP-5, 14-3-3, RhoGDI and PGP9.5 following kinesin 
immunoprecipitation of spinal cords of animals with SCI or conditioning. E, Neurite outgrowth of 
DRGs following transfection with R18, or infection with lentivirus expressing shRNA to CRMP-5, 
RhoGDI or PGP9.5 (n=3). *p<0.05, **p<0.01 and ***p<0.001. 
 
Transport of mitochondria in the central branch of DRGs is increased following 
peripheral injury  
To determine whether axonal transport of organelles was also affected by a 
conditioning lesion, we used explants of DRGs from MitoMice (Misgeld et al., 
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2007) and imaged mitochondrial movements in the attached nerves. A peripheral 
injury increased the number of transported mitochondria, not only in the 
peripheral branch (Fig. 2A-C), but also in the central branch (Fig. 2A-C). This 
increase was found both in the anterograde (Fig. 2B) and retrograde (Fig. 2C) 
direction. A 1.5-fold increase in anterograde transport was already observed at 1 
day following SNI and was sustained 1 week following injury (Fig. 2B). In the case 
of retrograde transport, an increase was only detected 1 week following injury 
(Fig. 2C). At this time point, a conditioning injury also increased the percentage 
of moving mitochondria both in the peripheral and in the central branch (Fig. 2D). 
Although the conditioning injury led to an increased number of transported 
mitochondria in the central branch, no increase in the speed of transport was 
observed (Fig. 2 E,F). 
 To evaluate if an injury to the central branch triggered a similar effect in 
axonal transport, we injected fluorophore-conjugated CTB in the spinal cord 
immediately following SCI in MitoMice, which allowed the identification of axons 
affected by SCI (CTB-Alexa488-positive; Fig. 2G). Injury to central axons failed to 
produce the same effect as the conditioning injury, since increased transport in 
the peripheral branch was not observed (Fig. 2A,B), and a 2.3-fold decrease in the 
percentage of motile mitochondria (Fig. 2D), relatively to naïve animals was 
found. In the central branch, SCI did not produce changes in mitochondria 
transport (Fig. 2B,C,D).  
 Peripheral injury performed after a central injury still increases the 
regenerative capacity of DRGs (Ylera et al., 2009). In MitoMice where SNI was 
done 2 weeks after SCI, transport was increased similarly to animals with SNI 
alone. An increased number of moving mitochondria (Fig. 2A,B,C) and an 
increased percentage of motile mitochondria (Fig. 2D) were observed. Overall, 
only a peripheral injury (even if performed after central injury) elicits increased 
transport of axonal mitochondria. 
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Figure 2. A conditioning injury increases the axonal transport of mitochondria. A, Kymographs of 
DRG explants from naïve MitoMice, MitoMice where SNI was performed 1 day or 1 week before (SNI 
1d and SNI 1w, respectively), MitoMice where SCI was performed 4 days before (SCI 4d) or MitoMice 
where SNI was performed 2 weeks after SCI and analysis was done 1 week later (SCI+SNI 1w; only 
the central branch was imaged). Upper panel, peripheral branch; Lower panel, central branch. Large 
vertical bands correspond to stationary mitochondria and fine diagonal lines are single motile 
mitochondria. (B-F) Number of B, anterogradely and C, retrogradely moving mitochondria, D, 
percentage of moving mitochondria, and speed of E, anterogradely and F, retrogradely moving 
mitochondria in the peripheral and central branches of DRG explants from naïve and injured 
MitoMice (SNI 1d, SNI 1w, SCI 4d and SCI + SNI 1w). G, Representative micrographs of peripheral 
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DRG axons of MitoMice injected with CTB-Alexa488 in the SCI site, 4 days before. CTB-Alexa488 
positive (left) and negative (right) axons are shown. Scale bar: 5μm.  
 
In DRGs, a conditioning injury leads to increased transport of lysosomes, and of 
synaptophysin- and APP-containing vesicles 
To evaluate how broad the alterations in axonal transport induced by 
conditioning lesion would be, we assessed axonal transport of lysosomes, 
synaptophysin and APP in DRGs from either naïve or conditioned animals. In 
DRGs labeled with lysotracker, whereas a conditioning injury did not alter the 
percentage of moving lysosomes (naïve: 40.1±3.0%, conditioning:  40.3±3.4%), 
the speed of transport was 1.6-fold increased specifically in the anterograde 
direction (Fig. 3A,B). In DRGs transduced with synaptophysin, similar changes 
were observed. Whereas no differences were detected in the percentage of 
moving synaptophysin-containing vesicles (naïve: 63.9±3.5%, conditioning:  
56.0±4.0%), a 1.5-fold increase in the speed of anterograde transport of 
synaptophysin was found in conditioned DRGs (Fig. 3C,D). Following APP-YFP 
transfection, a 2.2-fold increase in the number of anterogradely transported APP-
containing vesicles (Fig. 3E,G), and a 1.3-fold increase in speed of transport in 
both directions, were detected (Fig. 3F). In summary, a conditioning injury leads 
to broad alterations in axonal transport, affecting the transport of proteins, 
organelles and vesicles, particularly in the anterograde direction. 
 
Figure 3. Conditioning injury increases the transport of lysosomes, and of synaptophysin- and APP-
containing vesicles. A, Velocity of anterogradely and retrogradely moving lysosomes in naïve and 
conditioned DRGs (at least 48 lysosomes/condition). B, Kymographs of DRGs from naïve or 
conditioned (cond) animals with lysosomes labeled with lysotracker. Scale bar: 2µm. C, Velocity of 
anterogradely and retrogradely moving synaptophysin-positive vesicles in naïve and conditioned 
DRGs (at least 44 synaptophysin-positive vesicles/condition). D, Kymographs of DRGs from naïve or 
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conditioned (cond) animals transduced with synaptophysin-GFP. Scale bar: 2µm. E, Number of 
anterogradely and retrogradely moving APP-positive vesicles in naïve and conditioned DRGs. F, 
Velocity of anterogradely and retrogradely moving APP-positive vesicles in naïve and conditioned 
DRGs (at least 42 APP-positive vesicles/condition). G, Kymographs of DRGs from naïve or 
conditioned animals transfected with APP-YFP. Scale bar: 2µm. *p<0.05, **p<0.01 and ***p<0.001. 
 
Increased levels of molecular motors and of polyglutamylated tubulin can 
underlie the early increase in axonal transport elicited by a conditioning lesion 
To understand the mechanism underlying the increased axonal transport in the 
central branch of conditioned DRGs, we analyzed whether conditioning would 
elicit alterations previously associated to the control of axonal transport, namely 
in molecular motor availability and suitable microtubule tracks. In DRGs, SNI was 
accompanied by 1.5- and 1.8-fold increased RNA levels of kinesin-1B and dynein-
1, respectively, as early as 1 day following SNI (Fig. 4A). In the case of kinesin-1B, 
this increase was not sustained, but dynein-1 was still increased at 1 week 
following SNI (Fig. 4A). At the protein level, only kinesin-1 was significantly 
increased in the dorsal root 1 day following SNI but not 1 week following SNI (Fig. 
4B). The anterograde transport of cargoes can be regulated by phosphorylation of 
kinesin light chain 1 (KLC1), as increased phosphorylation leads to disruption of 
cargoes from the transport complex (Morfini et al., 2004). However, decreased 
levels of dephosphorylated KLC1 were present in dorsal roots 1 week after SNI 
(Fig. 4C), failing to explain increased anterograde transport.   
 Since tubulin modifications can alter the binding affinity to microtubules, 
we tested whether changes in tubulin in the dorsal root could explain the 
conditioning-induced transport alterations. Tyrosination of tubulin is a marker of 
dynamic microtubules and can inhibit kinesin-1 binding to microtubules (Dunn et 
al., 2008). Interestingly, increased levels of tyrosinated tubulin were found 1 day 
and 1 week following conditioning injury (Fig. 4D,E), suggesting a more dynamic 
state of dorsal root microtubules. Tubulin acetylation has been associated with 
increased anterograde transport given improved kinesin-1 binding to 
microtubules (Reed et al., 2006). However, no alterations in tubulin acetylation 
were found (Fig. 4D,F). As kinesin-1 also binds more effectively to 
polyglutamylated tubulin (Ikegami et al., 2007), this modification was 
subsequently evaluated. Indeed, 1 day following conditioning injury, 
polyglutamylated tubulin was increased in dorsal roots (Fig. 4D,G). However, this 
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alteration was not sustained (Fig. 4G). In summary, increased levels of kinesin and 
polyglutamylated tubulin can underlie, at least partially, the early increase in 
anterograde axonal transport elicited by conditioning lesion. 
 
Figure 4. Increased levels of molecular motors and of polyglutamylated and tyrosinated tubulin are 
elicited following conditioning lesion. A, qPCR of kinesin and dynein expression in DRG from either 
naïve rats or collected from rats 1 day or 1 week following SNI (SNI 1d and SNI 1w, respectively; n=7 
naïve, n=4 SNI 1d and n=7 SNI 1w). B, Representative Western blots and quantification of kinesin 
and dynein in L4,5 dorsal roots from either naïve rats or collected from SNI 1d and SNI 1w; 
n=4/group. C, Quantification of Western blots of dephosphorylated KLC in L4,5 dorsal roots from 
either naïve rats or collected from SNI 1d and SNI 1w; n=5/group. D, Representative Western blot 
analysis of tubulin in L4,5 dorsal roots from either naïve rats or collected from SNI 1d and SNI 1w; 
n=5/group. E, F and G Quantification of D. *p<0.05 and **p<0.01. 
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Discussion 
We show that besides broad changes in expression, a peripheral injury induces a 
global increase in axonal transport. Consequently, once a central injury occurs, 
any regenerative effort of the central branch can be rapidly supported. While 
increased cAMP is a central mediator of the conditioning effect (Qiu et al., 2002), 
cAMP analogs fail to reproduce its full effect (Blesch et al., 2012). Interestingly, 
cAMP is not able to increase axonal transport (Han et al., 2004). Besides, 
rolipram, a phosphodiesterase inhibitor used to increase cAMP and promote CNS 
regeneration (Nikulina et al., 2004), did not alter transport in DRGs (not shown). 
 We identified several glycolytic enzymes with increased anterograde 
transport in central axons following conditioning lesion. Interestingly, glycolysis 
is a central source of energy for vesicle transport (Zala et al., 2013). Besides, 
transport of cytoplasmic proteins in SCb occurs through intermittent association 
to membrane-bound vesicles (Tang et al., 2012). Thus, the higher abundance of 
glycolytic enzymes, together with the increased transport of vesicles following 
conditioning lesion, may explain the increased transport of axonal proteins here 
identified.  
 Our approach allowed the identification of transported putative 
regeneration enhancers, such as 14-3-3 and RhoGDI. Supporting its relevance 
during axonal growth, 14-3-3 regulates axon guidance during development (Kent 
et al., 2010). Similarly, RhoGDI may be critical to regenerating axons as it inhibits 
RhoA, a central mediator of growth cone collapse (Sasaki and Takai, 1998). 
Surely, other proteins identified remain as interesting candidates to evaluate 
during axonal regeneration. 
 Molecular motors and polyglutamylated tubulin were increased in the 
dorsal root shortly after a peripheral lesion. As these effects were transient, the 
sustained increase of axonal transport at later time points remains to be 
explained. After conditioning lesion, the levels of tyrosinated, likely dynamic 
microtubules, were persistently increased. A precise control of microtubule 
dynamics is needed to optimize axon regeneration. Indeed, PNS neurons require 
decreased microtubule stability in the growth cone to regenerate (Cho and 
Cavalli, 2012). Hence, persistent alterations in microtubule stability might explain 
some of the effects observed.  
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Our work stressed that understanding the intersection between injury-
induced signaling and axonal transport is an important aspect to consider. In 
summary, we propose that a broad increase in axonal transport is a major player 
during axon regeneration. 
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General conclusion and future perspectives 
 
SCI is a severe condition that usually results in loss of sensitive and motor 
function, as well as autonomic functions, culminating in lifetime medical care, as 
the available treatments are limited. As such, the development of novel therapies 
that may lead to improvements in the patient quality of life are needed. For that, 
our basic knowledge on both extrinsic and intrinsic mechanisms controlling axon 
growth and regeneration need to be expanded. 
Initially, the limited regeneration of CNS axons was attributed mainly to the highly 
inhibitory environment formed following SCI. Upon injury, the glial scar functions 
as a physical barrier, but also as a biological barrier, since it contains numerous 
axonal regeneration inhibitors, namely myelin proteins and CSPGs. We were able 
to identify novel axonal regeneration inhibitors present in the injury milieu. 
Specifically we determined that besides myelin proteins, myelin lipids are able to 
inhibit axonal growth, particularly cholesterol and sphingomyelin. The use of 2-
hydroxypropyl-β-cyclodextrin, a drug capable of sequestering cholesterol and 
sphingomyelin, in vivo, allowed increased axonal regeneration of dorsal column 
fibers following spinal cord hemisection. It will be interesting to determine now 
whether 2-hydroxypropyl-β-cyclodextrin is able to promote axonal regeneration 
of other axonal tracts and to produce functional recovery. 
Although several studies have shown improved axonal regeneration by blocking 
inhibitors present in the glial scar, such results are still shy from a major effect 
that could be translated to clinical trials. Recently, modifying the intrinsic ability 
of CNS neurons emerged has an interesting target to promote regeneration. While 
PNS neurons are able to mount a strong regenerative response following injury, 
CNS neurons usually fail to produce such response. A key aspect of the ability of 
PNS neurons to respond to injury is the generation of injury signals upon lesion. 
Whether these signals are present following a CNS injury is not known. Here, we 
used the dorsal root injury as a model of CNS injury, since it produces only a mild 
response to injury and does not result in axon regeneration. Surprisingly, ERK, 
JNK and STAT-3, the best described injury signals in the PNS, were also activated 
and retrogradely transported following dorsal root injury. To identify possible 
differences in the injury signaling mechanism following peripheral and dorsal 
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root injury, we used an antibody microarray to analyze the axoplasm content 
upon each lesion. We were able to determine that a dorsal root injury elicits the 
differential activation of signaling molecules. From these, ROCK-II and Hsp-40 
were increased following dorsal root injury whereas GSK3β was decreased after 
sciatic nerve injury. ROCK-II and GSK3β are known inhibitors of axonal 
regeneration. Our results, especially for ROCK-II, suggest that following dorsal 
root injury besides transport of positive injury signals, there is also the transport 
of signals that may repress regeneration. Hsp-40 has been associated with 
protection in neurodegenerative diseases. Its knock down in neurons showed 
signs of toxicity, suggesting that the increase in Hsp-40 following dorsal root 
injury is probably not a direct player in the regenerative process but instead, 
participates in protection mechanisms. 
The conditioning injury model has been extensively used to dissect the increase 
in the intrinsic ability triggered by a peripheral injury. By in vivo radiolabeling we 
identified newly synthesized proteins that are anterogradely transported upon 
conditioning injury. From these, several potential novel RAGs were identified, 
from which we were able to validate RhoGDI and 14-3-3 as playing a role in 
neurite outgrowth. There are certainly other candidates identified in our 
screening that are worth studying in the context of axon growth and 
regeneration. 
Furthermore, our data demonstrated that a conditioning lesion elicited the 
transport of newly synthesized proteins, organelles and synaptic vesicles. These 
transport alterations were independent of motor levels, however the changes 
observed in microtubule post-translation modifications, such as tyrosination and 
polyglutamylation could at least in part explain the increased axonal transport. At 
this stage, the molecular mechanisms controlling the increased transport should 
be further dissected. Although the levels of the motors are similar, following 
injury is there an increase in the percentage of motile motors? Is the increased 
transport due to higher run lengths and decreased pauses among run lengths? 
Does tyrosination and polyglutamylation increase motors binding and transport? 
Answering these questions could help to further understand the mechanisms that 
participate in improving axonal transport. Besides, whether increased axonal 
transport is a general feature of conditions where increased axonal regeneration 
occurs, as is the case for instance in PTEN and SOCS-3 KO mice, should be further 
investigated. Combined, this knowledge may allow the future targeting of the 
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transport machinery as a means of promoting axonal regeneration. Also, it would 
improve treatment of several neurodegenerative diseases where defficient axonal 
transport is present. 
In summary, we were able to identify novel extrinsic cues that can impair axonal 
growth such as cholesterol and sphingomyelin, but also novel mechanisms that 
can contribute to increase axonal regeneration following conditioning injury, 
namely a robust increase in axonal transport of proteins, mitochondria and 
vesicles. 
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